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It has recently been shown that intensive prophylactic dietary and 
environmental control measures during early infancy may reduce the incidence 
and/or postpone the onset of atopic disease. 
In order to institute this prophylactic regime, early identification of the 
infants genetically 11 at risk 11 for atopic disease is essential, since 
sensitisation begins at birth, or even during intra-uterine life. 
European and Scandinavian studies have shown that a raised concentration of 
cord blood serum immunoglobulin E (CBsigE) is an excellent predictive marker 
for the subsequent development of atopic disease. Other potential predictive 
atopic markers such as cord blood eosinophils, platelets and anti-cow's _!llilk 
serum IgG have also been suggested as having possible predictive relevanc~ for 
newborns in terms of the development of subsequent atopic disease. 
PROBLEM DEFINITION 
Most of the work in this field has been done on Caucasian neonates, in 
Westernised, First World countries. In South Africa, it has been shown that 
the Black adult ethnic group has serum irrmunoglobulin E concentrations (sigE) 
which are significantly higher than that found in the South African White 
adult ethnic group. Furthermore, it has been suggested that the elevated sigE 
in the adult Blacks may be raised independently of allergic disease. It is, 
therefore, important to ascertain whether this elevation of sigE in Black 
South African adults is evident already at birth in the cord blood sera of 
Black South African newborns. If so, it is imperative to ascertain whether 
any such elevation is reflective of a high genetic load for atopy in these 
Black newborns, and furthermore whether these Black newborns are consequently 
11 high-risk 11 for the development of subsequent atopic disease, as has been 
previously reported in the literature fo"r White newborns. Arising from an 
awareness of these specific South African prob 1 ems, the following hypothesis 
was developed. 
HYPOTHESIS 
The hypothesis states that: 
11 Black South African newborns without an atopic family history (aFH) have 
significantly higher CBslgE values than similar White and Mixed newborns. An 
aFH does not influence the CBsigE values in the Black newborns, as it does in 
the White and Mixed newborns. The CBsigE values in Black newborns are not, 
furthermore, predictive for the development of subsequent atopy in infancy, as 
they are in the other ethnic groups 11 • 
A description of the three South African ethnic groups considered in this 
study is provided in Section IV, (Pg. 74). 
AIMS OF THE STUDY 
The aims of the study were three-fold: 
: 
1. To test the hypothesis. 
2. To assess the relevance of alternative cord blood markers (eosinophils, 
platelets and anti-cow's milk serum IgG) as predictive atopic markers in 
each of the three ethnic groups. 
3. To provide epidemiological information with regard to genetic and 
environmental influences on CBslgE, cord blood total eosinophil counts 
(CBTEC's) cord blood platelet counts (CBPlC's) and cord blood anti-cow's 
milk serum IgG concentrations (CBacmlgG). 
STUDY DESIGN 
In order to achieve these aims, a cross-sectional study to investigate the 
cord b 1 ood markers with respect to genetic and environmenta 1 influences on 
their values (Phase I) and a prospective longitudinal follow-up study to 
document the development of atopic disease in the newborns during infancy and 
to relate this clinical information back to the cord blood marker values 
(Phase II) was designed. Fifty three Black, 52 White and 58 Mixed 
consecutively selected full-term newborns born in the Cape Peninsula of South 
Africa were admitted to the study. 
RESULTS 
Tne study confirmed tne hypotnesi s Dy proving tnat tne Black newborns without 
an aFH nad significantly higher CBsigE values tnan their White and Mixed 
counterparts. It snowed also tnat, wnile an aFH significantly influenced tne 
CBslgE values in the White and Mixed newborns, definitive evidence for tnis 
effect on the Black newborns was not possible owing to tne small number of 
Black newborns with an aFH (5 cases). Furthermore, the study showed that tne 
CBsigE values in the Black newDorns who developed atopy during infancy were 
1 ower than in those who remained hea 1 thy, a 1 though this diff ere nee was not 
significant. In the White and Mixed newborns, the CBsigE in those wno 
developed atopy during infancy were significantly higner than in those who 
remained nealthy, confirming the conclusions of the previously published 
literature in this field. The study also demonstrated a high degree of atopic 
sensitisation in tne Black infants, thereby contradicting previously published 
opinion as to the low incidence of atopy in this ethnic group. 
Tnis study also provided information as to tne atopic and predictive relevance 
of alternative cord blood markers (CBTEC, CBPlC and CBacmigG). With the 
exception of the CB TEC in the Black newDorns, no otner marker showed any 
promise as a potential predictive atopic marker in the South African context. 
Epidemiological data as to the effect of genetic and environmental influences 
on all of the four cord blood markers studied was provided. 
CONCLUSION 
In the Black South African ethnic group, it was shown that genetic and 
environmental factors are at play which prevent the clinical use of CBsigE as 
a predictive atopic marker for the development of atopic sensitisation during 
infancy. Furthermore, among the 47.2% sample of Black infants that were 
followed for one year, atopic sensitisation occurred in a higher proportion 
than tneir White and Mixed counterparts. In the case of the White and Mixed 
newDorns, we confirmed tne conclusions of the previously published literature 
on the relevance of raised concentrations of CBsigE as a predictive atopic 
marker. None of the otner 3 cord blood markers studied were unequivocally 
effective in predicting the development of atopic sensitisation during infancy 
in the Black newborns. 
NOTE: The literature quoted in this tnesis has Deen reviewed up until 
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GLOSSARY OF TERMS 
That genetic effect which is not obviously related 
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racial factors. 
That genetic effect which finds express ion through 
immunological mechanisms. 
SECTION I 
INTRODUCTION, PROBLEM DEFINITION, HYPOTHESIS AND AIMS OF STUDY 
CHAPTER I INTRODUCTION 
1 .1 PRINCIPLES OF THE PREDICTION AND PREVENTION OF ATOPIC DISEASE 
Various studies have confirmed the impression that the incidence of 
atopic disease has increased in recent decades (Glaser, 1966; 
Kishimoto et al, 1980; Denis et al, 1984; Turner et al, 1984). Tnis 
trend has focussed much of the current ongoing research effort onto 
the estaolishment of methods designed to prevent or modify the 
development of the allergic response. 
During the past decade, researchers from predominantly Fi rs t World 
European and Scandinavian countries have produced evidence to 
suggest tnat the 11 high-allergic-risk 11 newborn may be identified at 
birth (i'1ichel et al, 1980b; Kjellman, 1982a; Duchateau and Casimir, 
1983; Kjel 1 man and Croner, 1984). This concept has encouraged the 
early application of preventive measures for atopy to the newborn and 
young infant, before atopic sensitisation can occur (Frick, 1985; 
Michel et al, 1986; Haus, 1987). 
The postponement of allergic disease in infancy per se appears to be 
associated with a decrease in the severity of any ensuing disease in 
adults (Bjorksten, 1983). Severe asthma, as well as other forms of 
allergic disease in childhood, are often preceded by eczema in 
infancy (i~atthew et a 1, 1977). It has therefore seemed appropriate 
to suggest that any methods aimed at preventing or even delaying tne 
onset of infantile allergic symptomatology should be encouraged 
(Businco and Cantoni, 1984). 
Since the beginning of this century, botn anecdotal and scientific 
reports Degan to associate distinctive feeding methods in infancy 
with the development of infantile atopy. The concept of allergy 
prevention grew out of a realisation that manipulation of critical 
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dietary, environmental and non-specific measures in infancy could 
delay or prevent the onset of subsequent atopic disease. Talbot, in 
1918, was one of the first modern-day allergists to appreciate the 
effect of diet on allergic symptoms in infants. He reported on the 
apparently causal relationship between the development of eczema in a 
3 week old breast fed neonate and the ingestion of a large amount of 
chocolate by the mother. Subsequently, specific dietary measures in 
infancy for the prevention of atopic disease have been advocated by 
numerous workers. These measures include prolonged or exclusive 
breast feeding (Grulee and Sanford, 1936; Saarinen et al, 1979; Juto 
et al, 1982), the delayed introduction of potentially allergenic 
solid foods (Saarinen et al, 1979a; Fergusson et al, 1981) and the 
avoidance of cow's milk protein (Glaser and Johnstone, 1952; Glaser 
and Johnstone, 1953; Duchateau and Casimir, 1983). 
Environmental manipulation, including the avoidance of aero-allergens 
(Matthew et al, 1977) and non-specific enhancing factors for allergy 
such as parental smoking (Kjellman, 1981; Bjorksten and Ahlstedt, 
1984) and respiratory viral infections (Frick, 1981; Welliver et al, 
1981) has also been advised. 
A delay in the administration of the Bordetella Pertussis vaccination 
in infancy (Frick, 1985; Haus et al, 1988a;) because of its adjuvant 
effect on the stimulation of the slgE response (Kjellman, 1982a; 
Bjorksten and Ahlstedt, 1984), and the avoidance of the pollen or 
spring season as the projected season of birth for the potentially 
11 high-allergic-risk 11 newborn (Bjorksten and Suoniemi, 1976; Bjorksten 
et al, 1980; Saarinen et al, 1982) are additional preventive measures 
which have received consideration. 
Even though the efficacy of some of these preventive measures, such 
as the role of exclusive breast feeding in infancy have been 
questioned (Halpern et al, 1973; Lindfors and Enocksson, 1988), 
Kjellman (1982a), in a comprehensive review of the evidence, reached 
the conclusion that the effective implementation of preventive 
measures in infancy reduced the incidence of early developing atopic 
disease. 
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It consequently seems justifiable to advocate the rigid 
implementation of preventive measures for all those newborns who are 
seen to be 11 high-risk 11 for the development of atopy, in spite of the 
considerable cost in terms of the time and effort involved in the 
effective implementation of the prophylactic regime. Because of 
these inherent difficulties, this regime should be reserved only for 
the 11 high-allergic-risk 11 infant (Michel et al, 1980a) and mother. 
The fundamental presumption and rationale of both the prediction of 
the 11 high-allergic-risk 11 pregnancy and newborn, as well as the 
prevent ion of subsequent a topic symptomatology in this subpopulation 
is based on immuno-genetic principles. The central concept is one of 
vigorous and total allergen avoidance in order to prevent atopic 
sens iti sat ion of the 11 h igh-ri sk 1i, genetically predisposed foetus and 
infant (Bazaral et al, 1971; Kjellman, 1982a; Lehrer et al, 1982) who 
experiences a transient, vulnerable period of p~imary 
immuno-incompetence (Soothi 11, 1976; Matthew et a 1, 1977; Bjorksten, 
1983) during the period from conception through early infancy. This 
immuno-incompetence is associated with a failure of T-suppressor cell 
function (Bjorksten and Juto, 1983a; Bjorksten and Juto, 1983b; Geha, 
1984), which in turn leads to discriminatory effects on various cord 
blood atopic markers at birth (Michel et al, 1980; Kjellman and 
Croner l 984) • 
The identification of the 11 high-allergic-risk 11 pregnancy needs to 
occur before, or as soon as possible after, conception in order to 
allow the mother to practice adequate ante-natal prophylaxis in terms 
of the modification of her diet. The human foetus is able to produce 
IgE from the 11th week of gestation (Miller et al, 1973; Singer et 
al, 1974). It has, furthermore, been shown that the unborn foetus is 
able to mount an intra-uterine allergic response to various allergens 
which are presumed to have crossed the materno-foetal placental 
barrier (Levine et al, 1971; Kuroume et al, 1976; Michel el at, 
1980a). The elimination of highly antigenic foods from the maternal 
diet before this stage is therefore advisable (Frick, 1985). Since 
atopic disease has been shown to be hereditary (Cooke and Van der 
Veer, 1916; Van Arsdel and Motulsky, 1959; Orgel et al, 1975), the 
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11 high-allergic-risk 11 pregnancy may be identified by an adequate 
obstetrical history which focuses on the presence or absence of atopy 
in the prospective mother, her husband and her existing children. 
Kjellman (1977) has laid down clear probability guidelines for the 
risk of atopic development in children born with an atopic family 
history (aFH). By incorporating these probability guidelines into a 
simple 11 rule of thumb 11 known as the Family Score System (Kjellman, 
1982), Kjellman allows the identification and prediction of the 
11 high-allergic-risk 11 pregnancy on the basis of the family history of 
the prospective newborn. In these index cases, the mothers are 
advised to practice ante-natal allergy prevention. 
During the delivery of the newborns, it has become possible to 
substantiate the suspicion of the 11 high-allergic-risk
11 pregnancy by 
monitoring the concentration of various cord b 1 ood a topic markers 
(Kjellman, 1982; Kjellman, 1982a; Hattevig et al, 1984; Haus, _1~87). 
The definitive identification of this 
11 high-allergic;risk 11 
subpopulation at birth will further indicate which newborns are 
candidates for the rigid preventive measures which have been 
advocated in infancy. 
1.2 IDENTIFICATION OF POTENTIAL CORD BLOOD ATOPIC MARKERS 
Many different immunological, haematological and biochemical 
substances inter-react in the cascade of events constituting the Type 
I anaphylactic or allergic response (Cohen, 1983). 
Some of these substances are eminently quantifiable in the cord blood 
of newborns, and constitute possible prognostic and predictive 
markers for the subsequent development of atopic disease. 
By definition, those markers with a predictive function for the 
development of future atopic symptomatology should be readily 
identified in the cord blood of newborn babies (Bousquet and Michel, 
1984). 
Four cord blood markers with varying degrees of documented atopic and 
predictive relevance will be assessed in this study. They are: 
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(i) Immunoglobulin E 
(ii) Eosinophils 
(iii) Platelets 
(iv) Anti-cow's milk Immunoglobulin G 
The rationale for the proposal that these cord blood markers have 
atopic and predictive relevance for the development of subsequent 
atopic disease is given in Section III. 
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CHAPTER 2 DEFINITION OF THE SOUTH AFRICAN PROBLEM 
2.1 SOCIO-CULTURAL AND ENVIRONMENTAL VARIATIONS IN THE PREVALENCE OF 
ATOPIC DISEASE 
Population variations in respect of the prevalence of atopic disease 
have been well described. In general, the published studies have 
suggested that childhood atopy is significantly less prevalent in 
developing, Third World traditional or rural co111nunities than in 
Westernised, First World or urban co1J111unities. 
Wesley et al (1969), in a South African study, found that all 5 Black 
children admitted to a Durban hospital for asthma were from an urban 
environment, and were children of professional, higher social class 
parents who had probaoly adopted many characteristics of the Western 
life-style and culture. -
Godfrey (1975), in a study in the North-West African state of The 
Gamoia, found no cases of asthma in 231 randomly selected rural 
school children and adults, while 44 astnmatics were easily 
identified in the urban environment of the capital town of Banjul. 
Merrett et al (1976), in a comparative study between urban and rural 
African populations in Rhodesia (now Zimbabwe), easily identified 80 
asthmatics in the city of Salisbury (Harare). Of the rural sampling 
of 100 suojects, none, however, presented with evidence of allergic 
disease, in spite of the fact that their serum IgE mean 
concentrations were significantly higher, at 1,613 U/ml, than their 
urban asthmatic counterparts (799 U/ml). This apparent anomaly was 
ascrit>ed to tne high degree of filarial parasitism in the rural 
population. 
Van Niekerk (1979), in a similar study of 671 rural tribal and 694 
urban Xhosa children between 6 and 9 years of age in South Africa, 
reported a rural prevalence rate for asthma of 0,14% (one patient 
only). The corresponding urban rate was 3,17%. 
Further studies reflecting a difference in the preva 1 ence of atopi c 
disease between urban and rural communities have recently been 
published by an Australian research group doing work in Papua, New 
Guinea (Dowse and Turner, 1986; Turner et al, 1986). 
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A socio-cultural and environmental differentiation in the prevalence 
of atopic disease is therefore evident within similar ethnic groups. 
Various explanations for this low rural prevalence rate have been 
proposed. These suggestions include the protective effects inherent 
in the persistence of traditional feeding methods such as breast 
feeding (Van Niekerk, 1979), the relative dearth of environmental 
aero-pollution together with the absence of the house-dust mite in 
rural tribal communities (Van Niekerk et al, 1984) and the high 
incidence of parasitism in rural societies. Parasitisation induces 
high concentrations of anti-parasite specific serum IgE 
concentrations in these communities (Godfrey, 1975; Merrett et al 
1976; Turner, 1980). It has been suggested by these workers that 
anti-parasite specific IgE may saturate the mast cell IgE-receptors, 
thereby blocking these receptors for specific, more ubiquitous, 
antibody binding. This presupposes that parasite-induced IgE:. is 
multispecific and shares common antigenic determinants with the=more 
ubiquitous anti gens. Turner et al ( 1984) go on to suggest that the 
high incidence of rural parasitosis may also suppress the host's 
ability to produce more harmful specific IgE antibodies. 
Not all authors share consensus on the protective effect of 
helminthiasis. Joubert et al (1979) for example, are of the opinion 
that Ascariasis may, in fact, predispose the host to allergic 
disease. Whatever the reasons, rural populations have been 
relatively spared from atopic disease. It has, however, been 
suggested that, once the traditional life-styles of these rural 
populations become modified, either because of their migration to 
neighbouring urban environments, or because of the evolutionary 
Westernisation of their cultural habits, a dramatic increase in the 
prevalence of atopy may be noted. Merrett et al (1976) found 
specific IgE antibodies in a fair number of their healthy rural 
African sampling. They suggest that this would indicate an increased 
susceptibility for the development of atopic disease if the rural 
subjects were to move into urban areas. An analogous situation 
seemed to be at play, he noted, when African and Asian inunigrants to 
Great Britain commonly became readily sensitised to grass pollen or 
Dermatopygoides pteronyssinus. 
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socio-cultural and environmental variations in the 
of atopic disease, ethnic differences per se have been 
This is not unexpected since it seems that both the 
hereditary nature of atopic propagation (Cooke and Van der Veer, 
1916; Van Arsdel and Motulsky, 1959) and the reaginic antibody 
response (Benacerraf and McDevitt, 1972; Marsh et al, 1981) are under 
genetic control. 
In the South African context, the White and Mixed ethnic groups have 
the highest prevalence of atopy. The Black ethnic groups have by far 
the lowest atopic prevalence. These conclusions have been the result 
of the following studies: 
Wesley et al (1969), in a South African study conducted at a Uurban 
hospital between 1963 and 1967, found that Black asthmatics accounted 
for only 0,02% of the total medical admissions, while White 
asthmatics accounted for 0,79% of the total medical admissions. 
During this period there were 24,731 Black and 5,313 White medical 
admissions to the hospital. 
Orren (1974), in an inter-ethnic comparative study of adult blood 
donors in Cape Town, South Africa, found that, while 17,5% of White 
subjects gave a positive family hi story of atopy, only 8% of Mixed 
subjects and 7,5% of Black subjects gave a similar history. 
In a similar inter-ethnic study of serum IgE concentrations in a Cape 
Town allergy clinic, Orren et al (1975) found 37 White, 62 Mixed but 
only 7 Black patients. 
Walls and Ordman (1983), in a further prospective study of asthmatic 
patients in a Cape Town allergy clinic, found 148 White, 158 Mixed 
and only 8 Black patients. The possibility that the low Black 
representation could have been an artificially low reflection of a 
realistically higher figure because of extraneous logistical causes 
such as transport or referral inadequacies was discounted. The other 
outpatient clinics at the same hospital had a predominance of Black 
patients during the same period. 
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In 1984, the statistical analysis of specialist out-patient 
consultations at the Red Cross War Memorial Children's Hospital in 
Cape Town (Annual Report, 1984) revealed the following information. 
Of the 29,764 consultations, 7,087 (23,8%) were for atopic problems. 
However, only 91 (1,3%) of these atopic consultations were with Black 
children, even though the total number of Black patients visiting the 
hospital for all medical conditions in the same period was 25% 
(38,114 of 152,456 patients). 
Significant ethno-genetic influences on the prevalence of atopy in 
South Africa appear, therefore, to be at play, with the Black group 
manifesting markedly less atopy than the White group. This fact 
needs to be taken into consideration in any inter-ethnic allergy 
study in South Africa, not only to allow for this variable in the 
formulation of any conclusions, but also to encourage the 
realisation that individualised guidelines may need to be given- for 
each ethnic group. ~ 
2.3 ETHNIC VARIATIONS IN TOTAL SERUM IMMUNOGLOBULIN E CONCENTRATIONS 
The normal ranges of immunoglobulins belonging to the classes G, A 
and M have been shown to vary in different population and ethnic 
groups in different countries (Buckley et al, 1968; Johansson et al, 
1968; Rowe, 1972). Within South Africa, differences in these 
immunoglobulin classes between the Black and the White ethnic groups 
have been described in adults (Milner and Ca 1 itz, 1971; Shulman et 
al, 1975), children (Shulman and Gilich, 1976; Roode, 1980) and 
newborns (Van Rijswijk et al, 1985). In most cases, the Black or 
Negroid ethnic groups have the highest normal values, when compared 
to the White or Caucasian groups. Milner and Calitz's study (1971) 
showed that healthy Black male adults had 40% more IgG, 30% more IgA 
and 32% more IgM than their White counterparts. 
Bazara 1 et a 1 ( 1974) have suggested that the inter-ethnic variations 
described in serum immunoglobulin levels may indicate a genetic 
effect on the levels of immunoglobulins in general. It has been 
generally perceived that the relative hyperga11111aglobulinaemia, as 
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manifested by the Black races, is an indication of a natural 
selective irrrnune advantage which they enjoy over other races. It has 
been brought into play over the centuries as part of their 
evolutionary development. This function has facilitated their 
survival against the ravages of microbial, parasitic and protozoan 
infestations so prevalent in many primitive African societies (Orren 
and Dowdle, 1975a; Joubert et al, 1979; Lehrer et al, 1982). 
Much of this phylogenetic advantage appears, however, to be redundant 
today, both because of the rapid Westernisation of the tra9itionally 
tribal life-style of the Black African races, and because of the 
effective chemical and pharmaceutical control of many of these 
hitherto life-threatening infections. 
2.3. 1. Ethnic variations in adult, childhood and infant serum irrrnunoglobulin 
E concentrations 
:: 
Ethnic variations in total sigE in adults, children and infants have 
likewise been documented in many parts of the world. This work is 
summarised in (Table I.1). 
Johansson et a 1, in 1968, showed that Ethiopian children had slgE 
concentrations many times higher than White Swedish children. 
Orgel et al, in 1974, similarly showed that American-born Filipino 
children had sigE values which were significantly higher than their 
age-matched White counterparts. 
Grundbacher (1975) compared sigE concentrations between American 
Whites and American Blacks. Mansfield et al (1978) also compared 
s I gE in these ethnic groups, but inc 1 uded American Japanese. The 
Blacks and the Japanese had significantly higher sigE than the Whites 
in both studies. 
Gerrard in 1976, similarly reported on sigE levels which were 
significantly higher in the Canadian Metis Indian population than 



























































































































































































































































It should be noted that these studies comprised unselected 
individuals. They may therefore have included those with atopic 
disease and helminth infestation, both of which influence sigE 
independent of ethnicity. Moreover, the incidence of both of these 
variables differ markedly in the various ethnic groups compared. In 
Johansson 1 s study, exclusion of those Ethiopian children with obvious 
Ascaris Lumbricoides infestation still, however, emphasised a marked 
ethnic difference between them and their Swedish counterparts 
(Johansson et al, 1968). It is important to appreciate the fact that 
direct comparison of the sigE values between the different studies is 
not adv i sab 1 e because of the different 1 aboratory methods used for 
the sigE immunoassays. This could be the explanation for the marked 
difference observed in the geometric mean sigE between the White 
Canadian and the White American populations in Gerrard's (1976) and 
Grundbacher 1 s (1975) study (Table I.1). The RIST technique, used by 
Grundbacher, is well known to produce higher results than the P_RIST 
technique, particularly with levels below 60 u/ml (Johansson et= al, 
1976). 
Ganju et al (1979) are of the opinion that environmental factors are 
more important than racial factors in explaining the differences in 
sigE observed between the ethnic groups. They determined the sigE 
in 115 healthy, non-atopic North American Black children living in 
Chicago, and found that their values approximated that of previously 
reported American Caucasian values, while being much 
previously reported African Black values. His study 
lower than 
was we 11 
designed, in that he excluded any observations which may have been 
biased by the presence of atopy, helminth infection or a family 
history of atopy. The environmental influence on sigE will be 
addressed again later in this chapter. 
In the South African context, clear ethnic differences, both in an 
unselected sampling of adult blood donors (Orren and Dowdle, 1975), 
and in a selected sampling of non-allergic adult blood donors (Orren 
et al, 1975) have been described (Table I.2). In both studies, the 
Black group had the highest sigE followed by the Coloured (Mixed) 
group. The White group had the lowest values. Of interest was their 
observation that the presence or absence of atopic disease seemed to 
have no significant effect on the high values of sigE in the Black 
group. 
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In contrast, however, the presence of atopic disease in the White and 
Coloured (Mixed) groups significantly influenced their sigE values, 
tending to obscure the influence of race on this measurement. These 
observations led the authors to conclude that, while a raised sigE is 
of undoubted benefit in terms o~ the diagnostic benefit for atopic 
disease in the South African White population, it is of "little value 
in the assessment of (South African) Black patients for allergic 
disease". 
Heese et al (1984), in a study of 237 unselected Mixed and Black 
infants in the rural environment of Rehoboth, Namibia, found sigE 
values which were significantly higher than previously reported 
values in age-matched studies reported from Western countries. It 
was thought that this difference was probably on the basis of 
ethnicity per se, since the populations studied were of the 
well-defined Mixed Baster and Black Nama ethnic groups. ~tool 
samples were, however, not examined for evidence of helminth 









not be excluded. 
found in the 
concentrations between the Baster and the Nama groups. 
No 
sigE 
The function of this evidently non-specific elevation of sigE in the 
Black races is still largely speculative. It has been shown, both in 
animal studies (Levine and Vaz, 1970; Katz, 1978; Binaghi, 1980; 
Marsh et al, 1981; Ishizaka, 1982), and in humans (Croner et al, 
1982; Kjellman and Croner, 1984) that genetically predetermined "high 
and low IgE responders" occur in the population. The group of high 
slgE responders tend both to maintain a higher level of sigE 
throughout life and also to become sensitised more readily than the 
group of low IgE responders. Kjellman et al, (1976) have suggested 
that patients with elevated sigE concentrations, in whom no obvious 
atopic symptoms could be found, could be good reagin producers who 
lack an organ target factor, similar to the situation where an 
increased bronch ia 1 hyperactivity exists in asymptomatic asthmatics. 
Kay (1979; 1980) has suggested that the 
IgE-mastcell-complement-eosinophil system forms a complex 












































































































































l~ansfield et al (1978), in attempting to rationalise the significant 
differences in racial elevations of sigE as found in their study, 
likewise implicated helminthotoxic mechanisms in their argument. 
They suggested that populations which were historically resident in 
areas where parasitic infestation is endemic would experience strong 
selective pressures over a prolonged period of time for the evolution 
of an effective anti-parasitic hyper-immune sigE response. He 
suggested that the survival-value inherent in such a response could 
be likened to the phenomenon of the sickle cell gene phylogenetic 
mechanism. Both of these responses seem to have persisted long after 
their survival advantage has diminished. 
Experimental evidence from work in inbred strains of rats supports 
the concept of a selective survival advantage inherent in the rats 
with a high baseline sigE (Bazin and Pauwels, 1982). Those strains 
which normally had low baseline sigE values had weak reagjnic 
responses. In contrast those strains with normally high sigE vaJues 
developed powerful reag1n1c responses on stimulation with most 
allergens (Rousseaux-Prevost et al, 1977; Pauwels et al, 1979). 
The endemic nature of parasitism in Africa could therefore explain 
the retention of the non-specific high IgE responder phenotype in the 
phylogeny of the Black African races. This effect, moreover, seems 
to be unrelated to the pathophysiology of the atopic response. The 
statement by Kjellman et al (1976) that "a child found to have a high 
IgE level is very likely to have or soon to develop a clinically 
significant atopic allergic disorder" is an oversimplification of the 
status quo in African countries, and may be relevant only for First 
World White populations. 
Ethnic variation in cord blood serum immunoglobulin E concentrations 
The documentation of normal reference values for newborn and cord 
blood sigE in various population groups has been the subject of many 
studies (Table I.3). 
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Direct comparisons of the published CBsigE geometric mean values are 
essentially misleading for various reasons. Firstly, it is 
well-known that a family history of atopy is associated with raised 
concentrations of cord blood serum IgE concentrations in First World, 
White newborns (Orgel et al, 1975; Kjellman and Johansson, 1976; 
Michel et al, 1980; Croner et al, 1982). Secondly, Weil et al (1983) 
have snown tnat increased CBsigE concentrations may be the result of 
maternal helminth infestation. Differences in both the study design 
and tne inclusion criteria of the various samplings are therefore 
important reasons for differences in the published values of CBsigE. 
Furthermore, differences in the assay methods employed in tne 
measurement of the samples, as well as differences in laboratory 
tecnnique and co-efficients of error need to be taken into 
consideration when assessing such sensitive results. Differences in 
assay sensitivity and minimum detection limits in the various studfes 
make comparisons equivocal. : 
Immunoglobulin E is, moreover, present in very low concentrations in 
the serum (1/50,000 of the IgG concentration in serum - Grundbacher, 
1975). Cord blood serum usually contains exceptionally low 
concentrations of sigE and requires highly sensitive methods of 
determination (Kjellman, 1982) such as the PRIST technique (Ceska and 
Lundkvist, 1972). This method has proved superior to the RIST 
technique, especially for the low ranges measured in cord-blood 
(Johansson et al, 1976). Thomas et al (1979) nave suggested that 
more sensitive techniques of assay are needed to establish reliable 
and accurate ethnic or population differences in epidemiological 
studies of this nature. Kimpen et al, (1987) have recently reported 
on a series of newborns where they assayed CBsigE using a metnod with 
a detection limit of 0.01 IU/ml. The method they used for this assay 
was, nowever, an ELISA technique, and not the PRIST. 
An awareness of the limitations inherent in making a relevant 
comparison of tne CBsigE concentrations in Table I.3, will give 
perspective to such a comparison. Relatively higher geometric mean 





























































































































































































































































































































































































on by Ganju et al (1979) and Magnusson (1984) compared with the White 
CBsigE values as reported by Magnusson (1984) and Kjellman et al 
(1976). These assays all used the PRIST technique. Kjellman's 
series was selected to include, however, only those newborns who had 
no family history for atopy and who did not develop any suspected 
atopic symptomatology at follow-up. Thomas et al's (1979) Black 
sampling had CBsigE values similar to Kjellman's White sampling. He 
admitted, however, that the standard curve of his PRIST assay was 
insensitive below values of 0,5 u/ml and that assay methods with more 
sensitive detection limits should be used in studies of this nature. 
Kimpen et al (1987) have recently published their data on CBsigE 
measured in a series of 5353 newborns in Belgium. These newborns had 
a heterogeneous ethnic parentage. Seventy four percent of these 
newborns had two Belgian parents, while 15% had two immigrant 
parents, either from Southern Europe or North Africa. Ten percent 
had parents of Mixed origin. They found, however, no signif~cant 
difference in the CBslgE values between the newborns of the diffe;ent 
ethnic origins. 
2.4 SUMMARY OF THE SOUTH AFRICAN PROBLEM 
In summary, it appears that the Black adult South African ethnic 
group, in contrast to the White adult South African ethnic group, has 
inappropriately high concentrations of IgE. These values appear to 
be non-specifically elevated, and unrelated to the presence of atopic 
disease. 
It is not unreasonable to speculate as to whether a similar 
non-specific ethno-genetic elevation may occur in the cord blood sigE 
of Black newborns. If such an elevation in Black CBslgE values is 
shown, furthermore, to be unrelated either to a family history for 
atopy or to the development of future atopic symptomatology in the 
newborn, then the use of CBsigE concentrations has little value as a 
predictive atopic marker in the Black South African ethnic group. 
This finding would contradict the statement by Hattevig et al (1984) 
that "high concentrations of IgE antibodies are almost exclusively 
seen in infants with atopic disease". This conclusion was reached 
because all of the newborns in their study with elevated CBsigE 
values above 1,2 kU/1 subsequently developed atopic disease. 
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It should be emphasised that the rapid urbanisation and 
Westernisation of the South African rural Black could enhance the 
risk of sensitisation 
( Merrett et a 1, 1976). 
in this previously non-atopic population 
This possibility emphasises the need for the 
documentation of effective and reliable predictive cord blood markers 
for Third World multi-ethnic populations. It is possible that 
alternative cord blood atopic markers, such as eosinophils, platelets 
or anti-cow's milk IgG may be more reliable than CBsigE in developing 
countries where genetic, dietary and environmental influences are 
appreciably dissimilar to those operative in Western societies. 
" 
21 
CHAPTER 3 THE HYPOTHESIS AND AIMS OF THE STUDY 
The specific problems intrinsic to South Africa in terms of the 
ability to institute the concepts of allergy prediction and 
prevention in this country have been highlighted in Chapter 2. Many 
of the problems are a result of the complex immuno-genetic influences 
at play in our Third World, multi-ethnic and multi-cultural 
population. 
It should be obvious from the preceding discussion that, before 
Western, First World criteria and conclusions be automatically 
extrapolated to hold true for African Third-World populations, 
studies need to be done in these populations to determine whether the 
conclusions and guidelines advocated for First World populations are 
equally relevant in Africa. 
More specifically, since different ethno-genetic and environme:ntal 
factors are at play in Africa, it is fundamental to assess the effect 
of these factors on the CBsigE values in each ethnic group before 
accepting the widely endorsed conclusion that raised levels of CBsigE 
are reflective of an atopic predisposition, both in terms of their 
association with a family history of atopy, and in terms of being of 
predictive significance for the development of subsequent atopic 
disease. 
3. l THE HYPOTHESIS 
Arising from an awareness of these specific South African problems, 
the hypothesis formulated to address these concepts reads as follows: 
"Black South African newborns without an aFH have significantly 
higher CBsigE values than similar White and Mixed newborns. An aFH 
does not influence the CBs I gE values in the Black newborns, as it 
does in the White and Mixed newborns. The CBsigE values in Black 
newborns are not, furthermore, predictive for the development of 




AIMS OF THE STUDY 
To test the Hypothesis 
Confirmation of the hypothesis wi 11 indicate that CBslgE is of no 
value as a predictive atopic marker for South African Black newborns, 
but that it does have this relevance for the South African White and 
Mixed newborns. The hypothesis would be confirmed by providing data 
which shows: 
i ) That the CBslgE values in the Black newborns without an aFH are 
higher than those in the White and Mixed newborns, using a 
highly sensitive modification of the standard PRISTR 
(Pharmacia) for the immunoassay. 
ii) That an aFH in the first degree relatives of the newb~rns 
influences the CBslgE values in the White and Mixed etpnic 
groups, but not in the Black ethnic group. 
iii) That the CBslgE values in those Black newborns who developed 
atopic disease during infancy were not higher than the CBsigE 
values in those who remained healthy, in contrast to the White 
and Mixed newborns, in whom the CBsigE values do demonstrate 
this difference between the subsequently atopic and the not 
atopic group. 
3.2.2 To assess the atopic and predictive relevance of alternative cord 
blood markers 
Various other cord blood markers have been thought to have atopic 
relevance (Section III, Ch. 2.3 and 4). They are: 
i) Eosinophils 
ii) Platelets 
iii) Anti-cow's milk IgG 
These wi 11 individually be assessed in the same way as the CBsigE 
concentrations, to determine: 
3.2.3 
23 
The influence of an aFH in the first degree relatives of 
the newborns on their values. 
Whether a significant difference in their cord blood values 
-
between those newborns who deve 1 oped atopi c disease during 
infancy and those who remained healthy can be demonstrated. 
To gather epidemiological information on the four cord blood atopic 
markers 
The influence of the following specific genetic and environmental 
factors on the cord blood atopic markers will be assessed: 
i ) Ethnicity 
ii ) An atopic family history 
iii ) Maternal Ascariasis --
iv) The newborn's sex 
: 
v) Maternal cigarette smoking 
The rationale for examining the influence of these variables is given 
in Section III, Ch. 1.8. This epidemiological information is not at 
present available for these cord blood markers in Black, White and 
Mixed South African newborns. 
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SEC TI ON I I 
THE DEVELOPMENT OF THE ATOPIC PHENOTYPE 
CHAPTER 1 THE DEVELOPMENT OF THE ATOPIC PHENOTYPE 
This study centres around cord blood atopic markers and their role in 
predicting atopic sensitisation of the infant. It is appropriate 
that some of the critica 1 events which interact together during the 
development of the atopic phenotype are addressed. 
The pathogenesis of atopic disease is subject to multifactorial 
influence. Both multigenic hereditary factors and non-genetic 
factors interact to determine the expression of atopic disease 
(Soothill, 1976; Marsh et al, 1981; Zeiger et al, 1986). . 
The genetic factors which control reagin production are considered in 
Section III, Chapter 1.3. These factors "set the stage", and provide 
the "fertile soil" for the development of an atopic response (Van 
Arsdel and Motulsky, 1959). Rapaport (1976) has estimated that a 
genetic inheritance of "allergic soil" is present in about 80% of 
those with clinical allergic disease. 
Non-genetic factors, in contrast, seem to act as triggers, and are 
necessary to "switch-on" the allergic response. Soothi 11 ( 1983) has 
made the point that, while the mechanisms involved in the genetic 
transmission of allergic disease are complex and interesting, we have 
no power to change a patient 1 s tissue type. Various antigen 
non-specific trigger mechanisms may, however, be influenced by 
effective environmental manipulation. The development of the atopic 
phenotype may therefore be prevented in this manner. 
Socio-cultural considerations in different populations groups are 
important factors in the pathogenesis of the allergic response 
(Joubert et al, 1988). The implication of environmental and other 
non-genetic factors in the pathogenesis of atopy was suggested after 
studies in monozygous twin pairs failed to show 100% atopic 
concordance (Edfors-Lubs, 1971; Bahna, 1984). Bazaral et al (1974) 
showed, furthermore, that the amount of serum IgE being formed in any 
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individual, while being of central importance, is not of exclusive 
importance in the development of the atopic response. Individual 
variations in effector cell and organ sensitivity are also important. 
Fundamental to an understanding of the concept of the allergic 
phenotype, is the principle that clinical atopy is the result of a 
complex set of interactions between the total individual (hereditary 
and intrinsic factors) and the total environment (non-genetic and 
extrinsic factors) (Rapaport, 1971). When these factors interact in 
such a way as to lower the individual's "allergic threshold" (the 
individual's constitutional level of resistance), clinical atopy may 
result. 
Katz ( 1978; 1980; Katz and Fu Tong, 1980) introduced the concept of 
the "allergic breakthrough" in rationalising the differences between 
the allergic and the non-allergic phenotype. He noted that the 
production of serum IgE was usually dampened or suppressed by v;rious 
non-specific suppressor factors of allergy (SFA). When these d~mping 
factors were disturbed by various extrinsic manipulations, the sigE 
response was stimulated, and "allergic breakthrough" occurred, with 
clinical evidence of atopic symptomatology. 
Various important intrinsic and extrinsic factors at play in the 
pathogenesis of the atopic phenotype in infancy merit consideration. 
l. l THE HEREDITARY NATURE OF ATOPIC DISEASE 
The hereditary nature of atopy was first reported on by Maimonides in 
1190 AD (Maimonides, 1963). It was left, however, to Cooke and 
Van der Veer (1916) to validate these impressions. Using Mendelian 
inheritance principles, they suggested that sensitisation was most 
likely to be inherited as a dominant characteristic. 
During the last 50 years, many different theories have been suggested 
to explain the genetic transmission of the hereditary trait for atopy. 
In 1936, Weiner et al proposed a genetic model for the transmission of 
atopic disease. He envisaged the genotype for atopy to be a single 
gene which desegregated into two alleles, a recessive 11 a11 and a 
dominant 11 A11 • The 11 a11 determined the atopic phenotype and the 11 A11 the 
non-atopi c phenotype. Homozygous subjects with respect to the a 11 el e 
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11 a11 would be expected to manifest atopic disease early on in life, 
wh i 1 e heterozygotes wou 1 d be expected either to be hea 1 thy 
transmitters of the gene, or to manifest atopic disease later in 
life. Turner et al (1974) were, however, at variance with this 
proposal. Their findings, in an inheritance study on hayfever versus 
asthma, showed that Weiner et al 1 s proposals were not applicable 
universally to every type of atopic disease complex, even though they 
may be of relevance for hayfever. 
In 1959, Van Arsdel and Motulsky investigated the frequency and 
hereditability of asthma and allergic rhinitis in 5,818 students at 
the University of washington, Seattle. Fifty six point five percent 
of allergic students had a family history for allergy, as compared 
with only 22,2% of non-allergic students. A genetic analysis of the 
data suggested that the transmission of the allergic inheritance was 
effected by an incomplete recessive gene, although a polygenic system 
for allergic susceptibility was not excluded. 
Kjellman and Johansson (1979) supported the theory of a polygenic 
transmission for atopic disease. They found, furthermore, that the 
risk of developing atopy increased as the number of first degree 
relatives who had atopy increased. If a single parent had atopy, the 
incidence of atopy in the offspring was 19,8%, in comparison with an 
incidence of 42,9% in the presence of bilaterally atopic parents. 
Kjellman also suggested a genetic influence on symptom specificity 
because of the high incidence (72,2%) of the same atopic symptom in 
children where their parents both had the equivalent symptom. 
The lack of consensus regarding the exact mode of transmission of 
atopic disease was considered by Edfors-Lubs (1971) to be 
predictable, in view of the conmon prevalence of atopy in the 
population and the variation in symptom severity and expression. She 
studied a large sampling of 7,000 twin pairs for penetrance and 
concordance but found low concordance rates in both monozygotic and 
dizygotic twins. This suggested that environmental factors were 
additionally of importance in the development of allergic disease. No 
distinction between Mendelian recessive, dominant or multigenic 
inheritance could be made. 
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In spite of the controversy over the mode of the genetic transmission 
of atopic disease various other clinical studies have confirmed the 
hereditary nature of atopic disease. 
Turner et al (1974) showed that the prevalence of asthma in the 
children of asthmatic parents was higher than that among children 
with healthy parents. 
Orgel et al (1975) found that 73% (8 of 11) of children who developed 
atopic disease within the first two years of life had a positive 
family history of atopy, while Michel et al (1980a) showed that 62% 
of children with atopy had allergic mothers as compared with only 27% 
of children with no allergic disease. 
In a study of 1,651 6 year old children in Sweden, Kjellman and 
Croner (1984) found that 42,9% of atopic children had a positive 
family history for atopy as coll',)ared with only 24,7% of non-atgpic 
children. Analysed alternatively, they found that 50,2% of children 
with a positive family history of atopy developed atopic symptoms 
within 6 years, compared with only 30,5% of children with no family 
history of atopy. 
Little doubt consequently remains today that atopy and the propensity 
to produce IgE is inherited as an autosomal dominant characteristic 
(Cookson and Hopkin, 1988). The high genetic load for atopy present 
in the newborns with an aFH is the intrinsic soil within which 
infants subsequently develop atopic sensitisation. 
1.2 IMMUNOLOGICAL CONSIDERATIONS 
It has been suggested by various authors that infancy represents a 
transient period of relative immunoincompetence in the 
hereditarily-predisposed 11 high-allergic-risk 11 newborn (Matthew et al, 
1977; Suoniemi et al, 1981; Gordon et al, 1982; Bjorksten, 1983; 
Soothi 11, 1983). 
It wi 11 be shown in Sect ion I II, Chapter l. 3 that the genetic message 




through their effect on IgE-specific T-suppressor cell and B cell 
activity. 
Other immunological mechanisms are, however, additionally at play in 
the development of the atopic .phenotype. Marsh et al (1981) have 
noted tha~ statistically significant linear relationships have been 
demonstrated between log IgE and log IgG antibody responses, and log 
IgE and log IgA antibody responses. This emphasises the point made 
by Soothi 11 ( 1983) that atopy is not recognized by an abnorma 1 IgE 
response in isolation, but is associated also with abnormal responses 
in other i11111unoglobulin classes. 
Immunoglobulin E 
The ro 1 e of IgE in the deve 1 opment of the Type I i11111une response is 
reviewed in Section III. Ch. l. -
Immunoglobulin A 
Taylor et al (1973) were the first investigators to suggest that, 
because of a transient deficiency of IgA in atopica lly predisposed 
infants, excessive allergen was allowed systemic access through the 
"unguarded" gastro-intestinal and respiratory mucosal "portal of 
entry". This resulted in IgE hyperstimulation and consequent atopy. 
It has also been suggested that IgA deficiency could predispose to 
sensitisation because of the resulting enhancement of adjuvant 
production in the bowel by endotoxin-producing E.coli (Matthew et al, 
1977). They showed also that the IgA deficiency at about 3 months of 
age is transient, with the atopic infants having developed higher 
1 eve 1 s of IgA than the non-atopic infants at 1 year of age. Other 
workers, namely Soothill (1976) and Kjellman (1983) share consensus 
that IgA deficiency at 3 months of age often precedes the development 
of eczema in infants of atopic parents, even though the deficiency 
has usually disappeared by the time the allergy becomes manifest. 
There are, however, some workers who have supplied data which does 
not support the contention that a relative IgA deficiency in early 
infancy predisposes the "high-allergic-risk" infant to develop atopic 




It has recently been shown that anti-lgA antibodies are conmonly 
found in IgA-deficient pregnant mothers (Petty et al, 1985). The 
offspring of these mothers often themselves have levels of serum IgA 
which are below the normal age-related mean concentrations. This 
would suggest that maternal anti-lgA exerts a transplacental effect 
on the foetal inmune system, causing the lgA deficiency described in 
early infancy. This may be another mechanism whereby the 
transmission of the genetic message for atopy is translated into the 
final common inmunologic effector pathway for the development of the 
atopic phenotype. 
Immunoglobulin G 
Serum IgG crosses the materno-foetal placental barrier, affording the 
newborn a degree of passive inmunisation (Raitt 1984). The 
concentration of neonatal lgG falls after birth, reaching a na~ir at 
3 months of age, after which time the infant begins to produce its 
own IgG. 
Jarret and Hall ( 1983) have produced interesting evidence that, in 
Hooded Lister rats, the newborn lgE antibody responsiveness to a 
specific antigen challenge was suppressed if the mothers had been 
previously inmunized with the same antigen while pregnant. The 
antepartum maternal inmunisation resulted in raised levels of 
antigen-specific IgG in the serum of both the mother and the 
newborn. These findings led to the concept that stimulation of 
maternal specific IgG by antepartum inmunisation could suppress the 
newborn IgE response, and therefore prevent atopy in infancy. 
Dannaeus et al (1978) documented the above phenomenon in human 
babies. They found that high concentrations of IgG antibodies to 
milk and egg proteins in the cord blood of the newborns on the study 
protected them from developing allergic symptomatology in the first 2 
years of life. This finding suggests that antenatal stimulation of 
the maternal IgG response by the administration of sufficiently high 
doses of cow•s milk or egg protein may be desirable for the 
preventive manipulation of the atopic response in infancy. This 
conflicts somewhat with the current reconmendation for mothers with a 
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11 h igh-a llergi c-risk 11 pregnancy to avoid or 1 imit allergenic foods 
such as milk and egg during the last trimester, in order to prevent 
intrauterine sensitisation of the foetus (Frick, 1985). It has, 
however, recently been reported that the development of atopic 
disease in babies whose mothers had abstained from milk and eggs 
during late pregnancy was no lower than in a control group whose 
mothers did not eliminate these foods from their diets 
(Falth-Magnusson and Kjellman, 1987). Falth-Magnusson et al (1987) 
have furthermore shown that maternal abstention from cows-milk and 
egg in 11 high-allergic-risk 11 pregnancies resulted in a significant 
fall in specific IgG antibodies to cows-milk and egg in these 
mothers. Seen in the light of the findings of Dannaeus et al above, 
this would seem to be an undesirable immunological trend. 
Unequivocal recommendations for mothers of 11 high-allergic-risk 11 
pregnancies are consequently still unclear. 
1.3. FEEDING METHODS IN NEWBORNS AND INFANTS 
Ever since Talbot (1918) described the relationship between the 
ingestion of a pound of chocolate by a breast feeding mother and the 
development of eczematous symptoms in her baby, much controversy has 
been generated by the role of feeding methods in the pathogenesis of 
the atopic phenotype. 
Various studies have shown that atopic symptoms in infancy may be 
prevented or delayed by prolonged and exclusive breast feeding in 
infancy (Grulee and Sanford, 1936; Saarinen et al, 1979(a); Juto et 
al, 1982; Duchateau and Casimir, 1983). Grulee and Sanford (1936) 
reported that the incidence of infantile eczema was seven times 
higher in artificially fed infants than in exclusively breast fed 
infants. Saarinen et al (1979a) have shown, furthermore, that serum 
IgE values in exclusively breast fed infants were lower than those 
fed cow's milk formulas. This difference disappeared once solid 
foods were introduced into the diet. 
In contrast, Fergusson et al (1981) found that exclusive breast 
feeding did not convey any protection against the development of 
eczema in infancy. They found, however, that the incidence of eczema 
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in infancy increased in direct proportion to the variety of solid 
foods that the infant had been given in the first 4 months of life. 
In 1982, Gordon et al reported on the relationship between breast 
feeding, serum IgE values and the development of atopic 
symptomatology in 250 infants from atopic families. They, likewise, 
could find no protective benefit against the development of either 
infantile atopy or abnormally high serum IgE values in those children 
who were breast fed if compared with those who were artificially fed. 
Bjorksten (1983), in an attempt to rationalise this conflicting 
information, reached the conclusion that much of the confusing data 
could be due to a non-uniformity of study design. Major differences 
in the selection criteria for the infants participating in the 
various studies were evident in a review of the literature. He 
concluded that breast feeding seemed to be of benefit only for those 
infants who were 11 at risk 11 for atopy by virtue of their inher_:ited 
genotype. No protective benefit was seen to be gained by br-=east 
feeding normal infants. The population as a whole would, therefore, 
not benefit from this practice. 
Some workers have gone even further, and have suggested that breast 
feeding may, in fact, be contra-indicated for the 
11 high-allergic-risk 11 infant. Gerrard (1979) has reviewed the 
literature dealing with the passage of ingested maternal food 
antigens through her breast milk. The conclusion reached was that 
foods taken by the mother may find their way into her milk, and 
subsequently sensitise her infant. Gerrard himself substantiated 
these findings in 18 infants who became sensitised to various foods 
ingested by their breast feeding mothers. Cant et al (1985) likewise 
showed that breast-fed babies who developed eczema could be 
sensitized by foods ingested by their mothers. In 1986, Cant et al 
showed, furthermore, that a modification of the maternal diet in 
breast feeding mothers was of benefit to some breast fed babies who 
had eczema. Hattevig et al, in 1984, also described specific IgE 
responses to egg and cow's milk proteins in 9 11 high-a llergic-risk 11 
infants, before the introduction of these nutrients into their diet. 
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It seems obvious, from these observations, that mothers who breast 
feed their infants in the hope that this practice will prevent the 
onset of atopic symptomatology in their infants should very carefully 
exclude all potentially allergic nutrients from their own diet 
(Firer et al, 1981). Failure to do this could, very easily, convert 
the practice of breast feeding in infancy from a prophylactic factor 
to an enhancing factor for the development of the atopic phenotype. 
To further complicate the issue of the protective role of breast 
feeding for atopic sensitisation, Bjorksten and Saarinen (1978} 
showed that the very small quantities of cow's milk antigen present 
in human breast milk are more likely to elicit the production of 
anti-cow's milk IgE in infants than the large quantities of antigen 
which are present in cow's milk based formulae. Juto and Bjorksten 
(1980} confirmed this impression in a clinical study of 
11 high-allergic-risk 11 babies with a positive aFH. They found }_hat 
those infants who had the longest duration of breast feeding also had 
the highest sigE values. They concluded that low antigen doses 
facilitated the IgE response. Firer et al (1981} also produced 
evidence to show that the levels of total sigE and milk specific sigE 
were significantly higher in a group of infants who had had minimal 
exposure to cow's milk as compared to a group of infants who had been 
fed substantial amounts of cow's milk. 
An interesting insight into the inconsequential role of breast 
feeding in infancy was provided in a study by Saarinen et al (1982). 
The effect of exclusive breast feeding in infants during the first 
birch pollen season of their life surprisingly conferred no 
protective benefit to the infants in terms of the development of 
birch pollen allergy in later life. Instead, those infants who had 
been weaned to cow's milk formulae during this period had a 
significantly reduced incidence of allergy against birch pollen in 
later life as compared to the exclusively breast fed infants. 
Bjorksten (1983} has suggested that the massive antigen load of cow's 
milk to which the vulnerable infants are exposed may stimulate and 
normalise their functionally defective i11111uno-regulatory systems. 
This mechanism could account for the protective effect of cow's milk 
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feeding against the development of birch pollen hypersensitivity in 
Saarinen's study. Lindfors and Enocksson (1988) have recently 
published data to suggest that the early feeding of 
11 high-allergic-risk 11 newborns with a cow's milk formula, before the 
introduction of breast milk, reduced the chances of them developing 
atopic symptoms in the first 18 months of life. 
These clinical findings have been supported by experimental evidence 
as to the potent reaginic response resulting from low-dose antigenic 
sensitisation. In 1970, Levine and Vaz studied the effect of antigen 
dosage on various inbred strains of mice. Their data suggested that 
low antigen doses favoured a reaginic rather than an IgG response. 
They concluded that the atopic response was, in part, a genetically 
predetermined capacity to respond to minute doses of antigen. 
Jarrett and Hall, in 1981, came to a similar conclusion when they 
analysed their data in which high IgE-responder egg albumin-immuQized 
Hooded Lister rats were repeatedly challenged with very small am~unts 
of antigen. Their results showed that extremely small doses of 
antigen were sufficient to stimulate IgE production. It was also 
shown, however, that repeated antigenic challenge of these immunised 
rats abrogated the IgE responsiveness due to the activation of an IgE 
class-specific suppressor mechanism. 
Immunological deficits in the breast milk of lactating mothers with 
allergic infants have recently been described by Machtinger and Moss 
(1986). Lower concentrations of both total IgA and specific IgA 
antibodies to cow's milk proteins were found in the breast milk of 
mothers with allergic infants when compared to the concentrations of 
these antibodies in the breast milk of mothers with healthy infants. 
It seems that sub-optimal concentrations of maternal breast milk IgA 
antibodies to common nutrient allergens may predispose certain breast 
fed infants to the development of atopic disease. 
It would seem, therefore, that multifactorial considerations hold the 
key to the rationalisation of the conflicting observations regarding 
the prophylactic benefit of breast feeding in infancy. 
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1.4 THE AOJUVANT EFFECT OF THE BORDETELLA PERTUSSIS (DPT) IMMUNISATION 
IN INFANCY 
It has been well documented in animal studies that various adjuvants, 
such as the Bordetella pertussis bacteria (Mota et al, 1974) and 
Nippostrongylus brasiliensis (Ishizaka et al, 1980), enhance the IgE 
antibody response. It has been shown that the Bordetella pertussis 
vaccine is capaole of inducing an early, high-titre reaginic response 
in mice (Mitchell, 1976). The lipopolysaccharide content of 
Bordetella pertussis is the principal active material responsible for 
this adjuvant effect (Mota et al, 1974). 
It is thought tnat this effect is also operative in humans (Bjorksten 
and Anlstedt, 1984). The development of specific IgE antibodies to 
Bordetella pertussis following immunisation with the trivalent DPT 
vaccine during infancy have recently been described by Haus et-·a l 
(1988a). In another study of IgE concentrations in infancy and early 
cnildhood, Orgel et al (1975) noticed that the greatest upward change 
in the median concentrations of serum IgE occurred between the ages 
of 6 and 9 months of age. The DPT i nocul ati ons in that study were 
administered at the ages of 2, 4 and 6 months. It is difficult, 
however, to unequivocally implicate the adjuvant effect of Bordetella 
pertussis in tnis reaginic response, particularly since other 
IgE-stimulating factors, such as the introduction of solid foods, 
often come into contention at this stage of infancy. 
In infancy, the adjuvant effect of the Bordetella pertussis vaccine 
on the IgE response is particularly relevant because of the routine 
immunisation of all infants witn the trivalent DPT. These 
inoculations are administered at the ages of approximately 3, 4 and a 
half and 6 months of age in South Africa. Any epidemiological 
comparative study of atopi c development in infancy should therefore 
take cognizance of any discrepancy in the incidence and timing of the 
DPT inoculations in the various samplings. 
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1.5 THE ~OLE OF VIRAL INFECTIONS 
It has been suspected for some time that viral infect ions are potent 
stimulators of the allergic response. Various authors have confirmed 
this suspicion by monitoring both clinical and laboratory parameters 
of the viral and immunological responses during acute infections with 
various viruses. 
Perelmutter et al ( 1978) presented evidence that sigE values rose in 
the acute phase of a viral infection, but fell again in the 
convalescent phase. They proposed that the viral agent itself had a 
dampening effect on suppressor T cell function, allowing an increased 
IgE response by the B ce 11 line of lymphocytes. In another study 
(Perelmutter et al, 1979), they suggested that the viral agent could 
possibly stimulate helper T cells in the acute phase of infection and 
that this could stimulate the increased production of IgE. -
Bahna et al (1978), in a study which monitored the IgE response 
during and after an infection of heterophile-positive infectious 
mononucleosis, showed an early elevation of sigE in the acute phase 
of the illness, followed by a significant drop by the 3rd 
convalescent month. This indicated that IgE production was very 
responsive. during infectious mononucleosis. It was thought that the 
drop in sigE during convalescence could result either from a 
suppression of IgE production or from an increased catabolism of IgE 
molecules. Frick, in 1981, furthermore demonstrated immunologic 
evidence of allergic sensitisation in infants together with, or just 
after, laboratory documented viral infections. The infants were a 11 
from families with a bilateral aFH. 
The production of specific IgE antibodies against the respiratory 
syncytial virus (RSV) in patients who wheezed during an acute RSV 
infection has been documented by Welliver et al (1981; 1985). They 
also suggested that the formation of these anti RSV IgE antibodies 
could be a bad prognostic sign for the development of future episodes 
of wheezing in certain children (Welliver et al, 1980). It seems, 
therefore, that RSV infection in infancy and early childhood may be a 
potent stimulant of both the IgE response and the subsequent 
development of allergic symptoms. 
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Without viral and immunological studies in the acute and convalescent 
phases of these episodes, no definitive cause or effect assumptions 
can, however, be verified. 
1.6 THE EFFECT OF CIGARETTE SMOKE 
It has been known for about 2 decades that the chi 1 dren of parents 
who smoke become i 11 more often than the children of non-smokers 
(Cameron et al, 1969). The illnesses described are primarily 
respiratory illnesses. 
Harlap and Davies (1974) showed also that infants of mothers who 
smoked had significantly more hospital admissions for bronchitis and 
pneumonia than those infants whose mothers did not smoke. The 
increased incidence of hospital admissions in those infants whose 
mothers smoked was moreover directly related to the numbJ?r of 
cigarettes which the mother smoked. The acute respiratory effe~ts of 
side stream and second hand smoke seem to be re 1 ated part i cu 1 ar ly to 
infancy (Landrigan et al, 1986), after which time this association 
seems to diminish. 
Recently, the issue of "passive smoking" by children has received 
further attention. Burchfiel et al (1986) have shown that passive 
exposure to cigarette smoke was associated with both asthmatic and 
non-asthmatic respiratory symptoms in a large study population of 
3,482 children from Tecumseh, Michigan. Pulmonary function tests 
(FEV 1, FVC and Vmax50 ) in children of parents who were current 
smokers were significantly worse than in children of parents who had 
never smoked. 
Tager (1986) has carefully reviewed the evidence generated by studies 
such as these, voicing concern as to the method of assessment in 
determining exposure to environmental tobacco smoke. It was pointed 
out that, in all the epidemiological studies to date, the smoking 
history had been evaluated by means of a questionnaire, which often 
did not take into consideration factors such as the room size, 
density of the smokers and ventilation. The evaluation of urinary 
cotinine has only recently provided a scientific yardstick which 
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correlates with the number of smokers in any one home. There 
nevertheless appears to be no reasonable doubt that passive exposure 
to tobacco smoke in childhood affects short-term respiratory health. 
The mechanism by which smoking exerts its detrimental effect on the 
respiratory system seems to be multi-factorial (BjHrksten and 
Ahlstedt, 1984). Besides being a mucosal irritant, Gerrard et al 
(1980) showed, in adults, that cigarette smoking is associated with a 
selective increase in the mean sigE in spite of a significant 
simultaneous decrease in both the mean IgG and IgM concentrations 
when compared to a non-smoking control group. Kjellman (1981) 
similarly reported that parental smoking gave rise to significantly 
elevated slgE values in their infants and young children. Venables 
et al (1985) have also recently shown that smoking may predispose to 
the formation of specific IgE antibodies to a hapten protein 
conjugate, tetrachlorophthalic anhydride human serum albumin. Atopic 
subjects were more liable to develop this specific IgE response than 
non-atopic subjects. 
These considerations suggest that the effect of passive smoking in 
infancy is liable to accelerate the development of atopic 
symptomatology by virtue of its stimulatory effect on IgE synthesis. 
While the effects of this extrinsic IgE augmenting factor should be 
recognised in any epidemiological study of IgE synthesis and atopic 
development, it would seem that reliable quantification of any 
possible dose-related effect is not feasible without an accurate 
scientific assessment of the number of smokers in any environment. 
The estimation of urinary cotinine concentrations remains, at 
present, the most re 1 i ab 1 e method for such an assessment, but is 
outside the scope of this study. 
1.7 THE EFFECT OF THE SEASON OF BIRTH 
Bjorksten and Suoniemi (1976) noticed that a group of male adolescent 
patients who were allergic to pollens had a month-of-birth clustering 
in the European Spring months of March, April and May. This birth 
distribution was significantly different to that of the general 
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population of Finland. They proposed that the concept of a 
vulnerable period for atopic sensitisation in early infancy would 
explain tneir observations. Certain variable seasonal environmental 
factors which could influence the development of subsequent atopi c 
symptomatology were thought to be present during one or other of the 
seasons. 
In a later study, Bjorksten et al (1980) showed that the risk of 
i111Tiediate hypersensitivity to bircn pollen in infancy correlated 
positively with the number of birch flowers in the environment during 
the first birch flowering season in Spring. They concluded that an 
exposure to pollens during the first 6 months of life increased the 
risk of pollen allergy. Kemp (1979) came to a similar conclusion 
wnen he studied the relationship between the season of birth and the 
development of grass-pollen allergy. He was of the opinion that 
infants are particularly susceptible to sensitisation at about~.3 
months of age. A recent study by Croner and Kjellman (1986) Qas 
clearly indicated, nowever, that the seasonal influence of the month 
of birtn on the development of the atopic phenotype is limited to tne 
nigh-allergic-risk genotype, and not to all newborns. Kimpen et al 
(19d7) have also recently shown a cyclical difference in the CBsigE 
in relation to tne month of birth in a series of 5353 newborns. The 
peak CBs I g£ was, as expected, seen in the European Spring m0nths of 
March, April and May, while the trough was in October, in the 
European Autumn. 
1 .8 THE EFFECT OF THE NEWBORN 1 S SEX 
The effect of sex on the sigE in various population groups has been 
the subject of conflicting reports. 
Some workers (Orren et al, 1975; Orren and Dowdle, 1975; Turner 
et al, 1974) have shown that males tend to have higher sigE values 
tnan females, wnile others (Nye et al, 1975) have shown no such 
differences. 
It is therefore not certain whether the newborn 1 s sex would 
preferentially influence the development of the atopic pnenotype in 
any group of subjects. 
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SECTION III 
CORD BLOOD ATOPIC MARKERS - DESCRIPTION AND RATIONALE 
CHAPTER 1 SERUM IMMUNOGLOBULIN E 
1. 1 BIOLOGICAL AND PHYSICO-CHEMICAL PROPERTIES 
IgE is the World Health Organisation designation for irmnunoglobulin 
E, an irmnunoglobulin antibody which shares general characteristics 
and antigenic determinants with the other irmnunoglobulin classes G, 
A, Mand D (Bennich et al, 1968; Johansson and Bennich, 1983). 
In 1966, Ishizaka et al described the unique physico-chemical 
properties of IgE. They discovered also that IgE possessed rea~inic 
activity, a fact which led to the realisation that IgE was the 
reaginic factor as described by Prausnitz and KUstner in 1921. IgE 
was therefore confirmed as being the mediator in the Type I 
anaphylactic reaction (Gell and Coombs, 1964; Johansson and Bennich, 
1983a). 
IgE is a non complement-binding glycoprotein, with a molecular weight 
of 190,000, a sedimentation constant of 8 and a carbohydrate 
concentration of 12% (Roitt, 1984). Its serum concentration is 
extremely low (0,0001 gram/1 itre) and it is stable in serum for at 
least 1 year at -20°c (Lehrer and Bozelka, 1982). 
Clinical studies have confirmed experimental evidence that maternal 
IgE does not cross the p 1 acenta 1 barrier and that CBsigE 
concentrations are foetal in origin (Kjellman and Johansson, 1976; 
Dannaeus et al, 1978; Section III. Ch. 1.8. 1)). 
1.2 THE ONTOGENY OF IgE BIOSYNTHESIS 
1'1iller et al (1973) showed that the human foetus may synthesise IgE 
in the f oeta 1 1 ung and 1 i ver from as early on as the 11th week of 
gestation, and in the foetal spleen by 21 weeks of gestation. Singer 
et al (1974) confirmed that IgE was present in amniotic fluid from 
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the 13th week of gestation, often at higher concentrations than those 
in cord blood samples. These findings suggest that the foetus is 
capable of intra-uterine sensitisation to antigens which cross the 
materno-foetal placental barrier. At birth, umbilical serum IgE is 
present in very small concentrations (Table I.3). Newborns with an 
atopic predisposition often have raised CBsigE on the basis of a 
hereditarily determined IgE-specific T-suppressor cell dysfunction 
(Bjorksten, 1983; Bjorksten and Juto, 1983a). 
During infancy and childhood, sigE values rise, along with the other 
immunoglobulins (Raitt, 1984). Maximal peak concentrations ·of sigE 
in normal, non-atopic populations occur in children at adolescence 
(Gerrard et al, 1974; Wittig et al, 1980; Bhalla et al, 1982). 
Kjellman et al (1976) confirmed these trends, finding maximal 
concentrations of IgE at the age of 10 years in their series of 207 
normal neonates, infants and children. _ 
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This rise of sigE in normal individuals is comparable to the rate of 
rise for sigA (Johansson and Berg, 1967; Berg and Johansson, 1969) 
but is markedly slower than the rise in sigG (Raitt, 1984). Atopic 
infants and children demonstrate both an earlier and a steeper rise 
in sigE in the early years of life, compared with non-atopic controls 
(Kjellman, 1976a). 
A gradual age-dependant decline in sigE usually occurs from the 
second decade onwards (Buckley, 1980). 
1.3 THE GENETIC CONTROL AND REGULATION OF THE IgE RESPONSE 
The ongoing investigation into the exact genetic transmission of 
atopic disease was greatly facilitated by the discovery of IgE in 
1966 (Ishizaka et al, 1966; Johansson, 1967; Bennich et al, 1968). It 
was soon realised that atopic diseases were mediated by IgE, and that 
IgE concentrations were elevated in atopic disease (Section III. Ch. 
1.4). Opree et al (1972) analysed the mean IgE levels of three 
different genotypes in random and allergic patients. Their results 
supported evidence for a common genetic control mechanism for both an 
atopic predisposition and the synthesis of IgE. These facts led to 
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the belief that IgE biosynthesis and regulation may likewise be under 
genetic control (Buckley, 1980). Many investigators have proposed 
various theories as to the mechanisms involved in the genetic control 
and regulation of the sigE response. 
In 1971, Bazaral et al measured IgE levels in normal infants and 
mothers, and proposed an inheritance hypothesis for the control of 
sigE. The sigE levels in 6 month old infants was substantially 
higher in those who had an allergic parent than in those who had 
healthy parents. The frequency distribution of the 35 maternal sigE 
values revealed 3 arbitrarily distinct, multimodal groupings arranged 
in a non-Gaussian manner. If the Hardy-Weinberg law, which 
mathematically decribes the frequencies of two alleles belonging to 
one genetic locus in any population, was applied to this 
distribution, a simple Mendelian hereditable effect on sigE values 
was indicated. This correlated with Weiner's proposed genetic ~odel 
for atopic transmission, where a single gene with 2 alJeles 
constituted the genotypic determinants (Weiner et al, 1936). 
Further frunily studies seemed to confirm a group distribution of IgE 
levels in normal populations which fitted the Hardy-Weinberg law. 
Bazaral et al (1974), during a study of sigE levels in both 
monozygous and dizygous middle-aged male twin pairs, observed a 
significant genetic effect on these levels. Monozygous twin pairs 
were more similar to each other in terms of their respective sigE 
levels than dizygous twin pairs. It was re-iterated that the 
multimodal distribution of sigE levels suggested that control of 
these levels was determined by a small number of alleles at one 
locus. The possibility of a multigenic effect on sigE levels was not 
exc 1 uded, however. It was al so not cl ear from this study whether 
sigE levels were directly under genetic control, or whether they were 
determined secondarily by other factors which themselves were under 
genetic control. Turner et al (1974), for example, on the basis of 
family prevalence studies for atopy and IgE production, proposed a 
sex-linked factor associated with an inherited capacity for IgE 
biosynthesis. They interpreted their data to implicate the 
X-chromosome as the gene carrier for IgE synthesis in man. 
The simple Mendelian two allele-one gene inheritance system for the 
control of IgE biosynthesis as described by Bazaral et al (1971;1974) 
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was challenged by the discovery of the Histocompatability-linked 
I11111une Response (Ir) gene in animals and in man. Animal studies into 
the genetic control of murine IgE responses to low antigen doses by 
Levine and Vaz (1970) stimulated interest in the role of the human 
HL-A system in the allergic response to complex antigens. Benacerraf 
and McOevitt (1972) and also Levine et al (1972), first described the 
Ir gene, which was essential for the generation of ragweed hayfever. 
This gene was involved in the recognition of low concentrations of 
specific antigens, and determined specific immune responsiveness. It 
was mapped within the I (inwnune) region of the H-2 locus of the Major 
Histocompatability Complex (MHC). It is believed that the HL-A 
haplotype system in man is the counterpart of the murine H-2 MHC 
(Roitt, 1984). It is thought that the Ir gene in man will therefore 
al so be mapped within the D region of the HL-A gene complex on 
chromosome 6 (Marsn et al, 1981). 
Apart from the Ir gene, Levine (1973) definitively described a second 
genetic factor which controlled the levels and magnitude of the 
reaginic immune response. This factor exercised its control by more 
than one locus, had no antigen-specific or dose effect, and was not 
linked to the MHC. This genotype was responsible for the high and 
low IgE responder phenotypes in animals (Levine and Vaz, 1970; Katz, 
1978; Binaghi, 1980; Marsh et al, 1981; Ishizaka, 1982) and in man 
(Croner et al, 1982; Kjellman and Croner, 1984). The action of this 
second genetic IgE control mechanism was possibly through its effect 
on suppressor T cells (Buckley, 1980). An insufficiency or 
functional abnormality of suppressor T ce 11 s has been shown to lead 
to increased levels of sigE (Bjorksten and Juto, 1982; Bjorksten, 
1983; Bjorksten and Juto, 1983(a); Bjorksten and Ahlstedt, 1984). 
Kishimoto et al (1980) confirmed, moreover, that the IgE antibody 
response was regulated by T and B cells which were IgE class specific. 
The experimental work of Levine (1973) was substantiated by a 
clinical study of serum IgE levels in parents and children by Gerrard 
et a 1 ( 1974). They concluded that in man, as in the mouse, HL-A 
linked Ir genes determined specific i11111une responsiveness per se but 
were not related to the actual level or magnitude of the IgE 
response. Two additional dominant genes determined whether any 
subject would be a high or a low IgE responder. Low IgE levels were 
43 
determined by the presence of both dominant genes, while the absence 
of one or the other dominant gene resulted in a high IgE responder 
phenotype. 
In 1981, Marsh et al reviewed ~nd summarized the epidemiology and 
genetics of IgE regulation. Apart from substantiating the role of 
the HL-A linked Ir gene and the non HL-A linked IgE regulating genes, 
he provided evidence of an inter-act ion between these two genetic 
regulatory systems. His conclusions were that family studies, 
particularly across ethnic barriers, would be necessary in further 
determining the relevance of the HL-A system in the epidemiology of 
atopy. 
1.4 CONDITIONS CAUSING RAISED SE~UM IgE CONCENTRATIONS 
Serum IgE concentrations are raised in various clinical set~ings 
(Table III. l). 
Many of these cond it i ans, including the atop i c diseases, are 
undesirable and not beneficial to man. It is therefore interesting 
that the IgE-mediated Type I anaphylactic reaction has survived 
selective evolutionary pressures for its discontinuation. 
The possible helminthotoxic function of IgE could very well have 
influenced the retention of the IgE-mast cell-eosinophil-complement 
system in phylogeny (Kay, 1979; Kay, 1980). While there is no 
universal agreement as to the precise role of IgE in the cytotoxic 
reaction against parasite infestation, various studies have 
demonstrated clear associations between metazoan infections in rats 
and mice and raised levels of sigE. This association is particularly 
marked when the parasites involved have prominent tissue or systemic 
phases in their host life-cycle (Radermecker, 1974). 
Rousseaux-Prevost et al (1977) documented a rise in sigE of up to 60 
times the basal level, in rats infected with Schistosoma mansoni. 
Ishizaka et al (1980) described a similar tendency in rats after 
infection with Nippostrongylus brasiliensis. Capron et al (1980) and 
Binaghi (1980) in his studies with Trichinella spiralis-infected 
mice, described the cytotoxic effect of IgE-activated macrophages on 
the offending parasites. 
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In developing Third World countries where parasitism is endemic, the 
beneficial effect of the helminthotoxic function of IgE could 
therefore be more important to the survival of the indigenous 
population than the often less life-threatening effects of atopic 
disease. Kay (1980) has suggested that "natural selection might well 
tolerate inappropriate allergic reactions which, although irritating, 
wi 11 only rarely be significantly damaging". 
The possible protective role of parasitic infection in the prevention 
of atopic symptomatology has been discussed in Section I. Chapter 2. 1. 
1.5 THE DIAGNOSTIC VALUE OF SERUM IMMUNOGLOBULIN E CONCENTRATIONS FOR 
ATOPY 
The relationship between atopic disease and raised concentrations of 
serum IgE was first noted by Johansson (1967), very soon after:- .he 
co-discovered IgE. He found that 63% of patients with allergic 
asthma had an elevated sigE as compared to only 5% of patients with 
non-allergic asthma. Since then, many studies have proved that the 
estimation of sigE concentration is a valuable diagnostic aid for the 
assessment of atopic disease (Berg and Johansson, 1969; Johansson et 
al, 1972; Wittig et al, 1980; Zetterstrom and Johansson, 1981), 
particularly in allergic asthma (Havnen et al, 1973), atopic 
dermatitis (eczema) (Church et al, 1976), allergic rhinitis (Seebohm, 
1978) food allergy (Bjorksten et a 1, 1983) and contact dermatitis 
(Bousquet et al, 1978) (Table III.1). 
1.6 THE PREDICTIVE VALUE OF SERUM IMMUNOGLOBULIN E CONCENTRATIONS FOR 
ATOPY IN INFANTS AND CHILDREN 
Foucard (1974) was the first investigator to report that a raised 
sigE may precede the onset of clinical atopy. He found that the 
estimation of sigE in infants and children during an initial episode 
of wheezy bronchitis could prognosticate or predict which of these 
patients could be expected to go on to develop asthma. Of the 
patients who subsequently developed asthma, 44% had a ra i sect sigE 
during the initial wheezy illness. Only 7% of the patients who never 
became asthmatic at the completion of the study had elevated levels 
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In 1975, Orgel et al supported Foucard's proposal. They stated that 
11 a sigE of more than 20 U/ml before the end of the first year of life 
is associated with a substantial risk of developing atopic disease". 
In their study of 34 infants from both atopic and non-atopic 
families, all 12 of the infants who had a sigE of more than 20 U/ml 
at l year of age, had developed definite or possible atopy by the age 
of 2 years, in comparison with only 6 of the 17 children who had a 
sigE of less than 10 U/ml at l year. The elevation of the sigE 
levels in these patients preceded the manifestations of the atopic 
diseases in 11 of the 12 infants. 
Kjellman, in 1976 and Kjellman et al, in 1977, confirmed the 
predictive function for atopy of raised sigE values in children. In 
the earlier study, Kjellman selected a group of 207 healthy children 
between 0-14 years of age. He followed these children up for 18 
months. Of those infants and children who had raised levels of ~IgE 
(more than GM + l SD) at the initial visit, 87,5% had consistently 
high levels again 18 months later. Of this group, 62,5%- had 
developed atopic symptomatology within this time. In the subgroup of 
patients between 0-1 year of age at the initial visit, 95% of those 
who had raised sigE levels at the initial visit had consistently high 
levels again 18 months later. Of these patients, 75% developed 
atopic manifestations within this period. It was similarly shown, 
therefore, that a rise in sigE often preceded the onset of atopic 
symptomatology. 
In another publication, Kjellman et al (1976) reported on the 
examination of 208 apparently normal children between the ages of 
0-14 years. Fifty three children had sigE values of more than GM+ 2 
SD for their age. Eighteen months later 24 of these had developed 
atopic disease. 
Kjellman cone luded that a child with a high sigE, greater than the 
normal reference level for his age, is very likely to have, or soon 
to develop, a clinically significant atopic disorder. 
1. 7 THE PREDICTIVE VALUE OF CORD BLOOD SERUM IMMUNOGLOBULIN E 
CONCENTRATIONS IN NEWBORNS 
Because of the very low concentrations of serum IgE reported in cord 
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blood samples (Grundbacher, 1975; Kjellman et al, 1976) (Table I.3), 
accurate and sensitive laboratory methods for measuring CBsigE needed 
to be established before CBsigE could be assessed in terms of their 
predictive value for the development of future atopy. 
Anticipating this need, Johansson et al (1976) compared 4 methods to 
quantify CBsigE. They concluded that the use of the paper-disc RIST 
(PRIST) direct sandwich radioimmunoassay, as described by Ceska and 
Lundkvist in 1972, was the most appropriate laboratory method for 
CBsigE quantification. 
Using this technique, numerous studies in the past decade have 
confirmed that elevated CBsigE values are excellent predictive 
markers for the identification of the 'high-allergic-risk' newborn 
(Table III.2). 
Kjellman and Croner (1984) have the biggest and longest foll~w-up 
prediction study to their credit. By 1984, they had followed up 
1,651 newborns till the age of 7 years, and had correlated their 
initial CBsigE values with the accumulated incidence of atopic 
disease which they had manifested up to the age of 6 years. They 
used a detection limit of 0,9 kU/1 on the IgE Phadebas PRIST. It was 
found that the use of this concentration level as a cut-off point for 
the differentiation between high and low CBsigE values was a better 
discriminator for the development of atopic disease over 7 years than 
the previously suggested cut-off limit of 1,3 kU/1, a level which was 
equal to the geometric mean + 2 SD for that population group 
(Kjellman and Johansson, 1976; Croner et al, 1982). Sixty three 
children (3,8%) developed atopic symptoms at an early stage (before 
18 months of age), and persisted with these symptoms up till the age 
of 6 years. Of this subset, 93,7% had CBigE values greater than 0,9 
kU/1. Only 3,5% of children who never developed any atopic 
symptomatology over 6 years had CBsigE values over 0,9 kU/1. 
This study did have shortcomings. No routine clinical examinations 
were performed to confirm a history of clinical atopy. No RAST's 
were done to confirm specific sensitisation. The histories were, by 
and large, obtained from a questionnaire filled in by the parents. 
This study remains, however, the most widely quoted and the most 
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Michel et al (1980b), in a study which looked at the influence of 
maternal factors on CBsigE values in 83 newborns, found CBsigE to be 
a better predictive marker than a family history for atopy. Using a 
detection level of 0,5 IU/ml, they found that 71% of the 17 infants 
who were either definitely or possibly atopic after 9 months were 
born with CBsigE values greater than 0,5 IU/ml. In contrast, only 
21% of the 66 infants who never became clinically atopic within this 
period of time had CBsigE values greater than 0,5 IU/ml. Looked at 
from another perspective, 26 newborns had CBsigE values greater than 
0,5 IU/ml. Of these newborns, 17 (65,4%) developed definite or 
possible atopic symptomatology within the first 9 months of life. 
In another study, Michel et al (1980a) followed-up 110 newborns for 
12-36 months. Of the 25 children who became allergic during the 
follow-up period, 16 (64%) had CBsigE values greater than 0,5 IU/ml. 
In contrast, only 20 of the 85 children (24%) who rema_ined 
non-allergic during the follow-up period had CBsigE values greater 
= than 0,5 IU/ml. 
Croner et al (1982) further substantiated the predictive relevance of 
CBsigE estimations. They also intimated that many of the 27 newborns 
with elevated CBsigE values (greater or equal to 1,3 kU/1) who never 
went on to develop atopic symptomatology within the first 18 months 
of life (false-positive results) actually developed atopy by 4 and a 
half years of age. The prolonged follow-up period effectively 
reduced the 30% incidence of false-positive results. 
Hattevig et al ( 1984) showed that every newborn with a CBsigE values 
above 1,3 kU/1 developed atopic disease within the 4 year follow-up 
period. This led them to conclude that 11 high concentrations of IgE 
antibodies are seen almost exclusively in infants with atopic 
disease". In the light of the discussion in Section I, Chapter 2, 
whereby elevated concentrations of serum IgE may be found in the 
Black races independently of atopic disease, this statement will be 
challenged by the data presented in this study. 
Other studies by Kjellman and Johansson (1976), Dannaeus et al 
(1978), and Chandra et al (1985) have additionally confirmed the 
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predictive relevance of CBsigE estimations. Chandra presented data 
to show that 44,3% of newborns with a positive family history of 
atopy had CBsigE values greater or equal to 0,7 u/ml, in comparison 
with only 16,0% of newborns with a negative family history. This 
emphasises the hereditary influence of a family history of atopy on 
the CBsigE values, an issue which will also be further examined in 
this study. 
Duchateau and Casimir (1983) likewise confirmed the validity of 
neonatal sigE screening for the development of atopic symptomatology 
in the first few weeks of life. They, however, collected the blood 
on the 5th day of life, to avoid the possibility of maternal 
contamination of the specimen. Their results are consequently not 
reflective of cord blood values. 
Magnusson's study (1984), apart from similarly confirming ___ the 
predictive value of CBsigE estimations in a sample of 190 BeJgian 
European infants, also described a significant ethnic or racial 
difference in CBsigE geometric mean values between his Belgian 
sampling and an equivalent African-Asian sampling. No follow-up of 
the African-Asian infants was, however, reported on. The predictive 
relevance of CBsigE values in Black ethnic groups has not yet been 
assessed. 
In summary, the estimation of CBsigE has been shown to provide 
valuable predictive information in terms of its abi 1 ity to forecast 
the development of future atopic illness in the infant and child. All 
of these studies have, however, been done on White newborns in 
European Continenta 1 and Scandinavian countries, and the conclusions 
reached from these studies should be confirmed to the population 
groups in thes countries. 
1.8 FACTORS INFLUENCING CORD BLOOD SERUM IMMUNOGLOBULIN E CONCENTRATIONS 
Various factors have been thought to influence the CBsigE found in 
the umbilical vein of the newborn. While the effects of some of 
these factors are still controversial, an awareness of these factors 
is necessary to avoid misinterpretation of the CBsigE estimations. 
1 .8. 1 
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The transplacental passage of maternal serum Immunoglobulin E 
Most of the clinical evidence reported in the literature supports the 
contention that CBsigE is foetal in origin. Johansson and Bennich 
( 1983), co-discoverers of IgE, characterized IgE and confirmed that 
it is unable to cross the materno-foetal placental barrier. 
r~any clinical studies in humans have supported this contention, on 
the following grounds: 
a. There is no corre 1 at ion in s I gE between ma tern a 1 and newborn 
serum samples (Bazaral et al, 1971; Kjellman and Johansson, 
1976; Oannaeus et al, 1978; Michel et al, 1980a). 
b. The very low values of CBsigE relative to the higher 
concentrations present in maternal serum seem to negate~_the 
existence of a passive equilibrium for sigE in the 
-
rnaterno-f oeta 1 circu 1 at ion, as occurs for serum IgG (Stevenson 
et al, 1971; Kjellman and Johansson, 1976). 
c. Food-specific serum IgE has been demonstrated in cord blood sera 
without the occurrence of a corresponding food-specific sigE 
for the equivalent food in the materna 1 serum (Michel et a 1, 
1980a). 
d. The converse situation, where specific IgE antibodies were found 
in maternal serum, but not in the cord b 1 ood serum of her 
newborn, has also been described (Kjellman and Johansson, 1976; 
Croner et al, 1982), further substantiating the foetal origin 
of CBsigE. 
e. An absence of reag in i c activity in the cord b 1 ood serum of a 
newborn, in spite of a high titre of reaginic activity in the 
maternal serum, has been reported (Stevenson et al, 1971). 
f. Mathur et al (1977) have suggested that CBsigE may be maternal 
in origin on the basis of the higher mean values of slgE which 
they measured in the umbilical vein relative to the sigE which 
l • 8. 2 
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they measured in the umbilical artery. Their statistical analysis 
revealed, however, that this difference was not significant. The 
assay used for the quantification of the sigE was, moreover, the 
Phadebas IgE RIST, a method which has been shown to be inaccurate in 
the lower ranges below 50 U/ml (J~hansson et al, 1976). 
On balance, most investigators assume that the CBsigE represents 
serum IgE which is foetal in origin. 
Intra-parturn contamination of the CBsigE sample by maternal blood 
The method which is used for cord blood venesection should be careful 
and precise, to avoid contamination by the maternal blood which 
inevitably surrounds the umbilical cord during parturition. 
Kjellman and Croner (1984) described maternal contamination of a .cord 
blood sample in one instance. Specific IgE antibodies had been round 
in a specific cord blood sample. They were, however, not detected 
again in another sample taken from the same neonate on the 5th day of 
life. This finding presumed maternal contamination of the cord blood 
sample, a situation which is largely eliminated by attention to 
detail during the venesection procedure (Section IV. Ch. 2.2.5). 
In order to confirm the foetal origin of any cord blood serum IgE 
sample, a serum IgA estimation, performed on the cord blood sample, 
is a reliable indicator of maternal contamination (Bjorksten -
personal contnunication, Sweden 1984; Kimpen et al, 1987). Foetal 
concentrations of serum IgA are very low. Normal cord blood IgA 
concentrations in the Black, White and Mixed South African ethnic 
groups have been shown to range between l, l and 7,2 mg/dl (Van 
Rijswikj et al, 1985). Normal female adult levels of serum IgA 
concentrations in the Black and White ethnic groups in South Africa 
have been reported to range between 48 and 368 IU/ml (Shulman et al, 
1975). Cord blood serum which gives an IgA concentration of less 
than 7,2 mg/dl is likely therefore to be foetal in origin. Kimpen et 
al (1987) excluded 157 cord blood samples with an IgA concentration 
of greater than 32 .3 mg/ml from their cord blood IgE study on 5353 
newborns, in the belief that those samples were probably contaminated 
with maternal blood. 
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This method remains the most reliable to date for the confirmation of 
the integrity of cord blood samples. 
l.8.3 Intra-uterine sensitisation of the foetus 
l.8.4 
The human foetus has the ability to manufacture IgE from the 11th 
week of gestation (Miller et al, 1973; Singer et al, 1974). This 
confers it with the potential to become sensitised in-utero to 
antigens which have crossed the materno-foetal placental barrier. 
The source of these maternal antigens are presumed to be from the 
mother's dietary intake during pregnancy (Kuroume et al, 1976; Katz, 
1979) • 
Clinical studies have confirmed the intra-uterine sensitisation of 
the foetus. The occurrence of specific IgE antibodies to cow's milk 
protein (Michel et al, 1980b) and penicillin (Levine et al, 197})_ in 
newborn serum, as well as haemagglutinating antibody titres ag~inst 
lactalbumin, soybean and egg white in human amniotic fluid (Kuroume 
et al, 1976), have confirmed a foetal immune response to sensitizing 
maternal antigens. 
Further evidence to suggest that a newborn may already be atopic was 
provided by Kaufman (1971) when he demonstrated a positive 
Prausnitz-KUstner reaction in a 3 hours old newborn. This finding 
presumed intra-uterine sensitisation, a factor which was 
substantiated by the demonstration of a cord blood reaginic IgE 
concentration of 71 ng/ml in the baby. 
Cord blood is normally thought to contain small amounts of IgE which 
is non-specific (Croner et al, 1982). The demonstration of specific 
IgE in cord blood samples by RAST indicates intra-uterine 
sensitisation, and may contribute to an elevation of the total 
CBsigE. 
The genetic effect of atopy and ethnicity 
The genetic control of sigE is manifest already at birth (Bjorksten, 
1983). The newborn who is hereditarily predisposed to atopic disease 
and who carries a high genetic load for atopy may be identified by 
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having a raised CBsigE value (Section I. Chapter l; Michel et al, 
1980; Michel et al, 1980b; Croner et al, 1982; Kjellman and Croner, 
1984). This high cord blood sigE responder phenotype is thought to 
be determined by the non HL-A linked gene (Section III, Ch. 1.3) 
which exercises its effect by controlling IgE-specific suppressor T 
cell function (Buckley, 1980; Kishimoto et al, 1980; Bjorksten and 
Juto, 1982; Bjorksten and Ahlstedt, 1984). 
In a clinical study of 1,701 newborn infants, Croner et al (1982) 
demonstrated the genetic effect of a positive family history for 
atopy on CBsigE. The hereditarily predisposed 11 hi gh-a llergic-ri sk 11 
genotype was often expressed as a high CBsigE responder phenotype. 
They found that a positive family history for atopy significantly 
influenced the concentration of IgE in the newborn's cord blood. 
Seven point two percent of newborns (38 of 528) with an i11111ediate 
family history of atopy had raised CBsigE values (greater than- 1,3 
kU/1) in contrast with only 3,8% of newborns (27 of 703) wtth no 
family history (p less than 0,01). This genetic effect was 
perpetuated throughout the 18 month follow-up period, in that those 
newborns with raised CBsigE values also had significantly higher IgE 
concentrations· 18 months later, compared to those newborns with low 
CBsigE values (less than 1,3 kU/1). 
The genetic effect of ethnicity per se on CBsigE values, independent 
of a hereditary predisposition for atopy, seems feasible. It has 
been shown that the adult Black races may manifest high 
concentrations of IgE in the absence of atopy, and that these 11 high 
IgE responder 11 phenotypes may have resulted from strong evolutionary 
selective pressures designed as a survival mechanism for the human 
host defence against endemic parasitism (Section I. Ch. 2.3. l). If 
the Black ethnic group in South Africa do represent a pool of 
genetically-coded 11 high IgE responders 11 , this effect may be observed 
already at birth, in the cord blood serum. It would seem, 
furthermore, that the genetic effect of ethnicity on sigE could be 
more efficiently assessed in a study of cord blood IgE sera rather 
than in adults. This would eliminate extra-uterine environmental 
influences on sigE (Ganju et al, 1979), although it would not exclude 
the effect of intra-uterine environmental influences on the foetal 
production of IgE (Section III. Ch. 1.8.3). 
1 .8. 5 
56 
Bazaral et al (1974) have agreed that the genetic effect on slg£ 
could be more efficiently studied early on in life. They snowed 
that variations and differences in sigE between individuals with tne 
same genotype (monozygous twins for example) arose largely after 
childhood. The mean intrapair variance in sigE of monozygous twin 
children was significantly less than that of monozygous twin adults. 
Magnusson (1984) (Table 1 .3) is the only worker to have documented a 
clear ethnic difference in CBsigE, using the same radioimmi.1noassay 
for the sigE quantification in a single study of White and Black 
newborns. The Wnite and Black populations in his study were, 
however, taken from dissimilar geographic loci, namely Belgium 
(Europe) and Africa respectively, and the radioimmunoassay method 
used for the quantification of his samples was sensitive to only 0.1 
u/ml. Furthermore, nis study did not differentiate between newborns 
with an atopi c or a non-atopi c family hi story, and this factor could 
obscure the effect of ethnicity per se. ; 
This is the first controlled study comparing different CBsigE values 
in different ethnic groups from a single geographic area using a 
hignly-sensitive radioinununoassay. The findings should clarify the 
extent of any ethno-genetic effects acting on CBsigE values, 
particularly since the CBsigE values will be compared in subgroups 
ooth witn and without an aFH between the various ethnic groups. 
Drug administration during pregnancy 
Sex steroid hormones such as progesterone have been implicated in the 
causation of immuno-suppression through their inhibitory effect on 
cellular immunity. Laboratory studies have described the in-vitro 
i nhi bi tory effect of progesterone on both phytohaemaggluti ni n 
stimulated lymphocytes (PHA) (Mori et al, 1975) and purified protein 
derivative (PPD) stimulated lymphocytes (Wyle and Kent, 1977). High 
concentrations of progesterone, which are prooably nonnally only 
achieved at its biosynthetic site in the foeto-placental unit, are 
necessary for this immuno-suppressive effect (Weinstein et al, 1977). 
1.8.6 
57 
It has been shown that IgE-specific B cells are under the direct 
control of IgE-specific T cells (Kishimoto et al, 1980), and that 
T-suppressor cell failure may lead to raised concentrations of IgE 
(Bjorksten and Juto, 1982; Bjorksten and Ahlstedt, 1984). 
Immunodeficiency diseases are, moreover, well known for their 
association with raised IgE concentrations (Table III. l). It is not 
unexpected, therefore, that the immune-suppressive and inhibitory 
effect of high doses of progesterone on eel 1-mediated immunity and 
lymphocyte transformation could be associated with raised levels of 
CBsigE, although not all workers share consensus on this issue 
(Mathur et al, 1977). 
In a clinical study, Michel et al (1980b) showed that the 
administration of progesterone to the pregnant mother tended to 
increase the mean values of CBsigE. Fifty three percent of newborn 
infants whose mothers had received progesterone during gestatio~_had 
CBsigE concentrations greater than 0,5 IU/ml as compared with "'only 
24% of newborn infants whose mothers had received no gestational 
progesterone. 
The effect of Salbutamol administration to the pregnant mother was 
also examined by Michel et al (1980b). The effect of such 
administration had no significant influence on the CBsigE. 
The effect of oral contraceptives on the CBsigE was likewise assessed 
by Michel et al (1980b). They found no significant effect on the 
CBsigE values in those mothers who had taken oral contraceptives just 
before or during the early stages of pregnancy. 
The effect of cigarette smoke 
The effect of passive smoking on the health and IgE concentrations of 
infants and children of smoking parents has been discussed in Section 
II Ch. 1.6. 
Whether maternal smoking in pregnancy likewise stimulates foetal IgE 
production in utero is uncertain. Magnusson (1984) found that 
mothers who smoked had newborns with significantly higher CBsigE 
values than mothers who did not smoke (p less than 0,05). 
1.8. 7 
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Michel et al (1980b), in contrast, did not find such a clear 
differentiation. This was possibly due to the fact that only 16 of 
their study sample of 136 mothers smoked, making statistical 
comparison unreliable. 
The possibility nevertheless ex1sts that maternal smoking during 
pregnancy may contribute towards raised CBsigE values. 
Prematurity 
It has been suggested by various studies that the effect of 
prematurity may influence CBsigE values. 
Michel et al (1980b) did not detect IgE in the cord blood of newborns 
before 36 weeks of gestation. However, the PRIST used for 
quantification of the CBsigE had a detection limit of 0,5 IU/ml~ and 
would not register concentrations below this level. A more sensitive 
method of measuring the CBsigE may wel 1 have detected IgE in those 
preterm newborns of less than 36 weeks gestation. In another study, 
Croner et al (1982) did not find CBsigE values greater than 0,9 
IU/ml in any cases where pregnancy lasted less than 37 weeks 
gestation. 
The effect of prematurity on CBsigE values is, therefore, still 
equivocal. 
1.8.8 Sex 
Various studies have shown that male newborn infants have higher 
CBsigE values than female newborn infants. 
In a study of 1,701 Swedish newborns, Croner et a 1 ( 1982) showed 
that 7,3% of boys had CBsigE values of greater than 1,3 kU/1 as 
compared with only 3,2% of girls (p less than 0,001). Magnusson 
(1984) also showed a significant sex differentiation in CBsigE 
values. In his study, boys more often had raised CBsigE values than 
girls (p less than 0,05). 
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1.8.9 Maternal Ascariasis 
Weil et al (1983) have reported on raised total CBslgE values 
occurring in Indian newborns whose mothers had i1T1Tiunological evidence 
of filarial helminth infestation. The cord blood sera of many of 
these newborns also contained specific IgE antibodies to filarial 
antigens. Th is study suggests that intra-uterine sens iti sat ion to 
maternal parasite antigens could be a contributing factor influencing 
CBslgE values. 
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CHAPTER 2 EOSINOPHILS 
2.1 INTRODUCTION 
The eosi nophil granul ocyte was discovered by Paul Ehrlich a 1 i ttl e 
more than a century ago (Ehrlich, 1879). 
Since then, an eosinophilia has been widely accepted as being 
intimately associated with atopic disease (Lowell, 1967; Otteson and 
Cohen, 1978). Reconfirmation of its role in asthma (Frigas and 
Gleich, 1986) its role in rhinitis (Mullarkey et al, 1980) and its 
modulating role in down-regulating the IgE mediated mast-cell 
dependant reactions (Weller and Goetzl, 1979; Kay, 1980) by degrading 
various mast-cell mediators (Kater et al, 1976; Henderson et al, 
1982) has firmly established this granulocyte as being integrally 
involved in the allergic Type I anaphylactic response. 
It is not surpr1s1ng, therefore, that its role as a cord blood atopic 
marker should be addressed (Dry et al, 1980). Its predictive 
potential has, additionally, stimulated interest since eosinophilia 
was reported as reflecting a susceptibility or a predisposition for 
allergy in young boys (Foucard, 1974). 
2.2 BIOLOGIC AND PHYSIOLOGIC VARIATIONS IN THE TOTAL EOSINOPHIL COUNT 
The consideration of biologic and physiologic variations in the 
number of eosi nophil s ci rcul ati ng at any one time is important. 
Circulating eosinophils represent a balance between the rate of their 
formation and re 1 ease from the bone marrow and their disappearance 
from the blood (Best et al, 1953). 
A natural diurnal fluctuation in the 
has been well documented (Fisher 
Strumia, 1952; Unrbrand, 1958). 
independent of the fluctuation in 
level of circulating eosinophils 
and Fisner, 1951; Donato and 
This variation seems to be 
total leucocyte levels. It 
appears, however, to be a function of adrenocortical activity, with 
eosinophil levels being a mirror image of the circulating adrenal 
cortico-steroids (Otteson and Cohen, 1978). 
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These hormones seem therefore to have an eos i nophi 1 opaeni c effect. 
Minimum TEC 1 s are consequently expected in the mornings, with maximum 
TEC 1 s occurring late at night. 
Various other factors have been shown to cause a peripheral 
eosinophilopaenia. Stress in general has an 
effect, which is mediated by an increase in 
eosinophilopaenic 
pituitary-adrenal 
cortical activity (Recant et al, 1950). The administration of oral 
ephedrine per se has been snown to cause an eosinophilopaenic effect, 
if given to normal subjects with an intact anterior pituitary 
ACTH-adrenocortical axis (Abelson and Moyes, 1950; Best and Samter, 
1951). This effect is effectively aoolished by propranolol 
(Koch-Weser, 1968), a beta adrenergic blocker. Trauma (Gabrilove, 
1950), surgical shock (Laragh and Almy, 1948; Davis and Hulit, 1949), 
physical aouse (Koch-Weser, 1968), the intravenous administration of 
insulin (Laragh and Almy, 1948) emotional stress (Humphreys and Raab, 
1950) and acute infections (Weller, 1984) have all been described-=as 
causing an eosinophilopaenia. 
The stress of 1 abour may a 1 so have an influence on the TEC of the 
mother. £osinophilopaenia during and after labour has been described 
by Davis and Hulit (1949), wno found that an almost total 
eosinophilopaenia was present in more than 50% of their patients 
during the immediate post-partum period fol 1 owing tne third stage of 
labour. The degree of this eosinophilopaenia was thought to be 
reflective of the degree of labour-induced stress. The TEC 1 s in 
their study returned to normal only at the end of the third 
post-partum day. 
The effect of physical exercise on the TEC is somewhat 
contradictory. Both a rise (Davis and Hul it, 1 949 in menstruating 
women) and a fall (Dal ton and Selye, 1939 in rats and rabbits) in the 
TEC following exercise has been reported. It appears that this 
disparity may be explained because of a bivariate response in the 
TEC, with a decrease in the TEC directly after strenuous exercise 
preceding a later increase. Some authors have described a sex 
difference for TEC 1 s with boys having higher values than girls 
(Cunningnam, 1975). There is no consensus on this issue, however, 
since other authors have not reproduced similar findings (Felarca and 
Lowe 11 , 1967). 
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To what extent these factors influence the cord blood TEC of the 
newborn remains unknown. It is, however, probable that some of these 
biological and physico-chemical variations are at play during labour. 
2.3 PATHOLOGIC EOSINOPHILIA 
Apart from its association with atopy (Section III. Ch. 2. l), 
eosinophilia is associated also with a host of pathologic 
disease-complexes (Otteson and Cohen, 1978). Parasitic infestation 
of the human host is a co111110n cause of peripheral and tissue 
eosinophilia (Kay, 1979; Kay, 1980; Weller, 1984). This observation 
is particularly noticeable for those helminths which do not confine 
themselves to an intra-luminal gastro-intestinal existence in their 
life cycle. Metazoan helminths are therefore more co11111only 
associated with eosinophilia than protozoan infections. 
2.4 THE CONCEPT OF NORMALITY FOR TOTAL EOSINOPHIL COUNTS 
Because of the many biological and physico-chemical influences on the 
level of circulating eosinophils, normal values have very little 
meaning, unless they are defined in relation to circumstances 
operative at the time of venesection. 
Normal values reported in the literature consequently range widely. 
Values of: 0-240 cells/mm3 (Disconi>e, 1946), 40-600 cells/mm3 
(Uhrbrand, 1958), 250 cells/111113 (Lowell, 1967), 70-450 cells/mm3 
(Best et al, 1953), 34-427 cells/111113 (Felarca and Lowell, 1967) 
have been reported in healthy adults. Values for children are said 
to be higher, with a mean of 240 cells/mm3 and a 95% confidence 
limit of 0-740 cells/mm3 (Cunningham, 1975). 
The terms "eosinophilopaenia" and "eosinophilia" need, therefore, to 
be seen in context with these widely spread normal values. 
2.5 CORD BLOOD TOTAL EOSINOPHIL COUNTS 
The rationale for a raised cord blood TEC in those newborns who have 
a family history for atopy and therefore a predisposition for the 
development of allergic disease is plausible, for two reasons. 
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Firstly, the regulation and control of eosinophil production seems 
to De under i 111Tiuno l ogi cal contra 1 ( We 11 er and Goetzl , 1979) with T 
lymphocytes actively participating in the eosinophilic response 
( Basten and Beeson, 1970; Bass et a 1 , 1 980) . For examp 1 e, 
congenitally athymic mice cannot respond with an eosinophilia to a 
Trichnella spiral is infection (Walls et al, 1971; Ruitenberg et al, 
1977), a condition which is usually an adequate antigenic stimulus 
for an eosinopnilic response in immunlogically intact species. Cord 
blood eosinophilia may therefore be expected in newborns who have a 
derangement of their T lymphocyte system, particularly if associated 
witn the relative increase of T-helper cell activity which is a 
consequence of tne imbalance in the OKT4/0KT8 T cell system in 
atopically predisposed neonates (8jorksten and Juto, 1982; Bjorksten, 
1983; Bjorksten and Juto, 19d3). 
Secondly, Kay (1979; 198U) has suggested that the IgE-mast 
cell-compl ement-eosi nophil system forms a complex irnmunol ogi~al 
link-up in terms of its helminthotoxic function. It is therefore 
reasonable to imagine that cord blood eosinophilia could well 
accompany the elevated CBsigE values which have been shown to occur 
in "high-allergic-risk" newborns (Section I. Ch. 1). A further 
factor favouring the association of cord blood eosinophilia with that 
of a raised CBsigE is the fact that eosinophils are motile cells, and 
are able to migrate and accumulate at the sites where Type I 
anaphylactic reactions are occurring (Kay, 1980; Weller, 1984). This 
migration and mobilisation occurs as a result of mast-ce 11 derived 
eosinophilotactic agents, such as the tetrapeptide "eosinophil 
chemotactic factor of anaphylaxis11 (ECF-A) (Goetzl and Austen, 1975), 
histamine (Clark et al, 1975), imidazole acetic acid (ImAA) (Turnbull 
and Kay, 1976) and complement-system fractions such as CS, CSa and 
C567 (Weller, 1984). Mono-nuclear leukocytes have also been shown to 
produce the human lymphokine 11 eosinophil stimulation promoter" (ESP) 
in response to non-helminthic antigens (Weller et al, 1978). 
Dry et al (198Ll) found a significant difference in cord blood TEC's 
in his group witn a positive family history for atopy relative to the 
cord blood TEC's in his group with a negative atopic family history 
(248 and 183 cells/mm3 respectively) (p less than 0,02). 
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No further data on the relationship between cord blood TEC 1 s and a 
family history for atopy, or on the predictive value of cord blood 
TEC 1 s for the development of future atopic disease has been published. 
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CHAPTER 3 PLATELETS 
The unactivated human platelet is a small, anuclear, smooth-surfaced 
disc, which has a life-span of 10 days in the peripheral blood 
circulation (Handin, 1981) 
The platelet is formed secondarily to the pnysical fragmentation of 
megakaryocytes. These megakaryocytes initially arise in the yolk 
sac, liver and spleen of the foetus, and then ultimately in the bone 
marrow of the infant (Aster, 1972). 
3.1. THE FUNCTION OF PLATELETS 
Blood platelets are intrinsically associated with the maintenance of 
normal haemostasis. This function is effected both by haemostatic 
and by thromboplastic mechanisms (Handin, 1981) -
The haemostatic function is effected by platelet reactions such as 
agglutination, adhesion, aggregation and cohesion, while the 
thromooplastic function is effected by a phosphol ipoprotein fraction 
known as platelet factor 3 (Williams et al, 1972) 
During the course of the last 2 decades, various investigators have 
provided evidence that the platelet may be implicated in the allergic 
Type I response. Some of this evidence is summarized below. 
3.2. THE ROLE OF PLATELETS IN THE ALLERGIC RESPONSE 
About 20 years ago, Barbaro and Zvaifler (1966) described experiments 
which demonstrated a correlation oetween antigen-induced histamine 
release by the platelets of rabbits producing homologous PCA antibody. 
The mediator responsiole for this reaction was later identified and 
characterized. It became known as 
paf-acether. Paf-acether is 
lysophosphatidylcholine. It is 
platelet activating factor, or 
an alkyl analogue of 
released from IgE-sensitised 
macrophages, basophils, neutrophils and platelets themselves, and 
functions as an immune mediator to activate platelet aggregation 
(Benveniste, 1980). 
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Various reviews and studies have since provided evidence that the 
platelet is intimately associated with the allergic response, in 
particular, that of allergic asthma (Morley et al, 1984; 1985; 




symptomatology could be exacerbated as a result of 
pulmonary platelet activation by paf-acether formation in 
Slater et al ( 1985) furthermore described an increase in pulmonary 
megakaryocytes in the lung tissue of 3 patients who died of status 
asthmaticus. In their opinion, this finding suggested that 
thrombopoeisis was being locally stimulated as a result of the 
increased pulmonary platelet activation and consumption which occurs 
after stimulation by paf-acether. 
Additional evidence for the mediating role of paf-acether in asthma 
was supp 1 ied by Page et a 1 ( 1985), who demonstrated that effective 
suppression of paf-acether-induced asthmatic responses could be 
realised by the administration of anti-asthma drugs such as ketotifen 
and theophylline. 
Further evidence of the role of platelets in the Type I allergic 
response was provided by Joseph et al (1986). They demonstrated the 
in-vitro cytotoxic function of platelets against schistosoma larvae 
by an IgE-dependant mechanism. This confirmed the presence of Fe 
receptors for IgE on blood platelets. 
Consensus on the role of paf-acether and platelet activation in the 
pathogenesis of allergic asthma has, however, by no means been 
reached. 
Halonen et al (1985), in a study of the role of platelets and 
paf-acether in the rabbit, concluded that neither paf-acether nor 
platelets were important in mediating the pulmonary anaphylactic 
mechanical alterations in the rabbit experimental model. Ind et al 
(1985) further questioned the ro.le of platelets in asthma. Using 
isotopically labelled platelets as markers, they found no evidence of 
intrapulmonary platelet accumulation in either normal or asthmatic 
patients who had undergone bronchial challenge with Dermatophygoides 
pteronyssinus antigen. 
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In another study, Durham et al (1985) measured circulating 
concentrations of the platelet-derived proteins, B-thromboglobulin 
and platelet factor IV during metacholine-induced 
bronchoconstriction in asthmatics. These platelet products are 
indicators of platelet activation, and should be raised as a 
consequence of pl ate let activation. This feature was, however, not 
demonstrated in their study. 
Greer et al (1984; 1985) similarly found no evidence of platelet 
activation in asthmatic subjects who had been challenged with either 
histamine inhalation or house dust mite antigen bronchial 
provocation. The levels of B-thromboglobulin and thromboxane B2, a 
stable metabolite of thromboxane A2 which is released by activated 
platelets, were unchanged in these patients. This again contradicted 
the hypothesis that platelet activation occurred in antigen-induced 
asthmatic responses in man. 
It is clear, therefore, that even though much of the available 
evidence favours the implication of platelets in the allergic 
response, the clinical implications and the exact conditions under 
which this mechanism seems to act, is still a matter of debate. 
3.3 CORD BLOOD PLATELET COUNT AS A PREDICTIVE ATOPIC MARKER 
The implication of platelets in the allergic response prompted 
Magnusson and de Weck (1985) to investigate platelet counts in the 
cord blood of newborns. They found, firstly, that a relative 
thrombocytopaenia existed in the newborns whose mothers were 
allergic, if compared to those newborns with non-allergic mothers (p 
= 0,014). Paternal and sibling allergic disease did not, however, 
influence the cord blood platelet counts. Furthermore, they found 
that a relative cord blood mean thrombocytopaenia (196,375/mm3) 
existed in those newborns who went on to develop atopi c symptoms 
within the fol low-up period of 18 months, if colll)ared with the cord 
blood mean platelet count of those newborns who remained healthy 
(285,902/mm3) (p = 0,002). They also found a positive correlation 
between cord blood IgE concentrations and cord blood platelet counts. 
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They assumed that the low pl ate let counts observed in the 
"high-allergic-risk" newborns could be reflective of intra-uterine 
sensitisation. The subsequent consumption of foetal platelets, 
secondary to a paf-acether mediated platelet activation mechanism in 
this atopically vulnerable foetal population, could be a logical 
explanation for the relative cord blood thrombocytopaenia. Halonen 
et al (1980) have shown that profound thrombocytopaenia may accompany 
paf-acether induced pulmonary anaphylaxis in the rabbit. 
Magnusson and de Week's (1985) study represents the only data on cord 
blood platelet counts to date. Furthermore, the newborns studied 
were European ethnics. No inter-ethnic comparative studies for cord 
blood platelets have been published, either for their potential 
ethnic variability or for their possible predictive relevance. 
In view of the unresolved differences of opinion as to the relevance 
of platelets in the allergic response, this study will attempt Jo add 
further perspective to the predictive relevance of cord blood 
platelets for atopic disease in different ethnic groups. 
3.4. PHYSIOLOGIC VARIATIONS IN NORMAL PLATELET COUNTS 
The factors which influence platelet counts in normal subjects are 
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CHAPTER 4 ANTI-COW'S MILK IMMUNOGLOBULIN G 
4. l THE ALLERGENIC CAPACITY OF COW'S MILK 
Cow's milk is known to contain up to 25 distinct proteins, all of 
which may induce specific antibody production in the foetus and 
newborn (Bahna and Heiner, 1980). The more important of these 
proteins, as well as some of their physical and antigenic 
characteristics are tabulated in Table III.4. 
The prevalence of allergy to cow's milk has been shown to be between 
0.3% - 7,5% in various age groups (Bahna and Heiner, 1980). Halpern 
et al (1973) showed that l,8% of 1,084 infants who were exposed to 
cow's milk in the first 6 months of life became allergic to it. 
The demonstration of various immunoglobulin classes of antJbody 
directed against specific cow's milk proteins has confirmed~ the 
allergenic potential of cow's milk. The presence of precipitating 
antibodies to cow's milk antigens in the sera of infants have been 
well documented (Barrett et al, 1979). Specific IgE antibodies to 
various cow's milk proteins have been similarly described in children 
with a positive clinical history of cow's milk allergy (Bjorksten et 
al, 1983). 
Growing interest has been generated, also, by the suggestion that 
antibodies of the IgG class may play a role in human allergy. In 
this respect, Bruynzeel and Berrens (1979) demonstrated both specific 
lg£ and IgG4 antibodies in the serum of patients with specific 
allergies. Bjorksten et al (1983) substantiated the development of 
specific IgG4 antibodies to cow's milk in children with cow's milk 
allergy. They found, however, that these antibodies did not seem to 
play a role in the allergic response of these children. 
While many of the immunological mechanisms associated with the cow's 
milk antibody response are still not clearly understood, the above 
evidence, and the evidence as reviewed by Bahna and Heiner ( 1980) 
show unequivocally that both lg£ and IgG antibody class production 
may be stimulated by specific cow's milk antigens. 
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4.2 THE MODULATING ROLE OF MATERNAL IMMUNITY ON THE INFANT 
In 1979, Jarrett and Hall produced experimental evidence that pointed 
to the existence of antigen specific IgE suppressive factors that 
were transferred in the milk of previously sensitised lactating 
rats. In l9d3, they provided experimental evidence in rats that 
maternal IgG antibodies had a suppressive effect on the IgE antibody 
responsiveness of their offspring. 
Maternal irrmunity was therefore seen, in animal experimental models, 
as playing an important role in setting the pattern for tne 
development of future allergic responses in their offspring. This 
subject has been previously discussed in Section II, Ch. 2.2. 
These experimental concepts were applied to the study of human 
mothers and newborns by Dannaeus et a 1 (1978). They showed thq_t. the 
concentration of IgG antibodies to the oeta lactoglobulin pi:otein 
fraction of bovine milk present in the cord blood of newborns played 
a modulating role in the development of atopic symptomatology during 
the first 24 months of their lives. Relatively high titres of 
anti-betal actogl obul in IgG were found in the cord ol ood of those 
newborns who remained symptom free during the foll ow-up period if 
compared with the cord blood titres of tnose newoorns who developed 
a topic symptoms during the same period. They suggested that high 
titres of specific anti-cow's milk IgG antibody in cord Dlood may 
confer a protective benefit on the newoorns insofar as the 
development of atopic symptomatology is concerned. 
This proposal supports the generally accepted role of passively 
transferred maternal IgG in the newborn and young infant as a 
protective immunoglobulin against bacterial toxins and 
micro-organisms (Roitt, 1984). Confirmation that the concentration 
of cord blood specific anti-cow's milk IgG was a result of a passive 
transplacental transfer of a similar maternal titre was also supplied 
by Dannaeus and his co-workers (1978). They found that the 
concentrations of the specific anti-cow's milk IgG in the cord blood 
sera were equivalent to the concentrations of the same antibodies in 
the relevant paired maternal sera. Furthermore, they observed that, 
as is the case for IgG in general, the titres of these specific 




































































































4.3 CORD BLOOD ANTI-COW'S MILK IMMUNOGLOBULIN G CONCENTRATIONS AS A 
PREDICTIVE ATOPIC MARKER 
It follows from the above considerations that low cord blood or 
maternal concentrations of anti-cow's milk IgG antibody may possibly 
constitute a predictive marker for the identification of the 
11 high-allergic-risk 11 newborn. Bousquet and Michel in 1984 and 
Kjellman in 1985 have similarly endorsed this concept, particularly 
if low concentrations of maternal anti-betalactoglobulin IgG 
co-incided with elevated cord blood serum IgE concentrations. 
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SECTION IV 
STUDY DESIGN AND RESEARCH METHODOLOGY 
CHAPTER 1 GEOGRAPHIC LOCATION AND POPULATION DESCRIPTION 
1.1 GEORGAPHIC LOCATION OF STUDY 
The study was executed in the Cape Peninsula of South Africa, an area 
situated at the South-Western tip of the African continent (Fig IV 1.) 
Most of this area is constituted by the greater metropolitan area of 
the city of Cape Town and its environs. Cape Town has a latitude of 
33 55 1 South and a longitude of 18° 28 1 East. 
- . 
Topographically, the peninsula consists of a central mountainous 
ridge and a flat plain area, the Cape Flats, on its eastern border. 
This flat plateau lies about 100 feet above sea level. The peninsula 
is surrounded by two oceans. The relatively cold Atlantic ocean 
flanks the North-Western shore of the peninsula, while the warmer 
Indian Ocean flanks the Eastern shore. 
The region enjoys a Mediterranean climate, with a winter rainfall and 
hot, dry sunvners. The prevailing winds are predominantly 
South-Easterly in the Summer, and North-Westerly in the Winter. The 
North West wind often precedes rainfall. 
The population is cosmopolitan and multi-ethnic. Commerce, 
agriculture, industry and tourism are the most important sources of 
their income. 
1.2 POPULATION DESCRIPTION AND DOMICILIARY DISTRIBUTION 
1.2. 1 
The 3 ethnic groups compared in the study were the Black, White and 
Mixed groups. The domiciliary and residential distribution of these 
groups in the Cape Peninsula is depicted in Fig. IV. 2. 
The Black ethnic group 

















































































































































FIGURE IV. 2. 
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Xhosa nation is one of the 9 Nguni ethnic tribes, each of which has 
its own individual socio-cultural, historical, political and 
liguistic characteristics, (van der Spuy, 1974). Historically, their 
domicile was in the Eastern Cape homeland states of Transkei and 
Ciskei. The patients in this study were, however, part of the 
migrant population to the urban environment of the Western Cape. 
This tendency to urbanisation has become increasingly preva 1 ent in 
the last two generations (van Niekerk, 1979). The duration of the 
mothers• domicile in the Cape Peninsula ranged from 1 year to 37 
years in our study group. Some mothers were born in the Cape 
Pen i nsu 1 a wh i1 e others mi grated there at some 1 ater stage of their 
lives. Rural patients who had come to the Western Cape only 
temporarily for their confinements were excluded from the study. 
The Blacks had the lowest socio-economic standards of the 3 ethnic 
groups in this study. Most of the families lived in crudely de~ised 
squatter accommodation on the Cape Flats. Even though these B]acks 
are rapidly becoming urbanised, strong tribal customs and folk-lore 
beliefs are still being exercised in terms of their life style, 
dietary habits during gestation and infant feeding methods. 
The White ethnic group 
The White group was drawn predominantly from the stable White 
established connnunity in the Cape Peninsula. This population is not 
a homogeneous group, but is divisible into Afrikaans-speaking, 
English-speaking and a third, mi see llaneous group. Botha and 
Pritchard (1972), in estimating blood group gene frequencies in the 
White and Coloured (Mixed) populations of the Western Cape, gave an 
indication of the differing genetic constitutions of these ethnic 
groups. The Whites were shown to be essentially of Western European 
stock, but small proportions of Asiatic, Bushman and nomadic 
Hottentot blood group genes were demonstrated in that study. 
Their socio-cultural, lifestyle and dietary practices, while having 
achieved indigenous characteristics over the 300 years since they 
first arrived at the Cape of Good Hope in 1652, nevertheless follow a 
First-World, Western pattern. They enjoy, on the average, a 
middle-class standard of living, and are domiciled throughout the 
study area in houses which they usually own themselves. 
1 • 2. 3 
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The Mixed ethnic group 
The Mixed group was drawn from the stab 1 e, es tab 1 i shed, so-ca 11 ed 
Cape-Coloured community. This group has become indigenous to the 
Western Cape. Originally, they had their origins as a result of 
intermarriage and temporary relationships between the surplus males 
of the early Western European Colonists and the indigenous, 
non-European population of the Cape which included the Hottentot, the 
Bushmen and South-East Asian stock. Botha and Pritchard (1972) 
confirmed this historical data by finding the blood group gene 
frequencies of the Cape Coloured ethnic group being representative of 
34% Western European, 36% indigenous Southern African and 30% Asian 
origin. 
The lifestyle of the Cape Coloured, while tending to the Western 
pattern, has developed a strong ethnic characteristic. They are 
socio-culturally, economically, linguistically and politically:.._more 
closely aligned to the local White ethnic group than the Black ethnic 
group. While the current average standard of living is somewhat 
lower than that enjoyed by the Whites, socio-political, educational 
and infra-structural changes are rapidly closing this gap. Most of 
the study group live in structurally sound rented or subsidized 
housing on the Cape Flats. 
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CHAPTER 2 STUDY DESIGN AND EXECUTION 
2.1 INTRODUCTION 
This study has been executed in. two phases in order to satisfy the 
11 Aims of the Study11 as specified in Section I. Ch. 3.2. 
( iJ PHASE I. A cross-sectional study, designed to investigate and 
compare the specified cord blood markers in each of 
the three ethnic groups (Section VII. Ch. 1. 1). 
(ii) PHASE II. A longitudinal, 1 year follow-up investigation of 
the newborns studied in Phase I, to es tab 1 i sh the 
development of atopic disease in these infants, and 
to relate any such occurrence back to the values of 
the cord blood markers at birth. This phas~-.was 
primarily intended to ascertain the pred(ctive 
relevance of the cord blood markers for the 
development of subsequent atopic disease in each 
ethnic group (Section VIII, Ch. 1. 1). 
2.2 PHASE I - CORD BLOOD CROSS-SECTIONAL STUDY 
2.2. 1 Time of execution 
2.2.2 
Th is phase of the study was executed in the South African autumn 
months of March, April and May, 1985. The newborn-maternal pairs 
which complied to the selection criteria (Section IV, Ch. 2.2.3) were 
obtained at the listed maternity homes between 9 a.m. and 3 p.m. on 
consecutive week-days, r~ondays to Fridays. 
Hospitals of execution 
The newborn-maternal pairs on this study were all seen and 
investigated in maternity homes and a midwife obstetric unit (M.O.U.) 
which belonged to the University of Cape Town's Peninsula Maternity 
Hospitals group. 
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The following institutions were utilized (see Fig. IV. 2 for 
geographic location). 
(i) Peninsula Maternity Hospital. This hospital admitted Black 
and Mixed mothers for confinement. 
(ii) Mowbray Maternity Home. This hospital admitted White and 
Mixed mothers for confinement. 
(iii) Hanover Park M.O.U. This unit admitted Black and Mixed 
mothers for confinement. 
2.2.3 Selection criteria 
The newborn-maternal pairs on tnis study were obtained from random 
deliveries in the maternity homes provided tnat the followtng 
criteria were met: 
(i) Neonatal selection criteria. 
(a) A birthweight equal or greater than 2,500g. 
(b) A gestational age of 38 weeks or more. This criterion 
was satisfied if all of the following indicators of 
gestational age were in agreement. 
- A clinical estimation of the gestational age during 
labour, using the history of the last menstrual 
period, estimating the expected date of delivery and 
palpating the mother's abdomen bimanually. 
- Ultrasound evidence of gestational age by means of 
biparietal diameter estimation of the foetus in the 
first or second trimester of pregnancy. 
- A modified Dubowi tz score of the newborn ( Dubowi tz et 
al, 1970) which was equal to or above, 35 points (a 
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(ii) Maternal selection criteria 
(a) No progesterone, intravenous insulin, oral epinephrine or 
propranol ol was to have been administered to the mother 
during pregnancy or labour. 
(b) The mothers were to have been resident in Cape Town for at 
least one year before the delivery of their baby. 
(c) Formal maternal consent to participate in the st1.1dy was 
mandatory (Section IV, Ch. 2.2.4, Appendix I). 
2.2.4. Logistics 
The researcn team consisted of the author, (M.H.) together with a 
paramedical assistant with a nursing and research background, (Mrs- D 
M Phillips). They established themselves in offices within the 
relevant hospitals and the midwife obstetric unit (M.O.U.) designated 
in Section IV, Ch. 2.2.2., between the hours of 09h00 and 15h00. 
These offices were in close proximity to the labour wards. 
On arrival at the hospitals or the M.O.U., the research team visited 
tne labour wards to identify those mothers in labour who would 
potentially satisfy tne selection criteria. These mothers were 
approached and asked whether they would consent to parti ci pati on in 
the study should the baoies, likewise, satisfy the selection 
criteria. If they answered in the affirmative, the consent fonn was 
signed (Appendix I) and they were admitted to the study. 
Arrangements were made with the sister-in-charge of the laoour ward 
to ca 11 the team when the identified mothers entered the third stage 
of labour. 
On de 1 i very of the baby, cord blood was obtained, as described in 
Section IV, Ch. 2.2.5. The baby was then weighed by the labour ward 
staff using a Salter Scale and checked by tne author. The newborn's 
length was similarly estimated. A modified Duoowitz scoring system 
( Dubowitz et al, 1970) was used to estimate the gestational age of 
these newborns (Fig. IV. 3.), and the decision was then made as to 





Maternal blood was taken after the delivery of the placenta (Section 
IV, Ch. 2.2.6). The mother was interviewed in depth during the first 
24 hours of the puerperium (Section IV, Ch. 2.2.8). A questionnaire 
was completed for each maternal-neonatal pair (Section IV, Ch 2.2.9) 
with the appropriate details of the history and examination of the 
mother and the newoorn entered onto this document. The patients were 
motivated to return to the Red Cross War Memorial Children's Hospital 
for tneir first follow-up visit approximately 3 montns later. An 
appointment card with the date of the follow-up visit was handed to 
each motner. This card contained an area on which either the mother, 
the baoy 1 s regular doctor or the clinic sister would note down any 
a i 1 ments, symptoms or i 11 nesses the baby may nave developed during 
this time, together with the diagnosis and any treatment which was 
subsequently prescribed (Section IV, Ch. 2.3.4). 
Cord blood venesection Method 
After delivery of the newborn, the umbilical cord was clamped in the 
standard way and severed. Care was taken to ensure that the cord 
clamp most proximal to the placenta was applied in such a way as to 
leave at least 30cm of cord protruding from the vulva. 
A large bore needle (no. 12 or 14) was connected to a 20ml disposable 
plastic syringe. Smaller needles tended to cause haemolysis and 
increased the time needed for venesection. A 5cm length of cord was 
swabbed with a dry absorbent swab, which removed any excess materna 1 
blood from the area to be punctured. The umbilical vein was pierced 
and approximately 15ml of blood was aspirated before the delivery of 
the placenta. 
During Caesarean Section, this procedure was similarly executed 
directly before the manual removal of the placenta through the 
uterine incision. 
Maternal venesection - Method 
Materna 1 venous b 1 ood was obtained from the cub i ta 1 vein during the 
inmediate post-partum phase of labour, after the delivery of the 
placenta. If Caesarean Section was required to effect delivery of 
2.2.7 
the foetus, the maternal sample was taken just prior to the induction 
of anaesthesia. 
Approximately 10ml of blood were aspirated into a 20ml disposable 
plastic syringe using a standard bore venesection needle (no. 6 or 8). 
Processing and storage of the haematological and serum samples 
After aspiration, both the cord blood and the maternal blood were 
intnediately transferred from the individual syringes to the following 
test-tubes in the following quantities: 
a) 2ml of each specimen into separate EDTA-primed test-tubes. These 
were stored in a fridge at 4°C for up to 18 hours. These 
specimens were sent to the Haematology Laboratory at the Red 
Cross War Memorial Children I s Hospital each day, for:.:. the 
estimation of the cord blood and maternal platelet counts. ~ 
b) 2ml of each specimen into a further two EDTA primed 
test-tubes. These were similarly stored in a fridge at 4 °c for 
up to 18 hours. These specimens were delivered to the A 11 ergy 
Laboratory at the Red Cross War Memorial Children's Hospital each 
day, for the estimation of the cord blood and maternal total 
eosinophil counts. 
cJ The remainder of the blood samples (approximately 10ml of the 
cord sample and 6ml of the maternal sample) were each transferred 
to a plain glass test tube, and allowed to clot for 30 minutes. 
These specimens were then centrifuged at 2,500 revolutions per 
minute for l O minutes to separate the serum from the plasma and 
cellular blood elements. The serum was then separated from the 
plasma using disposable plastic laboratory pipettes. Each serum 
sample was transferred into a separate plain plastic test tube 
and stored at - 20°c for up to 3 months until assay. 
Once a 11 the required patients had been admitted to Phase I of 
the study, this batch of serum was transferred to the laboratory 
of the Department of Clinical Science and Immunology, Medical 




Clinical history and examination of the mother and newborn 
Within 24 hours of the delivery of the newborn, the mother was 
interviewed in detail by Mrs Phillips. This interview was supervised 
by the investigator (M.H.), and appropriate translators were used on 
the occasions where a communication problem presented itself. This 
problem was occasionally encountered during the questioning of the 
Black ethnic group, and every effort was made to ensure that the 
quest ions and answers were understood by both the mothers and the 
interrogators. 
The criteria used to define a positive atopic family history for the 
newborns are considered in Section VII, Ch. 1.3. 
Phase I Questionnaire 
The information obtained from the mother, together with the relevant 
details accruing from both the examination of the newborn and the 
special haematological and immunological laboratory investigations, 
were entered onto the Phase I Questionnaire in a format which 
facilitated the transfer of this data onto computer punch cards. 
This Questionnaire, together with details of the information 
gathered, is represented in Appendix II. 
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2.3 PHASE II - LONGITUDINAL FOLLOW-UP STUDY 




The Phase II longitudinal follow-up study was designed to run for the 
first 12 months (1 year) of the newborn's life (ie. during infancy). 
The motivation and argument for the decision on this time-frame is 
presented in Section VIII, Ch. 1.2. 
Follow-up protocol 
The infants were seen and examined at 3, 7, and 12 months of age (+/-
2 weeks). The 3 month visit was planned so that it occured before 
the infant received the first 3-in-1 Diptheria, Pertussis and Tetanus 
(DPT) vaccination, usually scheduled for 3 months of age. 
Fo 11 ow-up venue 
The mothers and infants were interviewed and examined at the Red 
Cross War Memorial Children's Hospital in Rondebosch, Cape Town. 
Three rooms were ava i 1 ab 1 e to the author and his team in the nurses 
home of the above-mentioned hospital. One served as a waiting room, 
the other as the examination room and the third as the procedure and 
venesection room. 
Usua 1 ly the mothers and their infants made their own way to the 
hospital. They received a standard travel allowance of R2,00 per 
vis it towards their commuter costs from our research fund. On the 
occasions when transport was a problem, the research assistant, 
Mrs Phillips, would either fetch the patients in her car or arrange 
for a Taxi to facilitate their transport. 
Motivation and contact strategy 
The success of Phase II depended on the quality of the motivation of 
the mothers to bring their infants back at the specified intervals 
for re-examination and assessment. Of note was the fact that the 
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majority of the babies were healthy. It was, therefore, 
understandable that some mothers were initially disinclined to return 
to the hospital for the evaluation of their infant, particularly 
since the infants venesection procedure usually reduced the infant to 
vociferate tears. Furthermore, the sight of a needle being inserted 
into the neck of their baby was an ordeal for those mothers who opted 
to stay with their infants during this procedure. 
Intensive motivation and the establishment of a meaningful, trusting 
and intimate relationship between the author and the mothers was 
mandatory. 
Before the mothers left the maternity hospitals after their 
confinement, they were handed a card with the date of their 3 month 
appointment noted on it. This card also served as a record card for 
the infant's doctor, paediatrician or the clinic primary care nursing 
sister. They were encouraged to enter the diagnosis and treatment of 
any condition or illness which the infant may have developed bet'ween 
the follow-up visits onto this card. This information was used at 
each follow-up visit to determine the clinical atopic classification 
for each infant (Section VII, Ch. 1). The mothers were also asked to 
ensure that the first DPT immunisation was not administered before 
the first visit, but to ensure that all three immunisations were 
completed in the 4 months time-period between the 3 and the 7 month 
follow-up visits. 
Full details of the study, with the objectives and the benefits to be 
gained by their infant from their participation in the study, were 
carefully explained to them. The early detection of any physical 
abnormality, as well as the early detection of any possible allergic 
symptomatology was an obvious benefit to them. The results of the 
cord blood and subsequent IgE concentration assays, together with the 
other haematological parameters measured at birth and at each 
follow-up visit, would be made available to them and their private 
doctors after each successive visit. They were given our telephone 
number at the hospital, and were encouraged to call us on any matter 
which was causing them concern. Finally, the research assistant 
(Mrs Phillips), promised to telephone them during the 2nd month after 
the newborns birth, in order to make an appointment to visit their 
respective homes on a courtesy visit. 
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Each mother was visited by Mrs Phillips approximately 6 weeks after 
the birth of the baby. In most cases where the families had 
telephones, these visits were by appointment. In those cases where 
no telephone existed (especially relevant in the Black squatter camp 
population in the Cross Roads area of the Cape Flats), these visits 
were unannounced. If the mothers were not at home, a message was 
left and the visit repeated soon afterwards. During these visits, 
the mothers were again encouraged to return to the hospita 1 for the 
first 3 month follow-up visit. It was also made clear to the 
families that treatment for any illness or medical condition the 
child may develop would be arranged for them, free of charge, should 
they not have ready access to medical assistance. This was 
especially relevant for the Black mothers and infants whom did not 
have access to private medica 1 care. The Red Cross War Memoria 1 
Children's Hospital has an enviable reputation among the public as a 
hospital of excellence, and this facilitated the compliance of the 
mothers to a large degree. 
During each follow-up visit, Polaroid photographs were taken of the 
babies and given to the mothers. Any co-incidental social problems 
were attended to, free of charge, and referral to other relevant 
departments or doctors were facilitated by us if this was necessary. 
Formal contact reports were sent to the infant's private family 
physicians where applicable, as a matter of courtesy. This served to 
enlist the support of those doctors, who then encouraged their 
patients to continue with the study. 
After each visit, the mothers were given a new appointment for the 
following visit. It was noticed that the opportunity for the mothers 
to meet each other again after the confinement and to renew the 
friendship which they had established during their confinement was a 
great incentive for them to return for each subsequent visit. Great 
care was subsequently taken to arrange the follow-up visits so that 
the various groups of mothers who were acquainted could return on the 
same days. 
Each mother was also circulated with a motivational letter about a 
month before the following appointment, both to act as a reminder to 
2.3.5 
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attend, and also to underpin the personal interest which the 
investigator (M.H.) had in the welfare of the infants concerned. 
Appendix III is an example of the letter sent out before the 7 month 
follow-up visit, and Appendix IV an example of the final letter of 
thanks sent out after the completion of the study. 
Of great concern during the follow-up period was the fact that South 
Africa was experiencing a time of escalating political, social and 
economic upheaval. Urban and township violence, intimidation, school 
and hospital boycotts, security force intervention in the Black 
townships and confrontation within and across racial barriers became 
the order of the day during 1985 and 1986. The result of this 
unstable political climate was the imposition of 2 States of 
Emergency in the Cape Peninsula during this period. Since much of 
the unrest was concentrated in the Black townships, many of our Black 
mothers found it impossible to attend for follow-up in spite qf the - . 
intensive efforts on our part to locate them. Many returned back to 
their original homes in Transkei and Ciskei (Fig IV. 1), while others 
were forced to flee the faction fighting occuring in the squatter 
areas of Cross Roads and to take refuge in the sprawling relief area 
of Kye 1 i tsha, 10km east of Cross Roads. This area had no roads or 
addresses at that time, and was a disaster zone for all intents and 
purposes. 
The drop-out rate for our White and Mixed patients was extremely low, 
but the events described above lead to a substantial loss of patients 
belonging to the Black ethnic groups during the 1 year follow-up 
period. 
Logistics of the follow-up visits 
Approximately 5 mothers, together with their infants, were booked for 
each morning during the fo 11 ow-up periods. Their appointment times 
were staggered so as to facilitate their processing and to give each 
mother and infant personalized attention and care. The research 
assistant (D.P.) welcomed the mothers, gave them a cup of tea, and 
weighed the infants on a Salter scale. The Polaroid photographs of 





The clinical examination and history-taking followed, after which the 
infants proceeded to the procedure room for venesection. Thereafter, 
the mothers were given the next appointment and were again motivated 
to continue with the study. 
Clinical history and examination of the infant 
Because it was necessary for the author personally to spend some time 
making social contact with the mothers, and also to do the 
venesection himself, it was necessary to enlist the help of two 
Paediatric Medical Officers to elicit the detailed history and to 
examine the infant. Any undue delay irritated some of the mothers, 
and jeopardized their further compliance in the study. The Medical 
Officers were Dr Sehaarn Abrahams and Dr Ruth Barruch. 
After each examination, the author consulted with these medical 
officers, and any positive features, either on the history or on-the 
examination, were personally assessed and confirmed by the author.~ 
Infant venesection - external jugular vein puncture 
The infants were wrapped in a restraining linen sheet with their head 
and neck accessible for venesection. The research assistant placed 
the infant on its side on a padded table top, with the head laterally 
extended over the edge to expose the external jugular vein. The skin 
over the vein was cleaned with a disposable PREPTIC swab, and the 
vein punctured with a scalp vein set needle. Ten ml of blood was 
aspirated from this vein. If the venesection failed on the one side, 
for technical reasons, the contralateral external jugular vein was 
visualized and punctured. 
On removal of the needle, a disposable gauze swab was applied to the 
puncture wound and pressure was exerted on this site by the author's 
thumb for 2 minutes in order to prevent the formation of a haematoma. 
Processing and storage of the haematological and serum samples 
The blood specimens obtained from the infants at each follow-up visit 
were processed and stored in the same manner as was described for the 
2.3.9 
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processing and storage of the cord Dlood and maternal haematological 
samples (Section IV, Ch. 2.2.7). 
The same haematological and immunologic parameters were measured on 
these infant specimens as were measured in Phase I of the study on 
the cord blood with the following exceptions: 
(i) Serum IgA concentrations were not measured. 
(ii) RAST for Dermatophygoides pteronnysinus was measur~d, in 
addition to the RAST for egg white and cows milk. 
(iii) RAST for Ascaris lumbricoides was not measured. 
Pnase II Questionnaire 
Tne information obtained from the nistory and examination of the 
infants, together with the results of the haematology and serological 
examinations were entered onto tne Phase II Questionnaire 
( Appendi X V). 
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TABLE IV.I. 
SUPERSENSITIVE PRIST: RADIOACTIVITY BINDING INDEX 
COUNTS(%) AGAINST STANDARD IgE TEST KIT UNITS. 
STANDARD PRIST KIT TIME COUNTS PER BINDING INDEX 
CONCENTRATIONS MINUTE (%) 
IgE (kU/1.) (C.P.M.) (REFERENCE) 
0.01 l.O 355.0 0.76% 
0.01 1.0 404.0 0.99% 
AVERAGE= 0.87% 
0.05 1.0 545.0 1.64% 
0.05 l.O 530.0 1.57% -
AVERAGE= 1.60% 
0.25 1.0 939.0 3.45% 
0.25 1.0 955.0 3.53% 
AVERAGE= 3.49% 
0.5 1.0 1533.0 6.19% 
0.5 1.0 1700.0 6.96% 
AVERAGE= 6.58% 
1.0 1.0 2282.0 9.65% 
l.O 1.0 2500.0 10.65% 
AVERAGE= 10.15% 
2.5 1.0 4697.0 20.78% 
2.5 1.0 4612.0 20.39% 
AVERAGE= 20.59% 
7.5 1.0 9437.0 42.64% 
7.5 1.0 9584.0 43.32% 
~ 
AVERAGE= 42.98% 


































































































































CHAPTER 3 LABORATORY TECHNIQUES AND ASSAY METHODS 
3.1 CORD BLOOD AND INFANT FOLLOW-UP SERUM IgE CONCENTRATIONS 
CBsigE was measured using a modification (Haus et al, 1988) of the 
commercially avanable IgE PRIST (Pharmacia) (Johannsen et al, 1976; 
Kjellman et al, 1976). Two hundred microlitres of standard serum, 
control serum or patient serum was incubated with IgE paper discs for 
24 hours with continued shaking. After washing three times, 100 
microlitres of 125 I rabbit anti-human IgE tracer were added and 
incubated with the disc for 24 hours at room temperature using a 
Braun Shaker. After washing three times, tubes were capped and the 
radioactivity counted using a Beckman ganrna counter. Counts bound 
for the standards were expressed as a percentage of the total 
radioactivity added in the tracer and plotted against the IgE 
concentration on linear log paper (Table IV, I). A standard~c-urve 
was constructed by diluting the standards of the Pharmacia IgE YRIST 
kit with IgE-free diluent at the following concentrations: 7.5, 2.5, 
1.0, 0.5, 0.25, 0.05, 0.01 kU/1. IgE-free diluent was used as a 
negative control and consistently gave readings of less than 0.01 
kU/ml. This assay gave predictable and reproducible results with 
dilutions of standard IgE sera. Since the standard curve reading of 
IgE from 0.01 - 2.5 ku/1 range was piecewise linear, (Fig. IV, 7) the 
assay was regarded as being sensitive to 0.01 kU/1. Reproducibility 
was further tested using control sera of known IgE concentration, 
diluted to fall within the range of the standard curve with IgE-free 
diluent. 
If either a cord blood or an infant follow-up serum IgE concentration 
was measured above the value of 2.5ku/l using this supersensitive 
technique, the assay was then repeated on the specimen using the 
standard overnight incubation Phadebas IgE PRIST R radioimmunassay 
(Pharmacia Diagnostics), with a standard curve covering a range of 
0.5 - lOOkU/1. 
Using dilution factors, serum IgE concentrations between 0.5 - 800 
kU/1 may be measured in this manner. 
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3.2 MATERNAL SERUM IgE CONCENTRATIONS 
The maternal serum IgE concentrations were assayed using the standard 
overnight Phadebas IgE PRIST radioimmunoassay {Pharmacia Diagnostics) 
as described in Section IV, Ch. 3. 1. 
3.3 CORD BLOOD AND INFANT FOLLOW-UP SPECIFIC IgE RAST {PHARMACIA) FOR EGG 
WHITE, COW'S MILK, ASCARIS LUMBRICOIDES AND DERMATOPHYGOIDES 
PTERONYSSINUS 
The cord blood and infant follow-up specific IgE concentrations for 
egg white, cow's milk, Ascaris lumbricoides and Dermatophygoides 
pteronyssinus were measured using a modification of the commercially 
available, standard single overnight incubation Phadebas RAST 
radioimmunoassay {Pharmacia Diagnostics). This modification 
increased the sensitivity of the test. 
One hundred microlitres of the patient's serum was incubated at room 
temperature on a shaker, with the relevant commercial RAST allergen 
disc, for 24 hours. After washing three times to eliminate any 
non-specific IgE, 50ml of radioactive anti-IgE 125 I tracer was 
added, and the test tubes were again incubated for a second time at 
room temperature, on a shaker, for 24 hours. After three more 
washes, the test tubes were capped and the radio-active specific IgE 
anti - IgE 125 I complex measured using a Beckman Gamma Counter. 
The patient counts were compared directly with counts of reference 
sera run in parallel, as well as with known negative and positive 
sera. 
Calculation of Results: 
References A, B, C, D and E were assigned to the Phadebas RAST Unit 
per ml {PRU/ml) values of 17.50, 3.50, 0.07, 0.35 and 0.11. The mean 
value of duplicate Gamma Counter counts for each reference serum were 
plotted against the assigned PRU/ml values in a logarithmic diagram. 
The unknown patient PRU/ml values for the test samples were then read 
from this reference. PRU/ml values of less than 0.11 represented 
absent or undetectable levels of allergen - specific IgE antibodies. 
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The RAST scoring and evaluation of the patients PRU/ml values are 
summarised in Table IV. 2. The definition for the corresponding RAST 
classes as reported in this thesis are also included in this Table. 
The reference serum volume was 100 microlitres, together with a Birch 
reference paper disc, while the control serum volume was also 100 
microlitres, together with a cat reference paper disc. 
control serum was calibrated to contain 2 PRU/ml of 
antibody. The accepted range was +/- 0.1 PRU/ml. 




3.4 MATERNAL SPECIFIC SERUM IgE RAST (PHARMACIA) FOR EGG WrlITE, COW'S 
MILK ANO ASCARIS LUMBRICOIDES 
The maternal specific serum IgE concentrations for egg white, cow's 
milk and Ascaris lumbricoides helminth were measured using the 
standard convnerci ally avail aDl e single overnight incubation Phadebas 
RAST (Phannacia Diagnostics) procedure. 
3.5 CORD BLOOD AND MATERNAL SERU1"1 IgA CONCENTRATIONS 
Both the cord blood and maternal serum IgA concentrations were 
estimated by nephelometry, using the Beckman Invnunochemistry 
Analyser. The units used to express the results were mg/dl. 
3.6 CORO BLOOD, Ir.JFArH FOLLOW-UP AND MATEKNAL ANTI-COW'S MILK SERUM IgG 
CONCENTRATIONS 
The cord blood and infant follow-up anti-cow's milk serum IgG 
concentrations were measured using an ELISA technique. 
Ninety six - well microtitres plates (Dynatech Labs) were used for 
the assay. Fifty microlites of a solution of approximately 20 mg/ml 
of whole cow I s milk were added to each we 11 and incubated at 4°c 
overnignt. This mixture was then washed three times with T.S.T. 
(Tris Saline Tween - 12.lG Tris, 11.7G Sodium Chloride and 1ml Tween 
20 made up to 2 litres and a pH of 8.0). Two hundred and fifty 
microlitres of a O.S'.t gelatin solution was added to each well and 
incubated at room temperature for l 1/2 hours. This was followed by 
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TABLE IV. 2. 
RAST SCORING AND EVALUATION 
COUNTS OF UNKNOWN (PRU/ml) 
Pnadebas Level of allergen 
RAST specific IgE 
Class Less than Greater than antibody 
counts of counts of 
4 - Reference A Very high 
17 .50 
3 Reference A Reference B 
17 .50 3.500 High 
2 Reference B Reference C 
3.500 0.700 Moderate 
l Reference C Reference D 
0.700 0.350 Low 




another two washings with T.S.T. Fifty microlitres of a 1/lOth 
dilution of the patient's serum was then added to each well and again 
incubated for 1 1/2 hours. This mixture was now washed four times 
with P.B.S. - 9 {Phosphate Buffered Saline - 9, containing 17.4G 
Sodium Chloride, 3.56G Sodium Hypophosphate and water added to make 
the solution up to 2 litres). Fifty microlitres of a 112000th 
solution of peroxidase conjugated sheep anti-human IgG {Cappal Labs) 
was now added, and again incubated for 1 1/2 hours. Another four 
washes with P.B.S. - 9 were done before the addition of 100 
microlitres of ABTS peroxidase substrate {100 rnicrolitres ABTS, 
100 microlitres of a 30% hydrogen peroxide solution and 10ml of 
citric acid buffer). 
Spectrophotometric analysis and reporting units 
The spectrophotometer was zeroed against blanks { ie, the components 
of the assay without the patient serum). The results were repo-rted 
in units which showed the optical density difference at ~414 
nanometres - n O.D. {414nm). 
3.7 CORO BLOOD, INFANT FOLLOW-UP AND MATERNAL TOTAL EOSINOPHIL COUNTS 
The TEC's were performed within 18 hours of venesection. The method 
used was a modification of the method as described by Dacie and 
Lewis, 1984. A mixture of 2% aqueous eosin {5ml), acetone {5ml) and 
distilled water {90 ml) was used as diluting fluid. The unclotted 
blood specimen was mixed on a rotator for 5 minutes, after which 0,02 
ml of the whole blood was similarly mixed with 0,38 ml of diluting 
fluid on the rotator for 5 minutes. The improved Neubauer counting 
chamber was filled with this mixture, which was allowed to settle in 
a moistened petri dish for 5 minutes. The whole area {3x3 = 9 
squares) was then counted. The TEC was obtained by multiplying the 
count by a correction factor, i.e. 
10 X 20 X X 
9 l l 
= 200 X X 
9 l 
= 22 x X cells/mm2 
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3.8 CORD BLOOD, INFANT FOLLOW-UP AND MATERNAL PLATELET COUNTS 
The platelet counts were performed using a Model S Plus IV Coulter 
Counter automated blood cell counter (Coulter Electronics). 
An Electrical Voltage Impedence automatic cell counter method was 
used. The blood sample was not subject to gravitational 
sedimentation nor was it contrifuged to achieve accelerated 
sedimentation before the sample was added to the Coulter Counter. 
The units reported on were multiplied by a factor of 109/litre. 
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CHAPTER 4 STATISTICAL CONCEPTS AND METHODS 
The dependent variables considered for analysis in this thesis are 
IgE, eosinophils, platelets and anti-cows milk IgG. 
The serum concentrations of IgE and IgG are measured on what can be 
considered a continuous scale. The accuracy to which serum IgE is 
measured is two decimal places, whilst the accuracy to which 
anti-cows milk IgG is measured, is to one decimal place. The 
platelets and eosinophils are discrete count values as they are 
measured as an integer number. For all variables, the number scale 
starts at zero and increases. These factors, together with the 
sample size, are taken into consideration in deciding which 
statistical test to use to test the hypothesis. 
4.1 STUDY DESIGN AND SAMPLE SIZE 
This is an exploratory study. The study design is to observe: a 
cohort from eacn of the three races under consideration at birth, and 
to recall each individual at 3, 7 and 12 months for observation. 
This gives rise to a cross-sectional study between the races at each 
observation period (where blood parameters and certain 
i11111unoglooulins can oe compared) and also to a prospective 
longitudinal study within each race group. 
Si nee no previous study on the 3 race groups observed here exists, 
there were no prior estimates of the average values or the standard 
deviation of the blood parameters under investigation. It was 
therefore impossible to calculate the necessary sample size for each 
race required to show a statistically significant difference. The 
decision as to how many people were included in the study was 
consequently determined by how many babies qualifying under the 
inclusion criteria were born during the 3 months of the Autumn 
season, in hospitals where the study was conducted, during the hours 
stipulated in Section IV. Ch. 2.2.1. 
Any future similar study should include sample size calculations as 
the required estimates of the statistical parameters needed for these 
calculations are now available. The contentious issue of whetner a 
statistically significant difference is clinically relevant still, 
however, remains. 
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Another issue remains. Can the sample selected be considered 
representative of the population and, by not specifying prior 
constraints, will the ratio of individuals in the sample presenting 
with an aHF to those without an aFH be representative of that ratio 
in the population? Without prior information, this can lead to 
unequal numbers in the groups compared. 
4.2 STATISTICAL CONCEPTS 
4. 2. l 
The following discussion addresses the concepts required to calculate 
the power of an hypothesis test, and why this calculation couJd not 
be done in this study. 
Hypothesis Testing 
Hypothesis Testing is the process of making a decision about whether 
or not to accept a certain statement about parameters from-" a 
population based on information contained in the sample drawn from 
the population. If, however, the sample is not representative of the 
population, either because the sample nas not been randomly drawn 
from the population or because the sample size is too small, caution 
must be exercised in generalizing the results. 
The null hypothesis under test is the statement about a statistical 
parameter cnaracterizing the distribution of some variable of 
interest. The null hypothesis is always tested against an 
alternative hypothesis, which is a statement that "the null 
hypothesis not true11 • 
The decision to accept the null hypothesis is not equivalent to the 
opinion that "the nul 1 hypothesis is true" but rather that "the nul 1 
hypothesis has not been shown to be false", which could be the result 
of insufficient evidence. 
In an exploratory study the alternative hypothesis should always be a 
directionless statement eg. that the medians of the two groups 
compared are not equal, giving rise to a two-tailed test. 
4.2.2 
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Testing hypotheses depends upon underlying probability distributional 
assumptions which will not be considered here. 
Components of an Hypothesis Test 
Consider that the test statistic (a function of the sample estimate 
of the population parameter under interest) is given in terms of the 
population mean, denoted by).{. For simplicity consider a one-tailed 
test, with null hypothesisµ =,l.( 0 and is tested against the simple 
a 1 terna ti ve hypothesis).{> Mo· 
FIGURE Z 
(b) 
Curve (a) represents the sampling probability distribution of the 
samp 1 e mean, X, when.,«= ,.t(o. 
Curve (b) represents the sampling probability distribution of the 
sample mean, X when .,tt > .Mo· 
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Here the sample mean, X, is calculated from the samples drawn and 
estimates the population mean,).(.. The accuracy of this estimate 
depends upon the 11 quality 11 of the data in the selected sample and 
also upon the sample size. 
If tne sample parameter differs greatly from the nypothesized value 
of the population parameter as stated in the nul 1 hypothesis, then 
the null hypotnesis would probably not be accepted. 
(a) Significance Level 
The level of significance, denoted by d... , is the maximum 
probability of not accepting a true null hypothesis. This area 
is tne dark shaded area under curve (a) to the right of(*) in 
the diagram . In all tests in this study, a 5% significance 
level,o( = 0.05, was used. 
(b) p-value 
The reported p-value is the smallest significance level at which 
the null hypothesis would not be accepted for the given 
observation. 
This value is compared to the chosen value of the significance 
level,rx. If the p-value is less than 0.05 then, on the 
information contained in the sample, there is evidence that tne 
nul 1 hypothesis cannot be accepted, and hence to accept the 
alternative nypothesis as being true. Tnis would indicate that 
the sampling distribution curve (b) in Figure Z would be correct. 
The larger tne p-va l ue, the stronger the evidence to accept the 
null nypothesis. When p=l .UO, it is accepted that the parameter 
values being investigated are considered identical. 
Decision 
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(c) Errors in Testing Hypotneses 
The types of errors which can be made in testing a hypothesis are 
tabulated oelow: 
Null Hypothesis 
Actua 11 y true Actua 11 y fa 1 se 
To accept error or type II 
null nypotnesis Correct error 
Not to accept - error or type I 
null hypotnesis error Correct 
The probability of making a type I error, (not accepting a true null 
hypothesis) is given by the significance level, denoted by r:J. in 
Figure Z. The probaoility of making a type II error, or of accepting 
the nu 11 hypothesis when it is actually fa 1 se, is denoted by the 
area/3, in Figure Z. Tnis area~, is under cure (b) to tne left of 
( *). 
Eitner error is undesiraole and it is desiraole to have and small. 
The quantities o{,f, and the sample size are inter-related and generally 
Doth o( and ~ can be small only by increasing tne sample size. 
Usually a desirable decrease in tne significance level, o(, is 
accompanied by an undesiraole increase inp'. 
(d) Tne Power of an rlypothesis Test 
The power of an hypotnesis test is the aoil ity of an nypothesis test 
to find a difference (if one exists) in the estimated population 
parameters, i e. it is tne probabi 1 i ty, denoted by 1- /,, of accepting 
the alternative hypothesis when it is true. 
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The power of an hypothesis test depends upon: 
the chosen level of significanceo<.., 
the size of the sample. (small differences will be easier to 
detect with a large sample, since it will increase the power of 
the test. Once a statistical difference has been shown, the 
question then asked is whether it is of practical importance or 
not). 
the variability of the data. (Generally the greater the 
variability of the data, the lower the power. The sample size 
also influences this facet, through the sample variance). 
the distribution of the sample mean, which asymptotically tends 
to normality ie. as the sample size increases to infinity so the 
distribution of the sample mean tends to the normal 
distribution. How quickly this distribution converges to the 
normal (Gaussian) depends upon the shape of the underlying 
population distribution from which the sample is drawn. Fpr 
highly skew distributions it would require large sample sizeJ, 
(probably n 100) before the distribution of the sample mean 
could be considered normal. 
Formula for calculating sample size. 
Assume that 2 groups are to be compared, and the groups are of equal size, 
ie. I"\ ::. n, =- r\2_, then: 
"~ ( c:1{'· ... e!:) [ :c.(~) + ~ (P)J'' 
( A-, - M.2.)4-
is the approximate sample size for each group, assuming an underlying normal 
distribution and that the population variances Cf. 2. a.:nd Cf; are known. If 
they are not known the t-distribution is used and the above formula only 
provides an approximation, which is good if n1 and n2 are large. 
If the distribution of the variable under consideration cannot be 
characterised or normality not assumed, the power of the test cannot be 
calculated as is the case in this study. 
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e) Asymptotic Relative Efficiency 
For non-parametic tests where the underlying distribution cannot 
be characterised the Asymptotic Relative Efficiency criterion is 
used to compare the behaviour of the non-parametic test to its 
parametic counterpart. More specifically the two-sample 
parametic test used to detect differences between means is the 
two sample t-test which assumes that the sample is drawn from a 
normally distributed population, in addition to other 
assumptions of the model. 
The non-parameti c counterpart of the two sample t-test is the 
Mann-Whitney-LI test. The Mann-Whitney-LI test is almost as 
powerful as the t-test if the normality assumptions are true and 
differs for other distributions. An interesting safety feature 
of the Mann-Whitney-LI test is that the Asymptotic Relative 
Efficiency is never less than 0.864, which is a valua~le 
property of this non-parametic test. 
The calculation of this property depends upon the sample size 
being very large. 
4.3 PROBLEM OF OUTLIER OBSERVATIONS 
The arithmetic mean is very sensitive to outlier values in the data 
set. The standard deviation, being a measure of variation about the 
mean is similarly sensitive to outlier values in a data set. Neither 
the median nor its corresponding measure of variation, ( the 
interquartile range) is sensitive to outlier values in a data set, 
since these statistical parameters depend upon the rank of tne 
observations in a data set. In transforming a data set onto the rank 
scale information is lost since the distance between the observation 
values of 0.01 and 0.02 on the untransformed scale is 0.01 and on the 
rank scale it is 1 unit. Likewise, the distance between 6.77 and 
15.00 on the untransformed scale is 8.23 units whilst on the rank 
scale it is 1 unit since these are the two largest values in the data 
set. 
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Using the data set is given in Table IV.3, tne transformation to 
ranks is illustrated in Figure IV.8. The sensitivity of the 
geometric mean (using the logarithmic transformation of the data), 
the aritnmetic mean, its standard deviation, the median and the 
inter-quartile range, using the data given in Table IV. 3, is 
illustrated in Table IV.4. 
4.4 DESCRIPTIVE SUMMARY STATISTICS FOR EACH VARIABLE 
Tne frequency distribution of tne values of this variable is highly 
positively skewed i.e. the majority of tne values are found in the 
lower region of the range witn a few very nign values which 
influences the average va 1 ue or measure of centra 1 tendency of the 
data set. One way to circumvent this problem is to transform the 
values onto the logarithmic scale to try to create a more symmetric·· 
frequency distribution of the data. (This attribute is sought in 
data sets where parametric tests e.g. the t-test, are used for the 
statistical analysis). 
The arithmetic mean of the untransformed values of lg£ is greatly 
influenced by the high outlying values. In transforming the 
individual values onto tne logaritnmic scale, the geometric mean 
(arithmetic mean of the logarithmic values) is still influenced, 
tnougn to a lesser extent, oy these influential outlying values. 
The median, nowever, remains relatively stable to fluctuations in tne 
outlying values and was thus the preferred measure of tne average 
value of tne serum IgE concentration value. The median is that 
observation such that half the observations exceed it and nal f fall 
below it i.e. it is that point of the frequency distrioution which 
divides it into two equal parts. Thus the median is the middle of a 
frequency distribution but only in the sense of the rank order of the 
magnitude of tne observations. When using the median to describe the 
average value or the measure of central tendency of a frequency 
distribution, the magnitude of the distance between ooservations 
(i.e. the actual values) is not used but only the ranked value of the 
observation. Hence information about the individual values in a data 
set is lost. 
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TABLE IV 3. 
CORD BLOOD SERUM IgE CONCENTRATION LEVELS 
VALUE COUNT VALUE COUNT VALUE COUNT VALUE COUNT 
0.01 2 0.12 3 0.33 1 0.96 1 
0.02 2 LI. 13 2 0.37 1 1.02 1 
0.03 3 0 .14 2 0.38 1 1.54 1 
U.04 1 0.16 2 0.44 1 1.92 1 
0.05 1 0. 17 l 0.46 1 2.03 1 
0.06 1 0.18 1 LI. 77 1 3.18 1 
0.07 1 0. 19 2 LI. 7 Y l 3.3d l 
0.08 2 0.23 1 u.84 l 6. 77 1 
Ll.09 2 0.24 1 0.86 1 1 s.oo 1 
0. 10 3 0.2d 1 0.90 1 
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Eosinophils, platlets and anti-cows milk IgG 
In order to maintain uniformity, the median was used to describe the 
average value of the above variables as well. 
General comments 
The descriptive measure of dispersion if the median is used is the 
i nterquarti 1 e range or the di stance between the 25th ( Ql ) and the 
75th (Q3) percentile. The standard deviation gives a measure of the 
spread of the observations around the arithmetic mean. The r~lative 
position of the mean and the median together with the associated 
measures of dispersion give an indication of the skewness of the 
frequency distribution of the variable. 
4.5 ANALYTICAL ~ETHODS 
4. 5. 1 
4.5.2 
The Kruskal-Wallis Test 
The i<ruskal-Wallis Test was used to test the null hypothesis that 
there is no difference in the median value of three or more groups 
against the alterriative nypothesis that there is a difference. This 
test was used when comparing blood parameters for all 3 race groups. 
The Mann-Whitney-LI Test 
The Mann-Whitney-LI Test was used to test the hypothesis that there is 
no difference in the medians (average value) of the two groups 
compared. The use of a statistical test like the Mann-Whitney-LI 
requires a transformation of the data by ranking. This transformers 
the values to those with a uniform distribution with not outliers. 
This test was preferred to the t-test since the number of 
observations in the groups compared were generally not equal and the 









































































1 obs. deleted. 
See note 5 
O









































































































































































The Fisher's Exact Probability Test 
The Fi sher I s Exact Probabi 1 i ty Test is often used when two 
independent samples (variables) are small in size and placed in two 
mutually exclusive classifications. The test determines whether the 
two groups differ in the proportion in which they fall into the two 
classifications. The level of significance (p-value) of this test is 
exact as the test does not depend on underlying distributional 
assumptions. 
This test was applied to this data set when the data for each race 
group was categorized at a cord blood IgE value of 0.50 kU/1 and the 
proportion of individuals above and below this value in the 
non-atopic and in the atopic family history groups were compared. 
4.5.4 The Spearman Rank Correlation Coefficient 
A correlation coefficient gives a measure of linear associat1on 
between the two variables considered. It can also be used to give an 
indication of tne strength of a linear trend in the data. 
The Spearman Rank Correlation Coefficient is a non-parametric measure 
of association and does not require the underlying assumption that 
the data is normally (Gaussian) distributed. The significance of the 
value of the correlation coefficient depends on the size of the 
sample used to calculate it. Caution must be exercised in 
interpreting the results when testing the hypothesis that the 
correlation coefficient is zero and hence that there is no linear 
association oetween the 2 variables against the alternative 
hypothesis that the correlation coefficient is not zero and that 
tnere is a linear association between the two variables. The results 
from this hypothesis test are greatly influenced by the sample size 
of each of the two variaoles. 
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SECTION V 
RESULTS - PHASE I 
CHAPTER I TECHNICAL DETAILS PERTAINING TO THE DATA ANALYSIS AND 
PRESENTATION 
1.1 DEFICIENT DATA 
1.1 .1 Sex code 
One of the Black baDi es (Patient Code Number 303) nad no sex code 
recorded. This case was omitted from the analysis when the data set 
was categorized on sex codes. 
1.1.2 Birtn mass 
The following babies had no mass recorded at birth: 
ltlhite Group: 
Patient Code Number 
402 
Estimated Gestational Age 
39 weeks 
409 40 weeks 
Since one of the exclusion criteria for the newborns was a birth mass 
of less tnan 2,500gm, this value was important. It was decided that, 
since the gestational age of the aoovementioned baDies was greater 
than 38 weeks, an assumption could oe made tnat the mass at birth was 
also acceptable. 
1 .2 NEWBORNS EXCLUDED FROM THE STUDY 
The exclusion criteria were: 
a) a gestational age of less than 38 weeks 
or b) a mass at birth of less than 2500 gm. 
or c) a Daby who was born to a mother who had not been resident in 
the Cape Peninsula for at least one year prior to the Dirth. 
Any one of these criteria needed to be fu 1 f i 11 ed for the baby to be 
excluded. The following newDorns were excluded on one or other of 
these criteria: 
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ETHNIC GROUP EXCLUSION CRITERIA PATIENT CODE RESULT 
NUMBER 
Black newborns - 1 on gestational age 220 35 weeks 
and on mass at birth 2300 gm 
- 1 on mass at birth 230 2150 gm 
White newborns - 1 on mass at birth 415 2360 gm 
Mixed newborns - 2 on mass at birth 51 2300 gm 
54 2060 gm 
. -·-
1.3 CATEGORIZATION OF THE DATA 
The data is presented in the form of the following 6 categorizing 
variables in each ethnic group for each of the four markers. 
(i) Ethnic group 
(ii) Sex 
(iii) Atopic family history 
(iv) Maternal Ascaris lumbricoides RAST (Pharmacia) 
(v) Combined negative maternal Ascaris lumbricoides RAST 
(Pharmacia) and negative aFH 
(vi) Maternal cigarette-smoking. 
The data will, furthermore, be presented in the following formats: 
i) Descriptive statistics for each category in each ethnic group. 
ii) Comparative statistical analysis for each category between or 
within the ethnic groups (whichever is the more appropriate to 
the category concerned). 
The definitions used to categorize the data into the six sub-groups 
are listed below. 
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1 .3.1 Ethnic group categorization 
1 • 3. 2 
This category was defined according to the conunon ethnic 
classification of the newborn's mother. 
Sex categorization 
This category was defined according to the sex of the newborn (male 
or female). 
1.3.3 Atopic family history categorization 
1 .3 .4 
A positive or a negative atopic family history for the newborn was 
decided on after questioning the motner according to the criteria for 
a family history of atopy as described in Section VII, Ch. 1.3. Only 
the first degree relatives of the newborn were considered (mother, 
fatner or sibling). 
a) Inclusions on a positive atopic family history. 
The newborns in this sub-group were those where one or more of 
the first degree relative had an atopic history. 
b) Inclusions on a negative atopic family history. 
The newborns in tni s sub-group were those where none of their 
first degree relatives had a history of atopic disease. If tne 
allergic status of any of the newborn's first degree relatives 
was unknown, the atopi c status of these family members was al so 
regarded as negative. 
Maternal Ascaris lumoricoides RAST (Pharmacia) categorization 
All newborns had negative Ascaris RAST results. The maternal Ascaris 
RAST result was therefore used to divide the data set into two 
sub-groups, based on newborns who had mothers with either a positive 
(Phadebas RAST class greater than O - see Table IV. 2) or a negative 





Combined negative maternal Ascaris lumbricoides RAST (Pharmacia) and 
negative atopic family history categorization 
For reasons which will be addressed in the discussion of this thesis 
(Section VII), this category was established by including only those 
newborns who had neither a positive maternal RAST for Ascaris 
lumbricoides nor a positive atopic family history. 
Maternal cigarette smoking categorization 
This category was established to differentiate the newborns into two 
groups, depending whether or not their mothers smoked cigarettes. 
This categorization was independent of the number of cigarettes 
smoked by the mother per day or the smoking habits of the rest of the 
family. 
THE NUMBER OF NEWBORNS IN EACH SPECIFIED CATEGORY AND 
SUB-CATEGORY 
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CHAPTER 2 CORD BLOOD ATOPIC MARKERS 
2.1 DESCRIPTIVE STATISTICS 
2. 1. 1 
2. 1.2 
2. 1.3 
2. l .4 
This data is presented for all six categorizations in each ethnic 
group for the following markers. 
Cord blood serum IgE concentrations 
This data is presented in Table V.2. 
Cord blood total eosinophil counts 
This data is presented in Table V.3. 
.. 
Cord blood platelet counts 
-,:. 
This data is presented in Table V.4. 
Cord blood anti-cows milk serum IgG concentrations 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































TOTAL EOSINOPHIL COUNT 
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Graphic distribution plot for CBsigE, relative to a atopic family 
history 
The distribution of CBsigE 
negative aFH were plotted. 
Fig 1 s. V. 1, V.2 and V.3. 
values relative to a positive or a 
This data is graphically depicted in 
The newborns with a positive aFH represented by a solid circle. The 
newborns with a negative aFH are represented by an open circle. 
Fig. V. 1. Cord blood serum IgE concentrations (Black newborns). 
Fig. V.2. Cord blood serum IgE concentrations (White newborns). 
Fig. V. 3. Cord blood serum IgE concentrations (Mixed newborns). 
2.2 COMPARATIVE STATISTICS BETWEEN THE ETHNIC GROUPS FOR 
DIFFERENT CATEGORIZATIONS 
2.2. 1 
The differences in the descriptive data presented in Section V. 
Ch. 2.1 between each ethnic group, for the following categorizations 
were tested for statistical significance. 
i) Ethnic group categorization (total group). 
ii) Atopic family history categorization. 
iii) Maternal Ascaris lumbricoides RAST (Pharmacia) categorization. 
Since the sub-groups with positive maternal Ascaris lumbricoides 
RAST 1 s were so small (Black 7; White 1; Mixed 7) it was decided 
only to compare the sub-groups with negative maternal Ascaris 
lumbricoides RAST 1 s. 
iv) Combined negative maternal Ascaris lumbricoides RAST 
(Pharmacia) and negative aFH categorization. 
The results are presented below. 
Cord blood serum IgE concentrations 
Table V.6. 
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2.2.2 Cord blood total eosinophil counts 
Table V.7. 
2.2.3 Cord blood platelet counts 
Table V.8. 
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SERUM IgE CONCENTRATIONS IN CORD BLOOD: COMPARATIVE STATISTICS BETWEEN ETHNIC GROUPS 
CATEGORIZING ETHNIC Mann-Whitney-LI Test or Kruskal-Wallis Test 
VARIABLE GROUPS COMPARED 
x2-approx df p-value Signif Statistical 
value at 5% Decision 
level 
Ethnic Groue Combined 6.84 2 0.0327 s difference 
Black - White 3.24 1 0.0720 ?NS* ? no diff.* 
Black - Mixed 6.06 1 0.0138 s difference 
White - Mixed 0.94 1 0.3311 NS no diff. 
Atoeic FH -
Positive Combined 0.93 2 0.6291 NS no diff ."'" 
Black - White 0.79 l 0 .3472 NS no diff. 
Black - Mixed 0. 14 l 0.7090 NS no diff. 
White - Mixed 0.34 1 0.5591 NS no diff. 
Negative Combined 12.76 2 0.0017 s difference 
Black - White 7.41 1 0.0065 s difference 
Black - Mixed 9.46 1 0.0021 s difference 
White - Mixed 0.05 1 0.8270 NS no diff. 
Maternal Ascaris 
RAST --
Negative Combined 8.00 2 0.0183 s difference 
Black - White 3.06 l 0.0801 NS no diff. 
Black - Mixed 7.24 1 0.0071 s difference 
White - Mixed 1.8 l 1 o. 1785 NS no diff. 
Maternal Ascaris 
RAST and atoeic FH 
-ve Ascaris RAST Combined 12.42 2 0.0020 s difference -ve atopic FH Black - White 6.41 1 0.0114 s difference 
Black - Mixed 9.95 1 0.0016 s difference 
White - Mixed 0.02 l 0 .8976 NS no diff. 
? * no definite statistical decision can be made. 
1 .34 
TABLE V.7. 
TOTAL EOSINOPHIL COUNTS IN CORD BLOOD: COMPARATIVE STATISTICS BETWEEN ETHNIC GROUPS 
CATEGORIZING ETHNIC Mann-Whitney-LI Test or Kruskal-Wallis Test 
VARIABLE GROUPS COMPARED 
x2-approx df p-value Signif Statistical 
value at 5% Decision 
level 
Ethnic Groue Combined 5.62 2 0.0602 ? * ? * 
Black - White 4.71 1 0.0300 s difference 
Black - Mixed 0.00 1 0.9594 NS no diff. 




Positive Combined 2.25 2 0.3252 NS no diff. 
Black - White 1.41 l 0.2358 NS no diff. 
Black - Mixed 0.02 l 0.8751 NS no diff. 
White - Mixed 1.35 1 0.2461 NS no diff. 
Negative Combined 0.67 2 0. 7166 NS no diff. 
Black - White 0.60 1 0.4375 NS no diff. 
Black - Mixed 0.02 1 0.8865 NS no diff. 
White - Mixed 0.54 1 0.4622 NS no diff. 
Maternal Ascaris 
RAST --
Negative Combined 3.35 2 0. 1871 NS no diff. 
Black - White 2.42 1 o. 1197 NS no diff. 
Black - Mixed 0.06 l o. 1137 NS no diff. 
White - Mixed 2.50 1 o. 1137 NS no diff. 
Maternal Ascaris 
RAST and atoeic FH 
-ve Ascaris RAST Combined 0.25 1 0.8834 NS no diff. -ve atopic FH Black - White 0.23 1 0.6338 NS no diff. 
Black - Mixed 0.01 l 0.9044 NS no diff. 
White - Mixed o. 18 1 0.6671 NS no diff. 
? * no definite statistical decision can be made. 
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TABLE V.8 
PLATELET COUNTS IN CORD BLOOD COMPARATIVE STATISTICS BETWEEN ETHNIC GROUPS 
CATEGORIZING ETHNIC Mann-Whitney-LI Test or Kruskal-Wallis Test 
VARIABLE GROUPS COMPARED 
x2-approx df p-value Sign if Statistical 
value at 5% Decision 
level 
Ethnic Graue Combined 5.93 2 0.0515 ? * ? * Black - White 0.09 1 0.7676 NS no diff. 
Black -·Mixed 3.44 1 0.0635 NS no diff. 
White - Mixed 5. 18 1 0.0228 s difference 
--Atoeic FH 
~ 
Positive Combined 4.86 2 0.0882 NS no diff. 
Black - White 0.04 1 0.8497 NS no diff. 
Black - Mixed 0.80 1 0 .3710 NS no diff. White - Mixed 4.93 1 0.0264 s difference 
Negative Combined 1.91 2 0.3843 NS no diff. 
Black - White 0.22 1 0.6381 NS no diff. 
Black - Mixed 1.83 1 0. 1758 NS no diff. 
White - Mixed 0.33 l 0.5637 NS no diff. 
Maternal Ascaris 
RAST --
Negative Combined 7.34 2 0.0255 s difference Black - White 0.00 l 0.9509 NS no diff. Black - Mixed 5. 13 1 0.0235 s difference White - Mixed 5.66 1 0.0174 s difference 
Maternal Ascaris 
RAST and atoeic FH 
-ve Ascaris RAST Combined 3.83 2 0. 1473 NS no diff. -ve atopic FH Black - White 0.41 1 0.5196 NS no diff. Black - Mixed 3.67 l 0.0553 NS no diff. White - Mixed 0.77 l 0.3798 NS no diff. 
? * no definite statistical decision can be made. 
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TABLE V.9 
SERUM IgG CONCENTRATION IN CORD BLOOD: COl1'ARATIVE STATISTICS BETWEEN ETHNIC GROUPS 
CATEGORIZING ETHNIC Mann-Whitney-LI Test or Kruskal-Wallis Test 
VARIABLE GROUPS COMPARED 
x2-approx df p-value Signif Statistical 
value at 5% Decision 
level 
Ethnic Graue Combined 19.08 2 0.0001 s difference 
Black - White 17.86 l 0.0001 s difference 
Black - Mixed 4.86 l 0.0274 s difference 
White - Mixed 6.32 l 0.0119 s difference 
Atoeic FH 
'-
Positive Combined 3.65 2 o. 1611 NS no diff.~ 
Black - White 2.07 l o. 1500 NS no diff. 
Black - Mixed 0.36 l 0.5510 NS no diff. 
White - Mixed 2.22 l o. 1359 NS no diff. 
Negative Combined 3.45 2 o. 1780 NS no diff. 
Black - White 1.48 l 0.2243 NS no diff. 
Black - Mixed 2.91 l 0.0881 NS no diff. 
White - Mixed 0.04 l 0.8362 NS no diff. 
Maternal Ascaris 
RAST -
Negative Combined 21. 77 2 0.0001 s difference 
Black - White 18.69 l 0.0001 s difference 
Black - Mixed 4. 12 l 0.0423 s difference 
White - Mixed 10.06 l 0.0015 s difference 
Maternal Ascaris 
R~ST and atoeic FH 
-ve Ascaris RAST Combined 3.93 2 o. 1403 NS no diff. -ve atopic FH Black - White 2.33 l o. 1266 NS no diff. 
Black - Mixed 2.66 l o. 1029 NS no diff. 
White - Mixed 0.47 l 0.4937 NS no diff. 
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The differences in the descriptive data presented in Section V. 
Ch. 2.1 within each ethnic group, for the fol lowing categorizations 
were tested for statistical significance. 
i) Sex categorization. 
ii) Maternal Ascaris lumbricoides RAST (Pharmacia) categorization. 
iii) Atopic family history categorization. 
iv) Maternal cigarette-smoking categorization. 
The results are presented below. 
Cord blood serum IgE concentrations 
Table V.10. 
Cord blood total eosinophil counts 
TableV.11. 
Cord blood platelet counts 
Table V. 12. 
Cord blood anti-cows milk IgG concentrations 
Table V.13. 
2.4 CO-ORDINATED RESULTS FROM STATISTICAL TESTS OF COMPARISONS 
The results from Section V, Chapters 2.2 and 2.3 have been 




TABLE V. 10 
SERUM IgE CONCENTRATION IN CORD BLOOD COMPARATIVE STATISTICS WITHIN ETHNIC GROUPS 
ETHNIC GROUP CATEGORIZING VARIABLE Mann-Whitney-LI Test 
x2-approx. df p-value Signif Statistical 
value at 5% decision 
level 
Sex -
Black Males vs Females 2.54 1 o. 1109 NS ~o diff. White Males vs Females 0.20 l 0.6512 NS Ito diff. Mixed Males vs Females 4.51 l 0.0338 s d_Jfference 
Maternal Ascaris RAST 
Black +ve vs -ve 0.33 l 0.5631 NS no diff. White +ve vs -ve - - - - * Mixed +ve vs -ve 3.90 l 0.0482 ? ** ? ** 
Atopic FH 
Black +ve vs -ve 0.21 l 0.6479 NS no diff. White +ve vs -ve 5.62 l 0.0178 s difference Mixed +ve vs -ve 5.26 l 0.0218 s difference 
Maternal cigarette smoking 
Black Smoker vs Non-smoker - - - - - * White Smoker vs Non-smoker 3.46 l 0.0629 ? ** ? ** Mixed Smoker vs Non-smoker 2.51 l o. 1130 NS no diff 
not enough observations in one of the groups in this categorization. Comparison not possible. 
? ** no definite statistical decision can be made. 
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TABLE V. 11 
TOTAL EOSINOPHIL COUNT IN CORD BLOOD COMPARATIVE STATISTICS WITHIN ETHNIC GROUPS 
ETHNIC GROUP CATEGORIZING VARIABLE Mann-Whitney-LI Test 
COMPARED 
x2-approx. df p-value Signif Statistical 
value at 5% decision 
level 
Sex -
Black Males vs Females o. 18 1 0.6728 NS no diff. 
White Males vs Females 0.01 1 0.9192 NS no diff. 
Mixed Males vs Females 0.04 1 0.8396 NS no diff. 
Maternal Ascaris RAST ·. 
Black +ve vs -ve 4.78 1 0.0288 s difference 
White +ve vs -ve - - - - - * Mixed +ve vs -ve 1.07 1 0.3006 NS no diff. 
Atoeic FH 
Black +ve vs -ve o.oo 1 1.0000 NS no diff. 
White +ve vs -ve o. 15 1 0.6954 NS no diff. 
Mixed +ve vs -ve 0.34 1 0.5583 NS no diff. 
Maternal cigarette smoking 
Black Smoker vs Non-smoker - - - - - * White Smoker vs Non-smoker 3.01 1 0.0827 NS no diff. 
Mixed Smoker vs Non-smoker 0.76 1 0.3835 NS no diff. 
* not enough observations in one of the groups in this categorization. Comparison not 
possible. 
140 
TABLE V. 12 
PLATELET COUNT IN CORD BLOOD COMPARATIVE STATISTICS WITHIN ETHNIC GROUPS 
ETHNIC GROUP CATEGORIZING VARIABLE Mann-Whitney-LI Test COMPARED 
x2-approx. df p-value Signif Statistical value at 5% decision 
level 
Sex -
Black Males vs Females l.06 l 0.3022 NS no diff. White Males vs Females 0.02 l 0.8989 NS no-diff. Mixed Males vs Females 0.24 l 0.6277 NS no _diff. 
Maternal Ascaris RAST 
Black +ve vs -ve l. 14 l 0.2857 NS no diff. White +ve vs -ve - - - - - * Mixed +ve vs -ve l.69 l o. 1935 NS no diff. 
Atopic FH 
Black +ve vs -ve 0.02 l 0.8866 NS no diff. White +ve vs -ve l.02 l 0.3120 NS no diff. Mixed +ve vs -ve 0.26 l 0.6125 NS no d iff. 
Maternal cigarette smoking 
Black Smoker vs Non-smoker - - - - - * White Smoker vs Non-smoker 0.01 l 0.9225 NS no diff. Mixed Smoker vs Non-smoker 0.01 l 0.9046 NS no diff. 
* not enough observations in one of the groups in this categorization. Comparison not possible. 
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TABLE V. 13 
SERUM acmigG CONCENTRATION IN CORD BLOOD COMPARATIVE STATISTICS WITHIN ETHNIC GROUPS 
ETHNIC GROUP CATEGORIZING VARIABLE Mann-Whitney-LI Test 
COMPARED 
x2-approx. df p-value Sign if Statistical 
value at 5% decision 
level 
Sex -
Black Males vs Females 2.26 l o. 1331 NS no diff. 
White Males vs Females 0.03 l 0.8566 NS no diff. 
Mixed Males vs Females 0.22 l 0.6414 NS no diff. 
Maternal Ascaris RAST 
Black +ve vs -ve 5.59 l 0.0181 s difference 
White +ve vs -ve - - - - - * Mixed +ve vs -ve 10.69 l 0.0011 s difference 
Atopic FH 
Black +ve vs -ve 0.02 l 0.8791 NS no diff. White +ve vs -ve 4.44 l 0.0351 s difference Mixed +ve vs -ve 1.36 l 0.2427 NS no diff. 
Maternal cigarette smoking 
Black Smoker vs Non-smoker - - - - - * White Smoker vs Non-smoker 1.40 l 0.2372 NS no diff. Mixed Smoker vs Non-smoker l. 12 l 0.2900 NS no diff. 




TABLE V. 14 (a) 
CORD BLOOD PHASE I CO-ORDINATE RESULTS FROM STATISTICAL TESTS OF COMPARISONS 
BETWEEN THE ETHNIC GROUPS 
CATEGORIZING ETHNIC GROUPS BLOOD PARAMETERS IN CORD BLOOD VARIABLES COMPARED 
IgE TEC Pl IgG 
Ethnic groue Combined s ? * ? * s Black - White NS* s NS s 
Black - Mixed s NS NS s 
White - Mixed NS ? * s s 
Atoeic FH 
Positive Combined NS NS NS NS 
Black - White NS NS NS NS 
Black - Mixed NS NS NS NS 
White - Mixed NS NS s NS 
Negative Combined s NS NS NS 
Black - White s NS NS NS 
Black - Mixed s NS NS NS 
White - Mixed NS NS NS NS 
Maternal Ascaris RAST 
Negative Co1nbined s NS s s 
Black - White NS NS NS s 
Black - Mixed s NS s s 
White - Mixed NS NS s s 
Maternal Ascaris RAST 
and atoeic F'R 
-ve Ascaris RAST Combined s NS NS NS -ve Atopic FH Black - White s NS NS NS Black - Mixed s NS NS NS 
White - Mixed NS NS NS NS 
? * no definite statistical decision can be made. 
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TABLE V.14 (b) 
CORD BLOOD PHASE I CO-ORDINATED RESULTS FROM STATISTICAL TESTS OF COMPARISON 
WITHIN THE ETHNIC GROuPS 
ETHNIC GROUP CATEGORIZING VARIABLES BLOOD PARAMETERS IN CORD BLOOD 
COMPARED 
IgE TEC Pl IgG 
Sex -
Black Males vs Females NS NS NS NS 
White Males vs Females NS NS NS NS 
Mixed Males vs Females s NS NS NS 
Maternal Ascaris RAST 
Black +ve vs -ve NS s NS s White - - - - - - - * Mixed +ve vs -ve ?** NS NS s 
Atopic Frl 
Black +ve vs -ve NS NS NS NS White +ve vs -ve s NS NS s 1"1ixed +ve vs -ve s NS NS NS 
Maternal ci 2arette smoking 
Black Smoker vs Non-smoker * * * * White Smoker vs Non-smoker ?** NS NS NS Mixed Smoker vs Non-smoker NS NS NS NS 
* not enough ooservations in one of tne groups in this categorization. Comparison not possible. 
? ** no definite statistical decision can be made. 
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CHAPTER 3 ANCILLARY INVESTIGATIONS 
Various ancillary investigations were done to give perspective to the 
data presented in Section V. Ch. 2. This data will be presented 
below. 
3. 1 THE CONCENTRATION OF THE ATOP IC MARKERS IN MATERNAL BLOOD 
The four atopic markers assessed in the cord b load of the newborns 
were also measured in the maternal blood. These results are 
presented for each ethnic group in Table V. 15. 
3.2 THE CORRELATION BETWEEN THE CORD BLOOD AND THE MATERNAL ATOPIC MARKERS 
The Spearman Correlation Coefficients for each ethnic group between 
the cord blood and the maternal values for the four atopic markers 
are summarized in Table V. 16. 
3 .3 CORD BLOOO ANO MATERNAL SERUM IgA CONCENTRATIONS 
This data is presented in Table V. 17. 
3 .4 THE CORRELATION BETWEEN CORD BLOOD AND MATERNAL SERUM IgA 
CONCENTRATIONS 
The Spearman Correlation Co-efficients for each ethnic group between 
the cord blood and the materna 1 serum IgA concentrations are as 
follows: 
Black ethnic group - 0.26245 
White ethnic group - O. 11898 
Mixed ethnic group - 0.01535 
3.5 CORD BLOOD AND MATERNAL SPECIFIC SERUM IgE CONCENTRATIONS RAST 
(PHARMACIA) 
3.5. 1 Cord blood 
No newborns developed specific IgE antibodies against egg white, 
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cow's milk, or Ascaris lumbricoides at birth as defined by a Phadebas 
RAST score of equa 1 to or greater than Cl ass 1 ( equa 1 or greater than 
0.110 PRU/ml-Table IV.5). 
3.5.2 ~aternal Dlood 
Specific IgE antibodies against egg wnite, cow's milk and Ascaris 
lumoricoides were measured. 
The Black ethnic group included 7 mothers with a positive RAST for 
Ascaris lumDricoides witn a Phadeoas RAST Class score of l and 2 
(between 0.110 and 0.350 PRU/ml). 
The ~hite ethnic group included 1 motner with a positive KAST for 
Ascaris lumbricoides with a Pnadebas RAST Class score of 2 (between 
0.35 and 0.7 PRU/ml) and 1 mother with a positive RAST for cow's milk 
with a Phadebas RAST Class score of 1 (between 0.11 and 0.35 PRU/ml). 
The r-ii xed ethnic group inc 1 uded 7 mothers with a positive RAST for 
Ascaris 1 umbricoi des with a Pnadebas RAST Cl ass score of l, 2 and 3 











































































































































































































































































































































































































































































































































CHAPTER 4 SUMMARY OF PrlASE l RESULTS 
4.1 CATEGORIZATION ON AN ATOPIC FAMILY HISTORY (Table V.l.) 
The Wnite ethnic group nad tne highest number of newborns with 
positive afH (39 = 75%) followed by the Mixed ethnic group (ld = 31%) 
and then the Black ethnic group (5 = 9.4%). 
4.2 CORO BLOOD SERUffl IgE CONCENTRATIONS (TABLES '1.2, V.6 and V.10) 
The key data from this section is su111Tiari zed in Table V .18. 
4.2.l Etnnic differences 
4.2.2 
The Black newborns had the hignest geometric mean and median CBsigE, 
followed by the White and then the Mixed newborns, In the sub-groups 
of newoorns with a negative aFH, a negative maternal Ascaris RAST and 
in the suo-group which included only those newborns with both a 
negative aFH and a negative maternal Ascaris RAST, tne Slack newborns 
had the highest values. 
Statistical comparison of the CBsigE oetween the uncategorized total 
etnnic group samples revealed significant etnnic differences between 
the Black-Mixed newoorns. These differences persisted when each 
etnni c group was categorized, and further s i gni fi cant differences 
between tne Black-White newborns were demonstrated in the sub-group 
with neither an afrl nor immunological evidence of maternal Ascariasis 
(i.e. -ve maternal RAST for Ascaris lumbricoides). 
In the sub-group with a negative aFH, the ethnic differences oetween 
the Black-White and Black-Mixed newborns persisted. The effect of a 
positive aFH obscured this difference, however, and the sub-group 
with a positive aFH revealed no statistical difference in CBslgE 
between any of the ethnic groups. 
The influence of an atopic family history 
An aFH influenced tne CBsigE in the White and Mixed newborns, but not 
in the Black newborns. It should be noted, however, tnat only 5 
Black newoorns had an aFH. Tne distribution of tne C8slgE values 
(Fig's. V.l, V.2 and V.J) with reference to either a positive or a 
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negative atopic revealed that, in the Black newborns, only 2 (14.3%) 
with CBslgE greater than or equal to O.SOkU/1 had an aFH. The 
remaining 12 newborns with CBsigE of O.SOkU/1 or above had no aFH. 
This included one newborn with a value of 15.00kU/l, the highest 
recorded value for CBslgE recorded in the 1 iterature. In contrast, 
the 9 White neonates with CBslgE greater or equa 1 to 0.50kU/1 a 11 
( 100%) had an aFH. The Mixed group had a ambivalent distribution 
pattern. Of the 11 newborns with CBsigE greater than or equal to 
0.5kU/l, 6 {58.3%) had an aFH. 
4.2.3 The influence of maternal Ascariasis 
Maternal Ascariasis had an equivocal influence on the CBsigE values 
of the Mixed newborns {p = 0.05), but no influence on these values in 
the Black newborns. Only one White mother had a -ve Ascaris RAST, 
making statistical comparison impossible for this ethnic group. 
4.2.4 The influence of the newborn's sex 
4.2.5 
The sex of the newborn influenced the CBslgE values in the Mixed but 
not in the Black or the White newborns. 
The influence of maternal cigarette smoking 
Maternal smoking did not influence the CBslgE values for any of the 
ethnic groups. 
4.3 CORO BLOOD TOTAL EOSINOPHIL COUNTS {TABLES V.3, V.7 and V. 11} 
The key data from this section is su11111arized in Table V.19. 
4.4 CORD BLOOD PLATELET COUNTS (TABLES V.4, V.8 and V. 12) 
The key data from this section is sul'l111arised in Table V.20. 
4.5 CORD BLOOD ANTI-COWS MILK IgG CONCENTRATIONS (TABLES V.5, and V.13} 
The dey data from this section is su111J1arized in Table V.21. 
f-Sl 
TABLE V. 18 
FACTORS INFLUENCING CORD BLOOD SERUM IgE CONCENTRATIONS WITHIN 
CATEGORIZING VARIABLE 
An atopic FH 
Maternal Ascariasis 
Sex of the newborn 
Maternal smoking 
EACH ETHNIC GROUP 
ETHNIC NEWBORNS 





ETHNIC NEWBORNS NOT 









*Only l observation with a positive maternal Ascaris RAST in White newborns precluded statistical comparison in this group. 
CONVERSELY 
1. Black CBsigE influenced by: - None of the variables. 
2. White CBsigE influenced by: - An aFH. 
3. Mixed CBsigE influenced by: - An aFH. 
- ? Maternal Ascariasis **. 
- Sex of the newborn. 
4. Ethnic differences in CBsigE, independently of Maternal Ascariasis 
and an aFH, were present between the Black-White and the Black-Mixed 
newborns. 
7 ** no definite statistical decision can be made. 
152 
TABLE V. 19 
FACTORS INFLUENCING CORD BLOOD TOTAL EOSINOPHIL COUNTS WITHIN 
CATEGORIZING VARIABLE 
An atopic FH 
Maternal Ascariasis 
Sex of the newborn 
Maternal smoking 
EACH ETHNIC GROUP 
ETHNIC NEWBORNS 
INFLUENCED BY VARIABLE 
Black 
ETHNIC NEWBORNS NOT 












*Only l observation with a positive maternal Ascaris RAST in White newborns precluded statistical comparison in this group. 
CONVERSELY 
l. Black CBTEC's influenced by: - Maternal Ascariasis. 
2. White CBTEC's influenced by: - None of the variables. 
3. Mixed CBTEC's influenced by: - None of the variables 
4. Ethnic differences in CBTEC's were present in the uncategorized total 
group samples between the Black-White groups, and marginally, between 
the White-Mixed groups ( p = 0.05). These differences disappeared, 
however, when only the newborns with both a negative aFH and a 
negative maternal Ascaris RAST were compared. 
1S3 
TABLE V.20 
FACTORS INFLUENCING CORD BLOOD PLATELET COUNTS WITHIN 
CATEGORIZING VARIABLt 
An atopic FH 
Maternal Ascariasis 
Sex of the newborn 
Maternal smoking 
EACH ETHNIC GROUP 
ETHNIC NEWBORNS 
INFLUENCED BY VARIABLE 
ETHNIC NEWBORNS NOT 













*Only l observation with a positive maternal Ascaris RAST in White newborns 
precluded statistical comparison in this group. 
CONVERSELY 
1. Black CBPlC's influenced by: - None of the variables. 
2. White CBPlC's influenced by: - None of the variables. 
3. Mixed CBPlC's influenced by: - None of the variables. 
4. Ethnic differences in CBPlC's were present in the uncategorized total 
group of newborns between the White-Mixed groups. These differences 
disappeared, however, when only the newborns with both a negative aFH 
and a negative maternal Ascaris RAST were compared. 
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TABLE V.21 
FACTORS INFLUENCING CORD BLOOD IgG CONCENTRATIONS WITHIN 
CATEGORIZING VARIABLE 
An atopic FH 
Maternal Ascariasis 
Sex of the newborn 
Maternal smoking 
EACH ETHNIC GROUP 
ETHNIC NEWBORNS 




ETHNIC NEWBORNS NOT 










*Only l observation with a positive maternal Ascaris RAST in White newborns 





Black CBacmigG influenced by: 
White CBacmigG influenced by: 
Mixed CBacmigG influenced by: 
- Maternal Ascariasis. 
- An aFH. 
- Maternal Ascariasis. 
4. Ethnic differences in CBacmigG were present in the uncategorized 
total group of newborns between the Black-White, and the White-Mixed 
newborns. These differences disappeared, however, when only the 
newoorns with both a negative aFH and a negative maternal Ascaris 
RAST were compared. 
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SECTION VI 
RESULTS - PHASE II 
CHAPTER I TECHNICAL DETAILS PERTAINING TO THE DATA ANALYSIS 
1. 1 INTRODUCTION 
In order to establish the relevance of the four cord blood atopic 
markers as predictive markers for the development of atopic 
sensitisation in infancy for each ethnic group (Aim of Phase II -
Section IV, Ch. 2. 1), it was essential to establish as far as 
possible, unambiguous criteria for the classification of the infants 
at the end of the 1 year study period into either: 
(i) the group who developed atopy during infancy 
or 
(ii) the group who never developed atopy during infancy. 
A firm and confident diagnosis of atopy is not always easy in studies 
of this nature. Firstly, the follow-up period was limited, and did 
not allow the repeated observation of the recurrent clinical 
manifestations which are the hallmark of the natural history of 
atopic disease. Secondly, the availability of special laboratory 
investigations supporting the diagnosis of atopic disease (Halpern et 
al, 1980) was not feasible in this study, since the well-documented 
atopic markers such as the total sigE or the TEC were the variables 
under scrutiny in this study. Finally, most of the published 
prospective studies on atopic disease in infancy have used 
inconsistent and varied criteria for atopic manifestations (Halpern 
et a 1, 1973; Orge 1 et a 1, 1975 Kjellman and Johansson, 1976; Matthew 
et al, 1977; Michel et al, 1980b; Frick, 1981; Kjellman and Croner, 
1984; Svensson et al, Cant et al, 1985;). Consequently, no 
definitive guidelines for the criteria for atopic manifestations in 
infancy exist. 
For the purposes of this study, the criteria used to categorize an 
infant as either 11 atopic, or 11 not atopic 11 at the end of the 1 year 
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follow-up period were based on a combination of clinical and 
immunological parameters. At the end of each follow-up visit these 
parameters were merged into a Rationalized Atopic Status (RAS) 
categorization for each infant. At the end of the 1 year study 
period a Cumulative Adjusted Atopic Status (CAS) categorization of 
either "atopic" or "not atopic" was given to each infant. The 
statistical analysis for Phase II was then based on the relationship 
between the specific cord blood atopic marker value in each newborn 
and the infant's CAS at the end of the study. 
1.2 CRITERIA FOR THE RATIONALISED ATOPIC STATUS (RAS) OF THE INF~NT AT 
EACH FOLLOW-UP VISIT 
1.2. 1 
1.2 .2 
Table VI. 1. sunmarises the steps involved in the determination of 
the RAS for each infant at each follow-up visit. It should be noted 
that the RAS is derived from both clinical and immunological 
parameters. 
The clinical categorization (cc) 
Most of the studies of this nature (Section VI. Ch. 1. 1) have used a 
system whereby infants were categorized clinically as being: 
(i) Not atopic 
(ii) Possibly or probably atopic 
(iii) Definitely or obviously atopic 
This study used the same categorizations for the cc. The criteria 
for the cc of the infants is discussed in Section VIII. Ch. 1.3. 
The inmunological categorization (ic) 
At each follow-up visit, the infants had their serum analysed by RAST 
(Pharmacia) for the development of specific serum IgE antibodies to 
the egg white, cow's milk and Dermatophygoides pteronyssinus antigens 
(Section IV. Ch. 2.3.8). Since the RAST's for egg white and cow's 
milk were all negative at birth, (Section V. Ch. 3.5.1) a positive 
RAST for these antigens during the follow-up period suggested 
subsequent atopic sensitisation. 
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The addition of the RAST for Dermatophygoides pteronyssinus was 
included for the reason that the house dust mite is a commonly 
occurring inhalant allergen on the coastal belt of the Southern 
African continent, where this study was executed (Ordman, 1971). 
The RAST for any of the allergens tested was considered to be 
positive if it had a Phadebas RAST score of Class 1, 2, 3 or 4 
(Table IV. 2). A RAST score of Class O was regarded as negative. 
The ic for each visit was given to each infant after consideration of 
the three RAST results in the following manner (Table VI. 1.): 
(i) If the RAST for one or more of the three allergens was positive, 
an ic of RAST positive for that particular fol low-up visit was 
given to the infant. 
(ii) If the RAST for all of the three allergens tested was negative, 
an ic of RAST negative for that particular follow-up visit was 
given to the infant. 
1.2.3 The Rationalized Atopic Status (RAS) 
The clinical and the immunological categorizations for each infant 
were merged to produce a RAS categorization at the end of each 
follow-up visit (Table VI. I.). 
The cc took dominance over the ic in this regard. Consequently a cc 
of 11 definitely atopic 11 gave a RAS of 11 atopic 11 irrespective of the 
outcome of the combined RAST status. Similarly, a cc of 11 not atopic 11 
gave a RAS of 11 not atopic 11 irrespective of the outcome of the 
combined RAST status. Only where the cc revealed a 11 possibly atopic 11 
status, were these infants re-distributed into either the 11 atopic 11 or 
the 11 non-atopic 11 RAS group depending on their ic. In this group, 
those with a positive ic acquired the RAS of 11 atopic 11 for that 
particular visit, while those with a negative ic acquired the RAS of 
11 not atopic 11 for that particular visit. 
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TABLE VI. I 
THE DETERMINATION OF THE RATIONALISED ATOPIC STATUS (RAS) AT 
EACH FOLLOW-UP VISIT (3, 7 AND 12 MONTHS) 
CLINICAL CATEGORIZATION (cc) 
after clinical 
examination 
IMMUNOLOGICAL CATEGORIZATION (ic) 
objective evidence of 








RAST (Pharmacia) status 
RAST 
-ve 






























RAST -ve 1-- -----Atopic 
RAST +ve 
RAST -ve] 





The rationale for using a positive RAST as a confirmatory objective 
laboratory indicator for the diagnosis of atopic sensitisation in 
those infants where the clinical picture was equivocal (i.e. the 
11 possibly atopic 11 group) was based on the suggestion by Zeiger (1985) 
that the development of specific IgE to egg and other antigens could 
be especially helpful in differentiating non-atopic infantile 
seoorrhoeic dermatitis from atopic dermatitis. It seemed reasonable 
to extrapolate this approach to the infants with other 11 possibly 
atopic 11 clinical disease entities, and to re-classify those infants 
with pas i ti ve RAST I s into the II definitely a 11 ergic11 group, and those 
infants with negative RAST's into the 11 non-allergic 11 group. This 
was, in the author's opinion, the most logical approach to 
differentiate the clinically categorized 11 possibly atopic 11 infants 
into those who shared objective irnnunological evidence of atopic 
sensitisation and tnose who remained unsensitized. It is accepted 
that the RAST monitored only two food antigens and one inhalent 
antigen, but these antigens have been snown, by Michel et al, 
(19800); Frick, (1981 ); Zeiger, (1985) and Croner et al, (1982) to be 
the most important ones at this age. 
1 .3 CRITERIA FOR THE CUMULATIVE ADJUSTED ATOPIC STATUS (CAS) 
CATEGORIZATION FOR EACH INFANT AT THE END OF THE STUDY PERIOD 
At the end of the one year study period, the infant's RAS for each of 
the tnree follow-up visits were considered in order to allocate the 
CAS for eacn infant. If an infant had a RAS of 11 atopic 11 for one or 
more of tne follow-up visits, a CAS of 11 atopic 11 for the total 
follow-up period was given, irrespective of whether or not the RAS 
for any of the other visits were 11 not atopi c" or if the infant 
dropped out subsequently. If an infant had a RAS of 11 not atopic" for 
each and all of the follow-up visits, a CAS of "not atopic 11 for the 
total follow-up period was given. 
If an infant had a RAS of 11 not atopic" for the initial follow-up 
visits, and then did not present for the subsequent visits, the CAS 
was not computed for that infant, since it is technically feasible 
that the inf ant may have acquired an II atopi c" RAS for the succeeding 
visits. Suen infants were then excluded from the statistical 
analysis for Phase II, and were regarded as "drop-outs" or 
"non-responders". 
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Alternately, if the infant did not attend for the initial follow-up 
visits, but attended subsequently until the completion of the study 
then the infant remained included in the study, and received a CAS 
for the study period, based on the RAS at the visits which the infant 
attended (i.e. a CAS of "atopic" if one or more of the RAS 
categorizations was "atopic" and a CAS of "not atopic" if all of the 
RAS categorizations which were available for consideration were "not 
atopic"). The rationale for this decision is that if the infant was 
"atopic" at 3 months, this would have become evident from the 
clinical and i111T1unological categorizations at the RAS during the 
subsequent follow-up visits. 
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CHAPTER 2 THE RATIONALISED ATOPIC STATUS AND THE CUMULATIVE ADJUSTED 
ATOPIC STATUS FOR EACH INFANT DURING THE STUDY PERIOD 
The data necessary to compute tne RAS at each foll ow-up visit, 
and the CAS at the end of the one-year study period is 
summarised in Taole's VI. 2, VI. 3 and VI. 4 for the Black, 
White and Mixed infants respectively. 
THE CODES USED TO ABBREVIATE THE PARAMETERS PRESENTED ARE AS FOLLOWS: 
CODE CATEGORIZATION SCORE INTERPRETATION 
cc clinical categorization 1 - not atopic 
(at each follow-up visit) 2 - possibly atopic 
3 - definitely atopic . - missing (infant not 
present at follow-up) 
E egg white RAST 0 - not sensitised 
1-4 - Phadeoas RAST class 
. - missing (result not 
availaole) 
M cow's milk RAST 0 - not sensitised 
1-4 - Phadebas RAST class . - missing (result not 
avail ab 1 e 
D Dennatophygoi des 0 - not sensitised 
pteronyssinus RAST 1-4 - Phadebas RAST class 
ic irnmunol ogical 0 - not sensitised to E, 
categorization Mand D (RAST -ve) 
(at each follow-up visit) 1 - sensitised to eitner 
E or Mor D (RAST +ve) 
RAS Rationalised Atopic Status 1 - not atopi c 
3 - atopic 
CAS Cumulative Adjusted Atopic 1 - not atopic during 
Status first year 
3 - atopic during first 
year 
Inf.code infant's code number . - drop out (not analysed 
for Phase II) 










RATIONALISED ATOPIC STATUS AND CUM



































































































































































































































































































































































































































































































































* For code 




















































































































































































































































































































































































































































































































































































































































































RATIONALISED ATOPIC STATUS AND 
CUM







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































RATIONALISED ATOPIC SCORE AND CUM



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































CHAPTER 3 DESCRIPTIVE STATISTICS OF THE ATOPIC MARKERS DURING THE 
FOLLOW-UP VISITS 
3. l CATEGORIZATION BY ETHNICITY AND FOLLOW-UP VISIT 
The descriptive data for the atopic markers, serum IgE 
concentrations, total eosinophil counts, platelet counts and serum 
anti-cow's milk IgG concentrations are presented in Table's VI. 5, 
VI. 6, VI. 7 and VI. 8, for each ethnic group at each follow-up 
period. 
3.2 CATEGORIZATION BY ETHNICITY, RATIONALISED ATOPIC STATUS AND FOLLOW-UP 
VISIT 
The descriptive data for the atopic markers, serum IgE 
concentrations, total eosinophil counts, platelet counts and serum 
anti-cow's milk IgG concentrations for the "atopic" and the "not 
atopic" RAS categorizations are presented in Tables VI. 9, VI. 10, 
VI. 11 and VI. 12 for each ethnic group at each follow-up visit. 
3.3 GRAPHIC DISTRIBUTION OF CUMULATIVE ADJUSTED ATOPIC STATUS AGAINST 
CORD BLOOD SERUM IgE CONCENTRATIONS 
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CHAPTER 4 COMPARATIVE STATISTICS OF THE CORD BLOOD ATOPIC MARKERS 
AND THE CUMULATIVE ADJUSTED ATOPIC STATUS 
The cord blood atopic markers in each ethnic group were compared 
between those newborns with a CAS of "atopic" and those newborns with 
a CAS of "not-atopic 11 • The p-values resulting from the statistical 
tests of comparison between these two groups of newborns in each 
ethnic group as well as their arithmetic means and median values, are 












































































































































































































































SECTION VI I 
DISCUSSION - PHASE I 
CHAPTER I GENERAL CONSIDERATIONS 
1.1 INTRODUCTION 
The aims of Phase I of this study were centred around the following 
priorities, as addressed in Section l. Ch. 3. 
( i) To demonstrate ethno-genetic differences in four cord blood 
atopic markers, independently of an aFH and maternal 
Ascariasis, between newborns of three defined ethnic groups in 
South Africa. 
(ii) To show that, while raised values of CBsigE in White and Mixed 
newborns in South Africa were related to the presence of an 
aFH in these newborns, the same did not apply to raised 
concentrations of CBsigE in the Black newborns. 
(iii) To assess the influence of various other genetic and 
environmental factors on the cord blood atopic markers in each 
ethnic group. 
The presentation and discussion of this data is difficult if one is 
to avoid confusion or repetition by virtue of the fact that the study 
attempts to look at 4 markers in 3 ethnic groups each for 5 
categorising variables. This leads to a combination of 60 critical 
observation criteria. For this reason, the data presentation and 
discussion for Phase I of the study has been considered separately 
from Phase II. 
1.2 AN ATOPIC FAMILY HISTORY AS THE REFERENCE PARAMETER FOR PHASE I 
In order to establish the atopic relevance of the four cord blood 
markers studied in Phase I, it was necessary to establish a 
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well-documented parameter which is known to reflect an atopic 
predisposition at birtn. This parameter could then become the 
reference against which the cord blood marker values would be 
measured, botn in terms of elevated concentrations in the case of 
CBsigE, or in terms of whether tne marker is influenced in any way by 
the atopic reference parameter or not. 
The rationale for using tne presence or absence of an aFH as the most 
reliable pre-natal non-invasive indicator of an atopic 
predisposition, is as follows: 
( i) Atopy has been snown to be hereditary, with the aFH a good 
marker for tne prediction of the atopi c genotype. ( Sec ti on 
II, Ch. I. 1). 
(ii) Between 50% - 70% of atopic patients have an immediate 
positive aFrl in their first degree relatives (Kjellman, 1977; 
Kj e 11 man, 1982 a) • 
(iii) Croner et al, (1982) showed that, while an elevated Ct3sigE 
alone (greater than l .3kU/l) predicted the development of 
atopic disease by the age of 18 months in 44.4% of cases, the 
addition of a positive aFH to an elevated CBsigE identified 
85. 9% of future a topics. They showed, furthermore, that the 
stronger the immediacy of an aFH, the greater the number of 
neonates Dorn witn a raised CBsigE. 
(iv) Clinical evidence of a genetic effect on IgE production was 
provided by Kjellman and Johansson (1976) who snowed that 
neonates born with an aFH tend to have higher levels of CBsigE. 
(v) Orgel et al (1975) and Michel et al (1980a) have confirmed the 
association between raised CBsigE values and an aFH. 
It snould be noted that, with tne exception of the study by Orgel et 
al, all of the studies quoted above were done in Europe and 
Scandinavia, using what was presumed to be a study population of 
predominantly First World, Western, Caucasoid newborns. 
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The rationale for using an aFH as a suitable reference parameter for 
the assessment of the atopic relevance of the various markers should, 
therefore, be seen in context as applying only for White, Caucasoid 
newborns in First World countries. This is precisely the point of 
reference and motivation for this study, that these conclusions are 
not of relevance to Black, Third World newborns. 
1 .3 THE CRITERIA FOR AN ATOP IC FAMILY HISTORY 
With the exception of the work by Cant et a 1 ( 1985), the criteria and 
definitions used by previous investigators to determine an aFH in 
studies designed to assess predictive atopic markers are vague, 
varied and inconsistent (Table VII. 1 ). 
In particular, it should be realized that by asking the mother about 
an aFH, one is often relying on the diagnosis of a third person, in 
many cases, the family's own general practitioner. While most 
general practitioners can be relied on to make an objective and 
accurate diagnosis for most of the atopic disease complexes, it must, 
nevertheless, be accepted that an incorrect diagnosis may be a 
confounding variable in this regard. This fact is unacceptable in 
this sort of study, but is convnon to all of the studies of this 
nature. 
Of note, also, is the fact that atopic disease in the Black ethnic 
group in this country has, historically, been almost unknown (Section 
I, Ch. 2.2). The exercise of eliciting an aFH from tne Black mothers 
in this study was, subsequently, a difficult task, over and above the 
limitations imposed by the language barrier (Section IV, Ch. 2.2.8). 
Within these constraints, every effort was made by the author (M.H.) 
to take a representative and consistent aFH from the Black mothers. 
In some previous studies of this nature, objective in-vivo and 
in-vitro i11111unological evidence was used to confirm the presence of a 
suspected allergic family history in the relevant family ment>ers. 
For example, Micnel et al (1Y80a) used the collaborative evidence of 
positive skin tests to aeroallergens, a raised total IgE 
concentration of greater tnan 250 IU/ml and the demonstration of 
specific serum lg£ antibodies using the RAST to confirm an aFH 
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TAt3LE VII.1 
CRITERIA FOR AN ATOPIC FAMILY HISTORY - PREVIOUS STUDIES 
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in both parents of their study population. Van Asperen et al (1984) 
similarly considered the patients to be atopic only if there was a 
positive reaction to one or other allergen in skin testing. 
For various reasons, this approach was not practical for or relevant 
to tnis study. Firstly, tne relevance of serum IgE concentrations as 
an atopic marker in the Black ethnic group in our country nas been 
questioned (Section I, Ch. 2.3.1) particularly since parasitosis is 
so co1T1Tion in this population. Secondly, skin tests on dark skins are 
often difficult to evaluate objectively. Finally, it was not 
feasible within the framework of tnis study to access all of the 
fathers and siblings of the families in order to do these special 
confinnatory examinations. The logistical implications of such an 
exercise were unacceptable (Section IV. en. 2.3.4). 
In order to contain diagnostic bias and eliminate inconsistencies and 
inaccuracies as far as possible, strict criteria for tne various 
clinical disease complexes in the spectrum of atopic disorders were 
carefully defined for this study as constituting an aFH in the 
newborn. An aFH implied disease only in the first degree relatives 
of the newoorn (i.e., tne mother, father and siblings). Where the 
term "medically confinned" is used in defining these criteria, it 
should be understood to mean that tne relevant clinical disease 
complexes were diagnosed as such by a medical doctor, or that the 
individual in question had received treatment for such a diagnosis. 
Following below are the criteria which were used to indicate a 
positive aFH for the newborn in his/her first degree relatives during 
the questioning of the mother (Phase I Questionnaire, Appendix II. A 
positive history for any of the atopic disease complexes listed 
below, in any one or more of the newborn I s first degree relatives, 
constituted an aFH. If there was any doubt as to whether the 
criteria given were fulfilled or not, the questionnaire was completed 
reflecting an entry of "unknown or unsure" for that person. In the 
statistical analysis which followed, these answers were regarded as 
being negative (i.e., the aosence of an aFH). 
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1.3. 1 Asthma 
1.3.2 
In view of the varied and often impractical definitions used for the 
diagnosis of asthma, the criteria proposed by an expert panel of the 
Allergy Foundation of America, chaired by Norman, have been used 
(Reed and Townley, 1983). Using their definition for a presumptive 
diagnosis of asthma when pu 1 monary function tests or other spec i a 1 
investigations are not done, (i.e., on history alone), the following 
criteria applied: 
Either 
a) Recurrent episodes of wheezing or dyspnoea, 
plus 
b) A history of episodes of wheezing induced or aggravated on at 
least two occasions by exposure to a recognised allergenic 
material; or seasonal appearance or aggravation of symptoms in 
the spring, sunwner or fall in at least two years. 
or 
c) Medically confirmed asthma. 
Note: The nature of the term 11 wheezing 11 was carefully differentiated 
by the author (M.H.) from other respiratory symptoms which 
could confuse the diagnosis in patients who were not familiar 
with the term. 
Allergic rhinitis 
The criteria used for the diagnosis of allergic rhinitis on history 
were: 
Either 
a) The combined criteria of Murray et al (1969) and Van Asperen et 
al (1984), namely 11 nose-rubbing 11 , fits of sneezing, snorting or 




for at least four weeks and excluding obvious infective 
rhinitis 11 • 
or 
b) Medically confirmed allergic rhinitis. 
Allergic conjunctivitis 
The criteria used for the diagnosis of allergic conjunctivitis on 
history were: 
Either 
a) Conjunctivitis occurring in relation to episodes of allergic 
rhinitis as defined in (1.3.2) above but unrelated to any 
infective or other pathological conditions of the eyes or 
conjunctiva. 
or 
b) Medically confirmed allergic conjunctivitis. 
Atopic dermatitis (eczema) 
The criteria used for the diagnosis of atopic dermatitis on history 
were: 
Either 
a) A combination of the criteria used by Halpern et al (1973) for 
adults and children and Van Asperen et al (1984), for infants. 
In adults and children, 11 either the acute form of 
erythematous, itching, papular vesicular 
characteristically distributed (flexural and 




In infants, 11 cl inica 1 evidence of typica 1 a topic dermatitis, 





primarily involving the flexural folds, face, cheeks or behind 
the ears. 11 
b) Medically confirmed atopic_dermatitis. 
Allergic urticaria 
The criteria used to determine whether allergic urticaria was present 
on history were: 
Either 
a) Clinical urticaria with or without angio-oedema if it was 
confirmed by at least two repeated challenges of the same food 
or other known allergen and if it was not due to drugs, 
insects, serum sickness or unknown causes (Halpern et al, 
1973; Kjellman and Croner, (1984)). 
or 
b) Medically confirmed allergic urticaria. 
Allergic gastro-intestinal food reactions 
The criteria used to determine an gastro-intestinal reactions present 
on history were: 
Either 
a) Vomiting, diarrhoea or colic after the ingestion of a specific 
food at least twice and occurring within the first four hours 
after the ingestion of the food. (Bahna and Heiner, 1980; 
Kjellman, 1983; Kjellman and Croner, 1984; Van Asperen et al 
1984). 
or 
b) Medically confirmed gastro-intestinal or food allergy. 
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A history of anaphylaxis, insect sting reactions or drug sensitivity 
was considered not to be relevant as constituting an aFH. The reason 
for this decision was two-fold. Firstly, these events have not 
commonly been seen as constituting atopic diseases in preceding 
studies of this nature (Table III. 1). Secondly, Smith (1983), in 
her review of the possible relationship between the above occurrences 
and asthma, allergic rhinitis and eczema, showed that the evidence 
was not convincing enough to warrant their inclusion as constituting 
atopic disease. Likewise, the inclusion of colic in infancy 
(unrelated to the definitive challenge of a specific food substance), 
was not included as constituting positive evidence for an aFH in this 
study. While many authors have implicated colic as a symptom of the 
atopic response (Bahna, 1980; Frick, 1981; Kjellman, 1983), it was 
felt that the remoteness of the history of such a symptom, as 
remembered by the mother for her entire family as well as for 
herself, would be an extremely grey area as far as its significance 
as constituting an aFH is concerned. It will be seen that the 
diagnosis of colic (cramps and flatus which persisted for longer than 
two months with occasional vomiting - Frick, 1981) during the 
follow-up visits of our infants in Phase II was classified as 
constituting "possible allergy". The reason for the addition of 
colic to the atopic classification in Phase II of this study and the 
way in which it affects the clinical categorization of the infants is 
discussed in Section VIII. Ch. 1.3. 
Even though the criteria given above for the diagnosis of atopy in 
the first degree relatives of the newborn have been described in 
scientific language, we simplified the description of these symptoms 
and signs into language which the mothers could understand during our 
interrogation. 
1.4 THE VARYING ETHNIC INCIDENCE OF AN ATOPIC FAMILY HISTORY 
The disparity between the incidence of an aFH between the difference 
ethnic groups was not unexpected if the comparative epidemiology of 
allergic disease in both Western, Third World Caucasoid and African, 
First World Black populations is appreciated. Much of the background 
to this issue has been presented in Section I. 
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It is feasiDle, however, that some unintentional and random bias 
towards either subgroup (with or without an aFH) may have occurred 
due to the relatively small size of the study sampling in each ethnic 
group ( 53 Black, 52 White and 58 Mixed newborns). Tni s fact in no 
way detracts from the use of this parameter as the reference marker 
against wnich the various cord blood markers in each ethnic group are 
compared regarding tnei r relevance as atopi c markers. It must be 
emphasised that this study is not concerned with incidence or 
prevalence rates of atopy in different population groups. 
The Black newDorns had a very low prevalence of an aFH (9.4%). This 
was anticipated, not Decause the symptoms or the questioning on 
atopic disease was not understood by tnem, or regarded as 
insignificant (great effort was made by tne author to elicit an 
accurate hi story in this regard, wi tn the 1 iberal use of 
interpreters) but ratner si nee it has been shown that Blacks from 
rural areas have minimal atopic diseases (Van Niekerk, 1979). 
Furthermore, our figure of 9.4% correlates well with the figure of 
7.5% given by Orren (1974) for the Black subjects on her study who 
had an aFH. The Black newborns in our study, even though born in an 
urban environment, historically had a rural heritage, (Section IV. 
Ch. 1.2.1), with many newborns having first degree relatives who had 
only later on in their lives moved to the metropolitan urban 
environment of Cape Town. 
The White newborns had a 75% prevalence of an aFH. This was 
undeniably high, but not excessively more so than some other series. 
Orgel et al (1975) had a series of newoorns with an aFH of 53%. The 
i nci de nee of a positive aFH should a 1 ways De far higher tnan the 
incidence or prevalence of atopic disease in any stable, 
influx-controlled population, and tnese two variables should not be 
confused. 
The incidence of an aFH in the Mixed newborns was, as expected, 
somewhere between that demonstrated in the Black and the White 
newborns (31%). The genetic inheritance which the Mixed group share 
with both the White and the Black group ( Botha and Pri tcnard, 1972) 
make this finding both rational and predictable. 
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1.5 RATIONALISATION FOR THE CATEGORIZATION CRITERIA OF THE DATA 
l .5. l 
1.5.2 
l.5 .3 
In order to fulfil the aims of the study, the data in Phase I was 
categorized into 6 sub-groups of newborns for analysis and discussion 
(Section V. Ch. 1.3). The scientific rationalisation for this 
categorization follows below. 
Ethnic categorization 
From the descriptive statistics in Table V .2. it can be seen that 
CBsigE's are higher in the Black South African newborns than in 
either the White or the Mixed South African newborns. In order to 
demonstrate that CBsigE values in the Black South African newborns 
are significantly higher than those of the White or Mixed South 
African group of newborns, the combined group of newborns in each 
ethnic group were compared for this categorization. The other 3 cord 
blood markers being assessed were also compared for this ethnic 
categorization. 
Ethnic categorisation, independently of an atopic family history and 
maternal Ascariasis 
Since both an aFH and maternal Ascaris infestation have been 
described as causing raised CBsigE values in newborns (Section I. Ch. 
2) the subgroup of newborns which excluded those with these variables 
were compared in order to establish the fact that any ethnic 
differences observed in CBsigE values were not reflective of atopy or 
obvious Maternal Ascariasis, but were reflective rather of other 
ethno-genetic factors. The other cord blood markers were also 
compared for this categorization. 
An atopic family history 
The newborns were divided into subgroups with either a positive or a 
negative aFH. This categorization was necessary, not only to assess 
the validity of ethnic differences in the potential atopic markers 
independently of an aFH, but also to determine the influence of an 
aFH per se on these markers. A marker which was influenced by an aFH 
would be considered as having some validity as an atopic marker. 
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1.5.4 Maternal Ascariasis 
1. 5.5 
In order to prove or disprove the influence of maternal Ascariasis on 
the various cord blood markers, this categorization was used on the 
basis of the maternal RAST for the Ascaris lumbricoides helminth. In 
this regard, it was decided that a positive maternal RAST for the 
Ascaris lumbricoides helminth would be regarded as reliable 
immunological evidence that specific serum IgE antibodies were 
produced in response to maternal exposure to the Ascaris antigen 
(De Filippi et al, 1981). This was the most practical diagnostic 
procedure available to assess maternal Ascaris infestation in this 
study, and was thought to be prefer ab 1 e to analysing materna 1 stool 
samples for the presence of Ascaris ova. For the purposes of this 
study, a positive maternal RAST for Ascaris lumbricoides was 
therefore equated with a diagnosis of maternal Ascariasis. 
Maternal cigarette smoking 
The evidence for the effect of maternal cigarette smoking on CBsigE 
values was reviewed in Section III. Ch. 1.8.6. This categorization 
was used to assess each marker in each ethnic group for this 
environmental variable, since this study provided a unique 
opportunity to make this observation. It should be emphasised, 
however, that neither the amount of cigarettes smoked by the mother, 
or the smoking habits of other members of the family sharing the home 
environment (the effect of passive or side-stream smoking) were taken 
into account in the statistical analysis. 
1.5.6 The sex of the newborn 
The evidence for the effect of newborn's sex on CBsigE values was 
reviewed in Section III. Ch. 1.8. This study provided an excellent 
opportunity to add to the epidemiological body of knowledge regarding 
the effect of other genetic factors such as sex on the cord b 1 ood 
markers considered. 
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1.6 THE INTEGRITY OF THE CORD BLOOD SPECIMENS 
This study is based on intimate materno-foeta 1 and materno-neonata 1 
relationships. Of fundamental importance to the credibility of the 
data generated is the integrity of the cord blood specimen, in the 
sense that it is not contaminated or influenced by materna 1 b 1 ood. 
This is particularly relevant since the venesection of the cord 
occurs seconds after the newborn is delivered, while the placenta is 
still in-situ, with a considerable amount of maternal haemorrhage 
distributed over a wide area of her perineum and surrounding area. 
Great care was taken, therefore, to ensure that the cord blood 
specimens were carefully aspirated from a cord which had been 
adequately cleaned (Section IV. Ch. 2.2.5). The rationale for 
assuming that an uncontaminated specimen of cord blood is foeta 1 in 
origin was given in Section III. Ch. 1.8.1. In this study, the 
general principles indicating the foetal origin of the cord blood 
samples were confirmed by our data, for the following reasons: 
i) The very poor correlation co-efficients between the cord blood 
and the maternal specimens for serum IgE concentrations, the 
total eosinophil counts and the platelet counts indicate that 
the two specimens reflected two separate haematological systems 
(Table V. 16). The correlation co-efficients for serum IgG 
concentrations between the cord blood and maternal specimens 
were, however, uniformly good. This was expected because the 
low molecular weight of IgG allows free transplacental passage 
of this immunoglobulin from the mother to the foetus. 
ii) The very low concentrations of serum IgE in the cord blood 
relative to the higher concentrations present in the maternal 
serum (Table V.15) negate the possibility of a passive 
equilibuium of maternal serum IgE across the materno-foetal 
placental barrier. 
iii) Various specific IgE antibodies were demonstrated in some of the 
maternal blood specimens, by the RAST (Section V. Ch. 3.5.2). 
In none of the cord blood specimens were any specific IgE 
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antibodies demonstrated even though a supersensitive, double 
incubation RAST method (Section IV. Ch. 3. 3) was used for the 
immunoassay. This further indicated that placental transfer of 
these antibodies did not occur, and that the cord blood samples 
were foetal in origin. 
To exclude intra-partum maternal contamination of the cord blood 
specimens each cord blood and maternal specimen was assayed for the 
serum IgA concentration. It has been shown that the concentration of 
serum IgA in cord blood is very low in comparison to that in maternal 
serum (Section III. Ch. 1.8.2). Any contamination of the cord blood 
specimen by materna 1 blood would result in concentrations of cord 
blood IgA which are appreciably higher than the normal values for 
newborns. 
In this study, none of the newborns had raised concentrations of IgA 
above the quoted normal values (Section III. Ch. 1.8.2). When 
compared to their corresponding maternal concentrations, they were 
furthermore of a different order (Table V.17). The maximum cord 
blood serum IgA concentrations in the Black, White and Mixed newborns 
were 5.70, 3.25 and 5.65 mg/dl respectively. These values are all 
lower than the quoted upper limit of normal for these South African 
ethnic groups of 5.80, 5.00 and 7.20 mg/dl respectively (Van Rijswikj 
et al, 1985). Contamination of our cord blood specimens was 
subsequently excluded. 
The evidence to suggest that the data attributable to the cord blood 
specimens in this study was of foeta 1 origin, and reflective of an 
uncontaminated haematological specimen, is therefore scientifically 
credible. 
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CHAPTER 2 CORD BLOOD SERUM IgE CONCENTRATIONS 
2.1 THE DEFINITION OF A KAISED CORD BLOOD SERUM IgE CONCENTRATION 
Normal reference values have not yet Deen established for CBsigE 
values in any of the South African ethnic groups. The definition of 
what constitutes a 11 raised level 11 has subsequently not yet been 
established in this country. 
Kjellman states that a "knowledge of serum IgE variations in 
age-matched subjects of similar ethnic backgrounds is a prerequ.isite 
for understanding the predictive capacity of a certain serum IgE 
concentration11 (Kjellman, 1982). He contends also that the 11 use of 
serum IgE as a parameter for the prediction of atopy implies prior 
knowledge of the relevant IgE values in healthy (non-atopic) 
subjects 11 (Kjellman et al, 1976). 
An acceptable definition of the upper limits of nonnality in tenns of 
sigE is the geometric mean plus or minus two standard deviations 
(GM+ 2 SD) (Kjellman, 1982). Based on this definition, a cut-off 
level greater than l ,3 u/ml was used by Croner et al ( 1982) and 
Kjellman and Croner (1984) and in their prediction studies to define 
the upper limit of normal for C8sigE. This corresponded to the GM+ 
2 SD for a normal Swedish newborn population in a previous study 
( Kj el l man et a 1 , l 9 7 6 ) • 
Lower CBsigE cut-off points of 1,20 u/ml (Magnusson, 1984), 0,9 u/ml 
(Kjellman and Croner, 1984), 0,7 u/ml (Chandra et al, 1985) and 0,5 
u/ml (Michel et al, 1~80a) have been subsequently suggested by 
various authors to include a greater percentage of potentially 
11 high-allergic-risk 11 newborns and to increase the predictive 
specificity of the CBsigE estimations. 
For the purpose of this study, an arbitrary CBsigE value of 0,5 kU/1 
was decided on to represent the point at which any value equal to or 
greater tnan this point was considered to be raised. 
This 11 cut-off point11 was especially relevant when assessing the 
relationship between an aFH and raised levels of CBsigE. 
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2.2 THE RELEVANCE OF THE SUPERSENSITIVE SERUM IgE PRIST LABORATORY 
IMMUNOASSAY 
In Section I. Ch. 2.3.2., it was noted that IgE is present in very 
low concentrations in cord blood • Highly sensitive immunoassays are 
therefore essential in epidemiological studies of this nature, 
particularly when small differences could be crucial to demonstrate 
comparative differences between ethnic groups, and in assessing the 
influence of various factors on CBsigE. 
For this study we used a modification of the standard IgE PRIST 
(Pharmacia) immunoassay for the estimation of the cord blood serum 
IgE concentrations (Haus et al, 1988), which differentiated between 
CBsigE values of 0.01 kU/1 (Section IV. Ch. 3.1). In previous CBsigE 
studies, the detection limits for CBsigE were of the order of 0.5 
kU/1 (Table 1.3). This is not a sensitive enough immunoassay for 
comparative studies of this nature. 
The detection limit of 0.01 kU/1 achieved for our PRIST i111nunoassay 
is the lowest yet described in the literature. The previous most 
sensitive PRIST reported on was by Magnusson (1984) who described a 
detection limit of 0.1 u/ml. Kimpen et al (1987) reported on a 
detection limit of 0.01 iu/ml, but the method used for the 
i111nunoassay was an ELISA technique and not a PRIST. 
The standard curve for the supersensitive PRIST technique used in 
this study (Fig. IV. 7) emphasises the accuracy and reliability with 
which serum IgE concentrations of 0.01 kU/1 can be differentiated. 
2.3 THE INFLUENCE OF ETHNICITY 
Phase I of this study has shown that the median CBsigE values in a 
random selection of Black South African full-term newborns is 
significantly higher than the corresponding values in a similar 
sampling of both White and the Mixed newborns, in those newborns who 
had neither a family history of atopy nor immunological evidence of 
maternal Ascariasis (Section V. Ch. 4.2. 1). The fact that no 
significant ethnic differences were demonstrated in this 
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sub-group between the White-Mixed newborns suggests that genetically, 
as well as socio-culturally, the Mixed ethnic group share a greater 
neritage with tne White group than with the Black group. This 
confi nns Botha I s findings on the b 1 ood group gene frequencies as an 
indicator of the genetic constitution of some ethnic groups in Cape 
Town (Botha and Pritchard, 1972). 
2.4 THE INFLUENCE OF AN ATOPIC FAMILY HISTORY 
In this study, an analysis of the CBslgE values in the White newborns 
in relation to an aFH reflected the previously published work in 
terms of their mutual interdependence (Section III. Ch. 1.8.4). All 
of the White newborns with a CBslgE value of O.SkU/1 or greater had 
an aFH (Fig. V. 2. ) • 
The Black newborns did not show tne same relationship. The high 
CBslgE values in the Black group were not related to an aFH. It 
should oe stressed, however, that we were unable to provide 
definitive evidence of the effect of an aFH on the CBslgE values in 
the Black newborns due to the fact that only 5 of these newoorns had 
an aFH. They had the lowest incidence (9%) of an aFH of all the 3 
ethnic groups (Table V. 1) in spite of having the highest CBslgE 
values. This could possibly be explained because of their rural 
heritage as discussed in Section VII. Ch. 1.4. The distrioution of 
the Black CBslgE values over a.so kU/1 (Fig. V. 1) showed that most 
were unrelated to an aFH including the newborn with the very high 
value of 15.00 kU/1. 
The Mixed newborn 1 s findings were inconclusive, in that the CBslgE 
values over 0.50 kU/1 were representative of both those with and 
those without an aFH (Fig. V. 3). Statistically, the influence of an 
aFH did, however, affect the CBslgE values (p less than 0.05). This 
clinical ambivalence may again be the result of tne genetic 
inheritance with the Mixed group share with both the White and the 
Black group (Botha and Pritchard, 1972). 
Some of the statistical calculations leading up to these conclusions 
could be open to criticism. For example, only 9 of tne 39 ~hite 
newborns born with an aFH had CBslgE values elevated above 0.5 kU/1. 
Based on this information from the White newborns, since 
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only 5 Black newborns were born with an aFH, it follows that only 23% 
of Black newborns with an aFH (i.e. 1 newborn) might have been 
expected to have a CBsigE values of greater than 0.5 kU/1. It may, 
therefore, be concluded that, since 2 of 5 such Black newborns with 
an aFH had CBsigE concentrations_ above 0.5 kU/1, it makes their data 
at least as significant as that of the White newborn's. Even though 
this argument is based on the same unsubstantiated premise which this 
thesis is designed to contest, that is, that the same reasoning and 
rationale which is applicable to the relevance of raised CBsigE 
values in White newborns may be extrapolated and be applicable to the 
relevance of raised values in Black newborns, it is nevertheless of 
interest to follow the statistical reasoning leading to the rejection 
of this hypothesis. 
The reasoning here is: 
39 White babies were born to atopic families. 
9 of these 39 had CBsigE values greater than 0.5 kU/1. 
i.e. 9/39 = 23% of this sample, had CBsigE levels greater than 
0.5 ku/l. 
If one considers what is happening in the Black group, using the 
White group as the baseline, one finds that 5 Black infants were born 
to atopic families. Working with the ratio calculated for the White 
newborns of atopic families with CBsigE values greater than 0.5 kU/1 
one would expect 23% of 5 = 1 Black infant to have CBsigE values 
greater than 0.5 kU/1. 
In the sample selected for this study, 2 of the 5 Black newborns of 
a topic families had CBsigE values greater than 0.5 kU/1. Hence the 
results for the Black group cannot be less significant than the 
results from the White group. 
The statistical significance of these ratios can be investigated 
using Fishers's Exact Test. The hypothesis which this test tests is: 
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Ho: the proportion of infants from atopic families with CBsigE 
values greater than 0.50 kU/1 is the same as the proportion of 
infants from non-atopic families with CBsigE values greater than 
or equal to 0.50 kU/1. 
against the alternative hypothesis: 
Ha: the proportion (described in Ho) differs. (It may be larger or 
smaller, but the direction of magnitude is not specified). 
Details of the frequencies on which this test is based follows: 
WHITE BLACK 
CBsigE CBsigE 
less greater Row less greater Row 
than than or= Tota 1 than than or= Total 
0.50 0.50 0.50 0.50 
kU/1 kU/1 kU/1 kU/1 
Atopic FH 
+ve 30 9 39 3 2 5 
-ve 13 0 13 36 12 48 
Column Total 43 9 52 39 14 53 
p-value: 0.091 p-value: 0.599 
Now using the following logic: 
The ratio between the 2 race groups was statistically compared in the 
following table for a positive aFH only: 
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CBsigE 
less equal or Row 
than greater than Total 
0.50 0.50 
RACE kU/1 kU/1 
White 30 9 39 
Black 3 2 5 
Co 1 umn tota 1 33 11 44 
p-value: 0.586 
The conclusion to draw here is that no statistical difference could 
be snown in the ratio of the number of infants of atopic families 
with CBsigE values less than 0.50 kU/1 in the Black and the White 
race groups, when compared to the ratio of those with CBsigE values 
equa 1 to or greater than O. 5 kU/1 . The i nabi 1 i ty to show such a 
difference could, however, be accounted for by the small numbers in 
each cell in the Black group. 
2.5 THE INFLUENCE OF MATERNAL ASCARIASIS 
It has been shown that increased CBsigE values may be the result of 
maternal helminth infection (Weil et al, 1983). This phenomenon is 
thought to be due to a foetal immune response to the parasite 
antigens rather than due to transplacental transfer of the serum IgE 
from mother to foetus. The foetus has been shown to be capab 1 e of 
IgE synthesis in utero by the 11th week of gestation (Miller et al, 
1973), and intrauterine sensitisation of the foetus has been well 
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documented (Michel et al, 1980b; Levine et al, 1971; Kuroume et al 
1976). In this study, it was therefore important to ascertain 
whether the relatively high CBsigE values in the Black newborns as 
well as the ethnic differences in CBslgE values between the 
Black-White and the Black-Mixed newborns were not possibly a 
resultof maternal Ascariasis. It was felt that a maternal 
imnunological response to the Ascaris lumbricoides antigen as 
demonstrated by the formation of specific lgE antibodies to this 
helminth using the RAST was a logical way to assess maternal 
Ascariasis. This consideration was particularly relevant to this 
study since many more Black mothers had a positive RAST for Ascaris 
lumbricoides (7 mothers) than White mothers (1 mother). 
The fact that the ethnic differences between the Black-White and the 
Black-Mixed groups persisted when the statistical analysis was 
performed on the subgroups which included only those newborns with a 
negative aFH together with a negative maternal RAST for Ascaris 
lumbricoides suggests that these differences are predominantly a 
reflection of ethno-genetic factors. No specific IgE to Ascaris 
lumbricoides was demonstrated in the cord olood specimens of any of 
the newborns. 
2.6 THE INFLUENCE OF TH£ NEWBORN 1 S SEX 
The influence of the newborn's sex on their CBsigE values was 
apparent only in the Mixed ethnic group. This variable did not 
impact in any way on the Black CBsigE values, and subsequently did 
not need to be taken into consideration when assessing the 
significance of the raised values in the Black newborns. 
2.7 THE INFLUENCE OF MATERNAL CIGARETTE SMOKING 
This variable did not impact on the CBslgE values in any of the 
ethnic groups. The data published by Magnusson (1984), where 
smoking mothers gave birth to newborns with elevated CBsigE 
concentrations relative to those newborns whose mothers never smoked 
(Section III. Ch. 1.8.6) was not reproduced by this study. The data 
generated by this study supports the findings of Michel et al 
(1980a) who could not find any differentiation in CBsigE values for 
this variaole. 
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2.8 GENERAL COMMENT 
Animal studies in defined, inbred strains of rats have shown that 
there is a correlation between the baseline total IgE concentrations 
and the magnitude of the resulting specific lg£ responses (Pauwels 
et al, 1979). Inbred strains of mice with low basal total IgE 
concentrati ans have weak specific slgE responses fa 11 owing anti gen 
stimulation (low-responder phenotypes), whereas strains with high 
basa 1 total slgE concentrati ans develop powerful specific IgE 
responses (high-responder phenotypes). The high CBslgE values found 
in the Black group in this study probably likewise represent a pool 
of genetic lg£ 'high-responder' phenotypes (Croner et al, 1982; 
Kjellman and Croner, 1984). Furthermore, the high CBslgE 
concentrati ans in the Black group is in 1 i ne with the genera 1 i zed 
hypergarrmaglobulinaemia which has been reported in various Black 
populations (Section 1. Ch. 2.3). It has been suggested that this 
irrmunological hyperactivity may represent the evolution of a natural 
phylogenetic advantage mechanism against the parasitic and microbial 
infections which are often endemic in Third World underdeveloped 
countries (Kay, 1979; Kay, 1980). The statement often made that 
11 hi gh concentrati ans of lg£ antit>odi es are al most exclusively seen 
in infants with an atopic disease 11 (Molkhou and Metayer, 1987) would 
therefore seem to be an oversimplification of the evidence as 
regards the Black ethnic groups in Africa. 
Whether these high 1 eve 1 s reflect a propensity for the deve 1 opment 
of atopic sensitisation later in infancy and childhood will become 
clear once these newborns have been followed up and assessed over a 
period of time. The outcome of Phase II of this study will indicate 
whether those who did develop atopic disease in infancy had higher 
values of CBslgE at birth. 
When considering the clinical significance of the high CBslgE values 
other potential causes for the raised concentrations needed to be 
excluded. In this study, there was no irrmunological evidence of 
intrauterine sensitisation in the newborns (all the cord blood 
RAST's for the development of specific slgE to egg white, cows milk, 
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and Ascaris lumbricoides antigen were negative). Croner et al 
(1982) have suggested, however, that CBsigE is probably non-specific 
in nature. This study supports their views. The possibility of 
maternal contamination of the cord blood samples was largely 
excluded (Section VII. en. 1 .6). Phase I of this study has 
supported that part of the hypothesis, (Section I. Ch. 3.2) which 
states trldt 11 the CBslgE values in a randomly selected sampling of 
South African ful 1-term Black newborns without an aFH are 
significantly higher than the CBsigE values of a similar sampling of 
South African White and Mixed newborns. An aFH does not, 
furthermore, influence the CBsigE in the Black newborns (as it does 
in the White and Mixed newborns). 
These differences il 1 ustrate the fact that immunogeneti c parameters 
vary in different ethnic populations. Black newborns in Third World 
African co11lilluni ti es may represent a poo 1 of high IgE-responder 
phenotypes, with the high levels of non-specific CBsigE possibly 
reflective of etnno-geneti c influences, unrelated to envi ronmenta 1 
factors. 
These considerations rnay render the use of CBsigE values of 1 imited 
value in Black populations as a predictive marker for the 
development of atopic disease during infancy. Pnase II of tnis 
study addresses this aspect of the hypothesis. 
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CHAPTER 3 CORD BLOOD TOTAL EOSINOPHIL COUNTS 
3.1 BIOLOGIC AND PHYSIOLOGICAL VARIATIONS IN CORD BLOOD TOTAL EOSINOPHIL 
COUNTS 
Section III. Ch. 2.2 reviewed the various factors which have been 
described as influencing the number of circulating peripheral 
eosinophils at any one time, in children and in adults. 
whether these factors impact on newborns remains to be proved. The 
exact relevance of raised or lowered CBTEC's should consequently be 
considered with circumspection and caution. The abstract by Dry et 
al, (1980) did not mention that any factors were adjusted for in 
attempting to standardise the TEC's of the newborns they studied. 
In this study, various of tne biological and physiological variants 
wni ch have been shown to impact on TEC' s in general were taken into 
consideration when planning tnis study, even thougn their possible 
influence on CBTEC's have not been unequivocally documented. 
The possioility of the influence of a diurnal fluctuation on the 
level of circulating cord blood eosinophils was addressed in this 
study by ensuring tnat all haematological specimens were taken during 
the 6-hour period between 09HOO and 15HOO (Section IV. Ch. 2.2.5). 
The eosi nophi 1 opaeni c effect of the stress of 1 abour on the mother, 
as described by Davis and Hulet (1949), was also demonstrated in this 
study (Table VII. 2). Seven mothers nad an absolute 
eosinophilopaenia (O cells/111n3), while 20 mothers had a relative 
eosinophilopaenia of 88 cells/mm3 or less. Of interest is the fact 
that 26% of the white mothers had TEC's below 88 cells/mm3 in 
contrast to the Black and Mixed motners, of whom only 13.4% and 12.5% 
nad corresponding values. This observation encourages speculation on 
a socio-cultural level as to whether White mothers do not possibly 
suffer more i ntra-partum stress than Black or Mixed mothers, 1 eadi ng 
to an increase in pituitary-adrenocortical activity (Recant et al, 
1950) and resultant eosinophilopaenia. Trauma and surgical shock 
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nave been described as naving an eosinophilopaenic effect (Laragh and 
Almy, 1948; Davis and Hulet, 1949; Gabrilove,1950). In our study, 
the White mothers did not undergo more Caesarean Sections than the 
Black mothers (Table VII. 3). The stress of intra-partum surgery 
was, therefore, not ooviously responsible for their trend to develop 
eosinophilopaenia more readily than their Black counterparts. 
In order to ascertain whether Caesarean Section per se had a 
statistically significant effect on the CBTEC's in the newborns, the 
newborns were divided into 2 subgroups, depending on whether or not 
they were delivered by Caesarean Section (Table Vll.4) •. The 
differences in tne CBTEC median values for each subgroup were then 
compared for statistical significance in each ethnic group. A 
similar statistical exercise was done for the maternal TEC's for 
comparison and interest. In no ethnic group did delivery by 
Caesarean Section influence the TEC's in either the maternal or the 
newborn specimens (Table VII. 5). It was, therefore, not necessary 
to adjust for the method of birth in assessing the CBTEC's for the 
other variables. 
Various drugs have also been shown to influence TEC's. During the 
questioning of the mother (Questionnaire, Section IV. Ch. 2.2.9), it 
was ensured that none of tne mothers on the study had been exposed to 
oral epinephrine, propranolol or intravenous insulin during pregnancy 
or labour, all of wnich have been reported to influence TEC's 
(Section III. Ch. 2.2). Whether these pharmacologically active 
substances have similar effects on cord blood TEC's is unclear. The 
precaution to exclude mothers exposed to these substances was 
nevertheless taken. 
The effect of physical exercise on TEC's (Dalton and Selye, 1939; 
Davis and Hulet, 1949) was not adjusted for in this study, si nee 
labour itself is a fairly active form of muscular activity, and 
quantitative assessment of this variable was not appropriate within 
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TABLE VI I. 3 
THE RELATIVE INCIDENCE OF CAESAREAN SECTION VERSUS VAGINAL DELIVERY 
IN THE MATERNAL STUDY COHORT 
ETHNIC GROUP NO. OF PATIENTS % 
VAGINAL DELIVERY 
Black 32 60.4% 
White 34 65.4% 
Mixed 41 71.9% 
CAESAREAN SECTION 
Black 21 39.6% 
White 18 34.6% 
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TABLE VII. 5 
MATERNAL AND CORD BLOOD TOTAL EOSINOPHIL COUNTS CATEGORISED ON CAESAREAN SECTION 
VERSUS NORMAL VERTEX DELIVERY 
SPECIMEN CATEGORIZING ETHNIC GROUP Mann-Whitnex-U Test 
VARIABLES 
x2-approx df p-value Signif. Statis-
at 5% tical 
value level Decision 
MATERNAL Caesarean Black 1.35 1 0.2457 NS no diff. 
Section 
vs White 3.26 1 0.0710 NS no diff. 
Normal Vertex Mixed o. 11 1 0.7432 NS no diff. 
Delivery 
CORD BLOOD Caesarean Black 0.67 1 0.4121 NS no diff. 
Section 
vs White 0.03 1 0.8624 NS no diff. 
Normal Vertex Mixed 0.25 1 0.3835 NS no diff. 
Delivery 
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Apart from the considerations addressed above no other potentially 
modifying factors were taken into consideration when assessing the 
effect of the other variables on CBTEC 1 s. 
3.2 THE CONCEPT OF NORMALITY FOR CORD BLOOD TOTAL EOSINOPHIL COUNTS 
No reference value (or range of values) for normality was suggested 
for the assessment of the CBTEC 1 s in this study for the following 
reasons: 
(i) The reference values for normality reported in adults. and 
children for TEC 1 s range widely (Section III. Ch. 2.4.). 
(ii) No normal reference values for cord blood TEC 1 s have been 
published. 
(iii) It is not precisely known which biological and physico-chemical 
factors influence the CBTEC 1 s in newborns. 
Because of these problems, the conclusions of Dry et al (1980) 
regarding the s i gni fi ca nee of raised CBTEC 's were reached by the 
consideration of a comparative stati sti cal assessment between those 
newt>orns with and those without an aFH. No absolute CBTEC value was 
established to indicate an eosinophilophilia. They reported, rather, 
on a 11 p11 value of less than 0.02 between the CBTEC 1 s of those 
newborns who had an aFH and those who did not. In their series, the 
mean CBTEC for the newborns with an aFH was 248 eel l s/111n3, while 
the mean for newborns without such a history was 183 cells/mm3• 
The CBTEC's in this study were consequently analysed in a similar 
manner, with the main emphasis being on the demonstration of 
statistical differences occuring on comparison between the 
categorising variables considered, and not relative to an absolute 
reference value for normality, (as was done for the assessment of the 
CBsigE values). 
3.3 THE INFLUENCE OF ETHNICITY 
Phase I of this study has demonstrated cl ear ethnic differences in 
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the CBTEC's between the total uncategorized groups of Black-White 
newborns, and a margina 1 ethnic differences between the White-Mixed 
newborns (Table V.7). These differences disappeared, however, when 
only the subgroups with both a negative aFH and the absence of 
maternal Ascariasis were compared. 
It will be seen below (Ch. 3.4 and Ch. 3.5) that, while an aFH did 
not influence the CBTEC's in any ethnic group, maternal Ascaris 
infestation did affect the CBTEC's in the Black newborns. It is 
possible, therefore, that the ethnic differences in CBTEC' s 
demonstrated between the total uncategorized Black-White newborns 
could be related to maternal Ascariasis rather than to ethno-genetic 
factors, making this marker even more susceptible to Third World 
environmental factors than CBsigE values. 
3.4 THE INFLUENCE OF AN ATOPIC FAMILY HISTORY 
An aFH did not influence the CBTEC's in any of the three ethnic 
groups of newborns. This contradicted the findings of Dry et al 
(1979), and compromised the speculation that atopically predisposed 
newborns could be identified at birth using this cord blood marker. 
Phase II of this study will indicate conclusively whether there was 
any statistical differentiation in CBTEC's between those newborns who 
developed atopic symptoms during infancy and those who remained 
healthy. 
3.5 THE INFLUENCE OF MATERNAL ASCARIASIS 
Maternal Ascariasis was shown to influence the CBTEC's in the Black 
newborns only. Of interest, however, is the unexpected finding that 
the median CBTEC's of the 7 Black newborns whose mothers did have 
i111nunological evidence of Ascaris infestation was, in fact, lower 
(166 cells/mm3) than the corresponding value for the subgroup whose 
mothers did not have maternal Ascariasis (233 cells/mm3) (Table 
V.3). Ascariasis and other helminth infestation of the human host is 
reported to result in an eosinophilia rather than an 
eosinophilopaenia (Section III. Ch. 2.3). It is feasible, however, 
that the demonstration of a relative eosinophilopaenia in those 
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newborns whose mothers had a positive Ascaris RAST when compared with 
the newborns whose mothers were not parasitised could be the result 
of the paucity of observations for the group of newborns from the 
parasitised mothers. 
It is significant, also, that the apparent ethnic differences in 
CBTEC's referred to in Section VII. Ch. 3.3 disappeared when those 
newborns with an aFH and maternal Ascariasis were excluded from the 
statistical calculations. This suggests that maternal Ascariasis 
obscured the effect of ethnicity on the CBTEC's, whatever the reason, 
since an aFH on its own was shown to have no effect on the CBTEC's in 
any of the ethnic groups. 
3.6 THE INFLUENCE OF THE NEWBORNS SEX 
No significant sex variation was found for CBTEC' s in any of the 
ethnic groups when the data was categorized into male and female 
newborns. 
Our results conflict, therefore, with those of Cunningham (1975), who 
found boys to have higher TEC's than age-matched girls. His results 
were, however, obtained from the examination of infants and children, 
and not for newborns. Furthermore, his study population was 
unselected, and included both atopic and non-atopic subjects. 
Felarca et al (1967), like us, showed no sex difference in their 
study of selected non-atopic subjects but, like Cunningham's series, 
his study population did not include newborns. 
3.7 THE INFLUENCE OF MATERNAL CIGARETTE SMOKING 
Maternal cigarette smoking did not influence the CBTEC's in any of 
the ethnic groups. 
No data has been previously published on this subject in relation to 
CBTEC's. In view of the equivocal reports published on the effects 
of maternal cigarette smoking on CBsigE values (Section III. Ch. 
l.8.6) this data is, nevertheless, of interest. 
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3.8 GENEKAL COMMENT 
The only variable which had an unambiguous statistically significant 
influence on the C~TEC 1 s in the various ethnic groups was the effect 
of maternal Ascariasis in the Black newborns (Table V.19). Even this 
effect was clouded by the contradictory finding of a relative 
eosinophilopaenia in those Black newborns who had mothers with 
i111nunological evidence of Ascariasis. If this effect is indeed 
spurious, it may be due to tne paucity of observations (7) relating 
to mothers with immunological evidence of Ascariasis. 
The influence of ethnicity on the CBTEC I s in the total uncategorized 
group of Black-White and White-Mixed newborns was similarly abrogated 
when an aFH and maternal Ascariasis were adjusted for. 
An aFH clearly had no influence on the CBTEC 1 s in any ethnic group. 
Unless a clear statistical difference can be demonstrated for this 
marker oetween those newborns wno deve 1 oped a topic symptoms during 
infancy and those who did not (Phase II), this cord blood marker 
would not seem to hold any promise as a predictive atopic marker 
during infancy. 
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CHAPTER 4 CORD BLOOD PLATELET COUNTS 
4. 1 THE CONCEPT OF NORMALITY FOR CORD BLOOD PLATELET COUNTS 
The normal range of platelet counts in healthy humans is 150-400 x 
109 platelets per litre of blood, with counts in individual 
subjects being relatively constant (Dacie and Lewis, 1984). Recent 
data published on a series of 564 normal patients in South Africa 
( Lamp are 11 i et al, 1988) reflected a mean pl ate 1 et count of 283 x 
109 /1 for the South African population. Unfortunately they did not 
mention the sex or the ethnicity of the study sampling, nor the age 
of the patients. This study did, however, reflect the fact that a 
progressive decrease in platelet counts occurred in pregnant women 
with advancing gestation, a parameter which was not mentioned in the 
review of variations in platelet counts by Dacie and Lewis (1984) 
(Table III. 3). 
The large variation in norma 1 values reported in the literature is 
thought, by Dacie and Lewis, to be due to differences in measurement 
and counting techniques. They have estimated that the co-efficient 
of variation (CV) using a visual method of counting is of the order 
of 10%, whereas electronic counting may lower the CV to 3-4%. 
Because of this large variation in normal values, and because no data 
is available for cord blood values in the different ethnic groups 
examined in this study, it was decided to structure the analysis of 
the CBPlC data around comparative statistical methods, (as we did for 
CBTEC' s) rather than use an arbitrary reference figure for 
thrombocytopaenia or thrombocytosis, as we did for the CBslgE 
evaluations. 
Magnussen and de Weck ( 1985) used a similar statistica 1 method to 
describe their data. Their definition of thrombocytopaenia was not 
referable to any absolute standard figure, but was instead that 
statistical mean value obtained from a subgroup of newborns who 
developed atopy by 18 months of age which was statistically 
significantly lower than the corresponding value from the sub-group 
of newborns who remained healthy. 
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This study has used the same principle to define relative differences 
between subgroups, and did not attempt to define normality for the 
CBPlC for the newborns. 
4.2 PHYSIOLOGICAL VA~IATIONS IN CORD BLOOD PLATELET COUNTS 
The documented physiological variations in platelet counts have been 
summarized in Table III. 3. As was the case for the CBTEC's it is 
not known whether these variations apply also for CBPlC's. 
What is known, is that age affects the platelet count, and that at 
birth and during infancy, the counts are at the lower levels of the 
adult normal range. Since our newborns were all full-term babies (a 
gestational age of 38 weeks or older), we are confident that we did 
not have to adjust the data further for age. 
The diurnal variations described for platelet counts have been 
thought to occur on a day to day basis, rather than during the course 
of a single day. Our specimens, as described in Section IV. Ch. 
2.2. 1, were in any event taken during the 6-hour period between 09HOO 
and 15HOO. 
The effect of menstruation on platelet counts was obviously not an 
issue in this study, and the influence of the newborn's sex was 
considered as part of the protocol for this study. 
4.3 THE INFLUENCE OF ETHNICITY 
The interpretation and relevance of the ethnic differences shown for 
CBPlC's (Table V. 8) are difficult to assess. It will be seen below 
that neither an aFH nor Maternal Ascariasis had any significant 
statistical effect on the CBPLC's in any of the ethnic groups (Table 
V. 12). It is difficult to rationalise, therefore, the effect which 
the non-consideration of these variables had in obscuring the effect 
of ethnicity on the CBPLC. 
It is tempting to speculate that other unknown factors which may be 
associated with those newborns with an aFH may be responsible 
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for the apparent ethnic differences observed when these categorizing 
variables are included in the sampling of newt>orns compared. Until 
any additional influencing factors are identified, it is important to 
appreciate that ethnic differences for CBPLC's, as described in this 
study, do exist. Whether these are due to ethno-geneti c or 
environmental influences is still unclear. 
4.4 THE INFLUENCE OF AN ATOPIC FAMILY HISTORY 
As mentioned in Section VII. Ch. 4.3, an aFH per se did not have any 
significant effect on the CBPlC's in any ethnic group (Table V.12). 
This finding contradicts the findings put> 1 i shed by Magnussen and de 
Weck (1985), and suggests that CBPlC's are probably not of value in 
the i dentifi cation of the 11 hi gh-all ergi c-ri sk II newborn. 
Unequivocal evidence to this effect will be generated by Phase II of 
the study, where a lack of differentiation in CBPlC's between those 
newborns who developed atopi c symptoms during infancy and those who 
remained healthy confirm its redundancy as a cord t>lood atopic marker. 
4.5 THE INFLUENCE OF MATERNAL ASCARIASIS 
Maternal Ascariasis did not directly affect the CBPlC's in any of tne 
ethnic groups. It snould be empnasised that only 1 White mother had 
a positive RAST for Ascaris, making comparative statistical analysis 
for this ethnic group impossible. 
4.6 THE INFLUENCE OF THE NEWBORN'S SEX 
The newborn's sex did not influence the CBPLC's significantly in any 
of the ethnic groups. It seems, therefore, that the sex 
differentiation documented by Dacie and Lewis (1984), where females 
had platelet counts 20% higher than males, is operative only later in 
1 if e, and not in newborns. It is interesting to note, however, that 
the female newborns in each ethnic group did have marginally higher 
median CBPlC values than the male newborns. This difference was not, 
however, statistically significant. 
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4.7 THE INFLUENCE OF MATERNAL CIGARETTE SMOKING 
Maternal cigarette smoking did not influence the CBPlC in any of the 
ethnic groups. Tne 1 iterature does not suggest that this variable 
has been ever assessed in relation to CBPlC's. In view of the recent 
discovery of the role of platelets in the allergic response, (Section 
III. Ch. 3.2) and the reported effect of cigarette smoking on CBsigE 
values in some series (Section III. Ch. 1.8.6), the relationship 
oetween materna 1 cigarette smoking and CB Pl CI s needed to be 
established. 
4.8 GENERAL COMMENT 
Phase I of this study suggests that CBPlC's are of no value as a cord 
blood atopic marker to predict the 11 high-allergic-risk 11 newborn. 
Phase II of this study will confirm this impression. 
Furthermore, none of the four variables investigated in Phase I of 
this study (ethnicity had an effect before exclusion of the positive 
aFH and pas i ti ve ma tern a 1 Ascari as is RAST sub-group) had any 
definitive effect on the CBPlC's. The contribution of tnis section 
of the study is, therefore, predominantly to challenge the data of 
Magnussen and de WecK (1985) in terms of their suggestion that 
CBPlC's may differentiate between those newborns with and those 
without an aFH. 
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CHAPTER 5 CORD BLOOD ANTI COW'S MILK SERUM IgG CONCENTRATIONS 
5. 1 NORMAL REFERENCE VALUES FOR CORD BLOOD ANTI-COWS MILK IgG 
CONCENTRATIONS 
No normal reference values for CBacmigG have yet been published. 
There are various reasons for this. 
Firstly, the estimation of the specific IgG antibody concentration as 
a potential predictive marker for atopy is of contemporary interest. 
Epidemiological studies to define and establish the range of 
normality for either maternal or CBacmigG have not yet been done. In 
particular, long-term predictive follow-up studies are necessary 
before retrospective analyses of which cord blood concentrations at 
birth constitute "normality•• for the development of atopic 
symptomatology is possible for this marker. 
Secondly, in the previously published studies concerned with specific 
IgG antibody concentrations, the investigators have used different 
laboratory techniques for the assay methodology as well as different 
descriptive methods for reporting on the data. Dannaeus et al (1978) 
used an IgG antibody assay method based on the binding of IgG to 
Staphylococcus protein A-coated Sepharose, using 125I-labelled 
allergen. They expressed their results as a percentage of a 
reference value, which was the geometric mean+/- 1 SD. Jarrett and 
Hall (1983), by comparison, estimated serum IgG concentrations in 
their test serum fractions by using a single radial illl11unodiffusion 
method, and used normal rat serum with a known immunoglobulin G 
concentration as the standard. 
Finally, since the cord blood concentration of specific IgG antibody 
is dependant on the ilTITiune reactivity of the mother, varying maternal 
ilTITiunological and dietary influences will result in a wide 
quantitative range for normal reference values. 
This study will, as did the study of Dannaeus et al (1978), interpret 
the results of the CBacmigG values as a relative comparison between 
the different categorizing variables. 
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5.2 THE INVERSE RELATIONSHIP BETWEEN COIW BLOOD ANTI-COW'S MILK IgG AND 
CORO BLOOD SERUM IgE CONCENTRATIONS 
A review of the modulating role of maternal immunity on the newborn 
and infant was presented in Section III. Ch. 4.2. In particular, tne 
animal studies of Jarrett and Hall (1979) suggested that an inverse 
relationship existed between maternal sigG antibodies and cord blood 
sigE antibodies. By corollary, since antibodies of the IgG class 
cross the materno foetal placental Darrier by virtue of their low 
molecular weight (Spiegelberg, 1974), the cord blood IgG 
concentration should closely mirror the maternal IgG concentration. 
This was demonstrated in our study, by the fact that the carrel ati on 
co-efficients of maternal versus cord blood anti-cows milk serum IgG 
concentrations were very high for each ethnic group (Table V.16). 
The extrapolation of these dynamics to the rel ati onshi p between cord 
blood serum IgG and IgE should therefore suggest that an inverse 
relationship in the quantitative concentrations of these two markers 
should also exist, irrespective of the clinical relevance of sucn a 
relationship. 
The data arising from this study did, in fact, demonstrate this 
relationship for the Black newborns. It was shown in Table V.2 that 
the median CBsigE values in the Black newborns were significantly 
nigher than those of the Wnite and Mixed newborns, wnile the median 
CBacmigG values in the Black newborns were significantly lower than 
those of either the White or the Mixed newborns (Table V. 5) Whether 
this indicates that tne Black newborns would develop relatively more 
atopic disease in infancy will be ascertained in Phase II. These 
ethnic differences and their implications will oe addressed more 
fully below. 
5.3 THE INFLUENCE OF ETHNICITY 
Ethnic differences in CBacmlgG values between all of the total 
uncategorized groups of newborns were demonstrated in this study 
(Table V.9). 
The fact that these differences persisted when those newborns who had 
evidence of maternal Ascariasis were excluded from the study, 
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indicates that the varying incidence of maternal Ascariasis in the 
different ethnic groups was not responsible for these ethnic 
differences. 
Alternatively, the fact that these differences disappeared when the 
newborns were split into subgroups depending on the presence or 
absence of an aFH strongly suggests that an aFH impacts 
differentially on the CBacmigG values in the different ethnic group. 
The ethnic differences were sti 11 absent when only those newborns 
with neither an aFH nor evidence of maternal Ascariasis were compared 
between the ethnic groups. This suggests that, as for CBsigE, the 
effect of atopy obscures the effect of ethnicity on CBacmigG. 
Alternatively, the ethnic differences in CBacmigG concentrations in 
the total group of newborns could reflect the unique maternal dietary 
customs in the different ethnic groups. Since dietary factors are " 
associated with atopic sensitisation (Section II. Ch. 2.3), it could 
possibly be the influence of these associated dietary factors which I 
are responsible for the abrogation of the ethnic differences when the l 
sampling is categorised on an aFH. 
5.4 THE EFFECT OF AN ATOPIC FAMILY HISTORY 
Only the White newborn CBacmigG values were influenced by an aFH. 
This indicates that this marker could have atopic relevance in terms 
of its predictive capacity, and this wi 11 be further addressed in "" 
Phase II. 
The fact that the Black newborn CBacmI gG values were not influenced 
by an aFH (as was the case for the Black CBsigE values) indicates 
once again that the expression of certain immunological markers in 
this ethnic group are not readily reflective of an atopic genetic 
inheritance, but are rather more sensitive to environmental stimuli 
(see Ch. 5.5). 
5.5 THE EFFECT OF MATERNAL ASCARIASIS 
The subgroups of newborns with maternal Ascariasis had significantly 
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higher CBacmigG values than those without maternal helminth 
infestation. Since none of the newborns had a positive Ascaris RAST 
(even though this immunoassay was highly sensitive) suggests that 
transplacental passage of the Ascaris antigen was not operative. 
Statistically, maternal Ascariasis affected the CBacmigG values in 
both the Black and the Mixed newborns. Ascariasis per se has been 
shown by Godfrey (1975) and Turner (1980) to protect against the 
deve 1 opment of atopy by the saturation of mast ce 11 IgE receptors 
with specific Ascaris IgE antibodies. 
The raised CBacmigG values in the newborns with maternal Ascariasis, 
together with the evidence that raised CBacmigG values are associated 
with the abrogation of the allergic response (Dannaeus et a 1, 1978) 
could be one of the immunological effector mechanisms responsible for 
the observation that Ascariasis seems to protect against atopic 
sensitisation. This immunological rationale needs to be investigated 
more closely. It could, however, be one of the mechanisms at play 
which relates the low incidence of atopic disease in the rural Black 
ethnic groups to the high prevalence of Ascaris infestation in Third 
World, developing countries. 
5.6 THE EFFECT. OF THE NEWBORN 1 S SEX 
From an epidemiological point of view, it is interesting to note that 
the sex of the newborn did not influence the CBacmigE values in any 
ethnic group. It is relevant, however, to appreciate that the 
influence of an aFH, maternal Ascariasis and perhaps other 
ethno-genetic factors on this marker could obscure any minor sex 
differentiation at birth. A larger study would be needed to make 
such a distinction. 
5.7 THE EFFECT OF MATERNAL CIGARETTE SMOKING 
While this variable did not have any influence on the CBacmigG values 
in any ethnic group, the same principle applies to the possible 
effect of this marker as was made above, namely that the effect of 
the other variables could possibly have obscured the effect of 
maternal smoking on this cord blood marker. 
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5.8 GENERAL COMMENT 
It seems evident that CBacmigG values are influenced by both 
environmental and ethno-genetic factors which could impact on the 
development of the atopic phenotype. It is the only cord blood 
marker other than CBsigE values which is influenced by an aFH in the 
White ethnic group, and by maternal Ascaris infestation in each of 
the ethnic groups. This finding may further clarify the role of the 
Ascaris helminth in the development of atopic sensitisation in Black 
populations in developing Third World countries (Phase II). 
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SECTION VI I I 
DISCUSSION - PHASE 2 
CHAPTER I GENERAL CONSIDERATIONS 
1 .1 INTRODUCTION 
The objectives of Phase II of this study were twofold. 
Firstly, the newborns were closely monitored, both clinically and 
immunologically, for tne development of atopic symptoms and sensitisation 
during the first year of their lives. At the end of the study period, 
they were classified on their Cumulative Adjusted Atopic Status (CAS) 
(Section VI. Ch. 1.3) as being either 11 atopic 11 or 11 not atopic 11 • 
Secondly, tne median values of the cord olood atopic markers for the 
11 atopic11 and the 11 not atopic11 group were then statistically compared for 
each ethnic group in order to determine whether the infants who developed 
atopy had cord blood marker values which differed from the cord blood 
marker values of the infants who remained healthy. This would give an 
indication as to a possible predictive relevance of each marker for the 
ethnic group. 
Tne rationale for approaching the analysis of the Pnase II data in terms 
of identifying a possible statistically significant difference in the 
cord blood markers between the 11 atopic 11 and the "not atopic 11 groups 
(rather than using a specific 11 cut-off-point11 for each marker) is based 
on the fact that no "normal values" for any of the cord olood markers 
exist for the South African ethnic groups studied (Section VII.). 
Kjellman et al (1976) made the point that, for the establishment of 
norma 1 va 1 ues of I gE at different ages, a number of criteria for the 
selection of a healthy, non-atopic study population was mandatory. The 
same criteria would also apply for the establishment of normal values for 
the other cord blood markers assessed during this study. Tne newborns in 
this study were unselected as far as an aFH was concerned ( Section IV. 
Ch. 2.2.3). This study was, furthermore, not designed to establish 
normal values, but was designed rather to establish the need for such 
reference values. 
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For this reason the demonstration of statistical differences in the 
cord blood markers between the 11 atopic 11 and the 11 not atopic11 group 
was considered to be the best method to establish whether the 
specific cord blood markers could possibly prospectively 
differentiate between the two groups of infants at birth. 
1 .2 MOTIVATION FOR THE 1 YEAR FOLLOW-UP PERIOD 
Previous studies examining the predictive relevance of various atopic 
markers in newborns, infants and cni 1 dren have varied significantly 
in design as far as the duration of the follow-up period is concerned. 
Halpern et al (1973) and Kjellman and Croner (1984) followed up 
newborns for 7 years, in order to assess the development of atopic 
disease in these children. Kjellman's study is still ongoing, and is 
the longest follow-up study in this field reported in the literature. 
Orgel et al (1975), Michel et al (1980b) and Croner et al (1982) 
followed their newborns up for much shorter periods of time, ranging 
from a 9 month follow-up period to 2 years. 
In order to decide on a practical time frame for the duration of our 
study, it was important that enough time was allowed during the 
fol low-up period to observe the development of atopic 
symptomatology. In tnis regard, the natural history of atopic 
disease is of importance. Halpern et al (1973) studied the 
development of cnildhood allergy over 7 years, and found that, of the 
study group who developed atopic symptoms over this time, 64% had 
developed their symptoms by 1 year of age. Furthermore, 93% of those 
who would develop gastro-intestinal allergy and 80% of those who 
would develop atopic dermatitis witnin the 7 year follow-up period, 
nad already developed their symptoms by one year of age. Van Asperen 
et al (1984), wno prospectively followed up a group of infants with 
an aFH from birth up to 20 months of age, similarly found tnat the 
majority of infants who developed either food allergy or atopic 
dermatitis during this period, did so in the first 12 months of age. 
Of those infants wno developed allergic rhinitis, most had developed 
these symptoms by 12 months of age. Furtnermore, tne prevalence of 
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atopic dermatitis and allergic rhinitis increased significantly 
during the first year of life but decreased markedly thereafter. The 
only potentially atopic symptom to increase its prevalence after 8 
months of age was wheezing. 
Arising from the consideration of the preceding arguments, it was 
decided that a follow-up period of 1 year after birth would give us a 
reasonable opportunity to make a balanced assessment of those infants 
who were predisposed to the development of atopic symptomatology. A 
longer follow-up period would certainly have provided a few more 
cases of atopy which would develop after the first year of 1 ife, 
particularly as regards the development of asthma. The advantages 
accrueable in extending the follow-up period were, however, 
considered to be outweighed by the fact that such an extension would 
inevitably result in a far greater drop-out rate than would have 
been acceptable. Some of the difficulties encountered in ensuring 
adequate compliance from the mothers on the study have been addressed 
in Section IV. Ch. 2.3.4. Of note, also, is the fact that, in 
contrast to some of the preceding studies in which most of the 
follow-up information was provided by means of a questionnaire and 
not a visit, (Croner et al, 1982; Kjellman and Croner, 1984), our 
mothers and infants were physically required to come into the 
hospital on 3 occasions during the year, with essentially healthy 
infants. This required a commitment on their part which was not easy 
to justify for a period beyond 12 months, particularly since the 
external jugular venepuncture (Section IV. Ch. 2.3.7) was an 
unp 1 easant occurrence which the mother had to come to terms with on 
every visit. 
1.3 CRITERIA FOR THE CLINICAL CATEGORISATION OF THE INFANTS AT EACH 
FOLLOW-UP VISIT 
In order to determine the cc applicable to each infant at the 
follow-up visits, (Section VI. Ch. 1.2.1) the author (M.H.) 




(i) The infant's medical history record card (Seeton IV. Ch. 2.3.4). 
(ii) The mother's history of the infant's health and medical status. 
(iii) The findings on the physical examination of the infant by the 
author (M.H.). 
Note: 
If the infant's own physician made a firm diagnosis of asthma, eczema 
or any other of our defined atopic manifestations according to his 
own criteria, and entered this onto the infant's medical· history 
record card, the author (M.H.) accepted this diagnosis as 
contributing to a cc of 11 definitely atopic 11 unless the findings of 
the author (M.H.) during the history and examination of the infant at 
the follow-up visit caused the author to change his opinion of the 
physicians• findings, in which case the author's decision overrode 
the diagnosis of the private physician. If, however, the physician 
or a primary care nursing sister at the clinic entered data onto the 
infant's medical history record card which was equivocal as far as 
the author's (M.H.) criteria for the classification of the atopic 
manifestations was concerned, a cc of 11 possibly atopic 11 was made. As 
in the previous example, any information which accrued to the author 
(M.H.) during the history and examination of the infant at the 
follow-up visits overrode any such diagnosis of 11 possibly atopic 11 • 
The specific clinical criteria for the cc of the infants at each 
follow-up visit into the three groups 
a) Definitely atopic 
b) Possibly atopic 
c) Not atopic 
are given below. 
Definite atopic signs or symptoms: (definitely atopic) 
(i) Definite asthma 
Two or more attacks of wheezing (Van Asperen et al, 1984; 
1 • 3. 2 
228 
Murray, personal communication), with at least one attack 
documented by the author (M.H.) and the other attacks 
documented by the infant's personal doctor or clinic sister 
(from infant's medical history record card). 
(ii) Definite atopic dermatitis (eczema) 
The criteria of Van Asperen et al (1984) were used, namely 
11 clinical evidence of typical atopic dermatitis, i.e., areas 
of scaly, erythematous, pruritic dermatitis, primarily 
involving the flexural folds, face, cheeks or behind the 
ears 11 • The pruritic element makes "scratching" a valid 
additional criterion, as babies with eczema are said to 
scratch from the age of three months. (Murray, personal 
convnunication). 
iii) Definite allergic gastro-intestinal food reactions 
A combination of the criteria used by Bahna and Heiner (1980) 
Kjellman (1983) Kjellman and Croner (1984) and Van Asperen et 
al (1984) were used, namely; vomiting, diarrhoea or colic 
after the ingestion of a specific food at least twice and 
occurring within the first four hours after the ingestion of 
the food. 
(iv) Definite allergic urticaria 
Clinical urticaria, with or 
diagnosed if it was confirmed 
challenges from the same food or 
without angi a-oedema, was 
by at least two repeated 
other human allergen, and if 
it was not due to drugs, insects, serum sickness or unknown 
causes. (Halpern et al, 1973; Kjellman and Croner, 1984). 
Possible atopic signs or symptoms: (possibly atopic) 
Infants were classified into tne "possibly atopic" group in the 
following instances: 
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(i) If the criteria given above for definite asthma, atopic 
dermatitis, allergic gastro-intestinal food reactions and 
allergic urticaria were not personally determined by the 
author (M.H.), but were rather based only on the infant's 
private physician's diagnosis or the diagnosis of the primary 
health clinic sister as documented on the infant's medical 
record card. 
(ii) If any of the following additional clinical criteria applied: 
a) Clinical evidence of seborrhoeic dermatitis 
The possible relationship of this clinical manifestation 
to the atopic state was suggested by Kjellman (1983), who 
reported on data where 53.6% of children who developed 
atopic dermatitis during a prospective study involving 
144 infants had a provisional diagnosis of seborrhoeic 
dermatitis made during infancy. 
b) Clinical evidence of possible allergic rhinitis 
The combined criteria of Murray et al ( 1969) and Van 
Asperen et al (1984) were used, namely, 11 nose-rubbing, 
fits of sneezing, snorting or sniffing, nasal discharge 
and/or blockage occurring continuously for at least four 
weeks and excluding obvious infective rhinitis 11 • The 
reason for classifying this symptom complex under the 
11 possibly atopic 11 and not the 11 definitely atopic 11 
category is two-fold. Firstly, many of the criteria 
mentioned above are subjective and open to bias in the 
maternal perception of her infant's health. Secondly, 
Van Asperen et al (1984) concluded that, based on the 
findings of their prospective study designed to define 
the role of atopy and IgE related mechanisms for many 
commonly occurring, so-cal led 11 a l lergic 11 symptoms in 
infancy, rhinitis was not shown to be definitively 
related to atopy. 
1 • 3 .3 
2JO 
c) A miserable and irritable infant who does not sleep well at 
night (Crook et al, 1961; Weinberg, personal co11D11unication). 
d) Recurrent otitis media (two or more attacks) Kjellman (1976a). 
e) Moderate to severe colic, continuously for more than one 
month, unrelated to the ingestion of any particular food 
(Bahna and Heiner, 1980). 
No a topic signs or symptoms: ( Not a topic) 
The infants were classified into this category at each follow-up 
visit if none of the criteria listed under Ch. 1.3.1 (definitely 
atopic) or Ch. 1.3.2 (possibly atopic) applied. 
1.4 INVESTIGATION OF A POSSIBLE NON-RESPONDER BIAS 
During the course of the l year follow-up period, some of the infants 
failed to attend at 3, 7 or 12 months, for one or other reason. 
These infants were regarded as drop-outs or non-responders, and were 
excluded from the data pool for that particular visit. 
In order to assess whether these non-responders introduced an element 
of bias to the results obtained for the various markers at each 
follow-up visit, we assessed the statistical effect of their drop-out 
at each visit with reference back to their cord blood birth data, 
since this was the reference point which was used to analyse the data 
for Phase II. If significant statistical differences were found in 
the cord blood marker values between the responder and the 
non-responder groups at the various follow-up visits, then the 
non-responder factor would be seen to have introduced an element of 
bias into the analysis of the Phase II data. The fact that no such 
differences were found in the cord blood marker concentrations 
between the responder and the non-responder groups at each follow-up 
visit in this study (Table VIII. l) indicates that the non-responders 
dropped out at random, and were not responsible for the introduction 
of any statistical bias to the analysis of the Phase II data. 
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1 .5 THE INFLUENCE OF SENSITISING VARIABLES DURING THE FOLLOW-UP PERIOD ON 
THE CUMULATIVE ADJUSTED ATOPIC SCORE OF THE INFANTS 
Phase II of this study was designed so that a confident diagnosis of 
either 11 atopic 11 or 11 not atopic 11 could be made for each infant 
completing the study (CAS). It was therefore important to ensure 
tnat, as far as possible, any variables having a sensitising effect 
on tne infants during the follow-up period should impact equally and 
uniformly on all of the infants. To a large extent, this was not 
within the scope of this study. 
In Section II. Ch. 1 the intrinsic and extrinsic factors which play a 
role in the sensitisation of infants were reviewed. The development 
of atopic sensitisation during infancy is clearly dependant on the 
extent, duration and timing of an infant's exposure to the extrinsic 
factors. 
Since this study was not designed to assess the effect of these 
factors on the development of atopic sensitisation in infancy and 
oecause the limited size of our study groups precluded 
suo-categorization dependant on the relevance of each of these 
factors, we did not adjust our data specifically for the impact of 
all of these factors in each infant. It was, for example, 
practically impossible to standardise these culturally, 
socio-economically and ethnically diverse families in terms of their 
feeding methods during infancy. We have shown, moreover, that much 
of the evidence available on the beneficial effect of oreast-feeding 
as far as its protective effect against tne development of atopic 
disease is concerned is contradictory and conflicting ( Sec ti on I I. 
Ch. 1.3). It was also outside the scope of this study to quantify 
objectively the dose-related effect of passive smoking by measuring 
the infant's urinary cotinine (Section II. Ch. 1.6). 
We specifically resisted the temptation to manipulate the infants 
environment by suggesting or prescribing 
the mothers during the follow-up visits. 
introduced bias into tne follow-up study 
any preventive measure to 
This would inevitably have 
by influencing the CAS at 
the end of the study period for some of the infants, depending on how 
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ade at the 5% significance level. 
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Our role during the follow-up visits was, therefore, confined to 
observing and investigating the infants as dictated by the protocol. 
If any specific problem areas were identified during these visits, 
the infants were referred back to their own physician or the 
appropriate referral centres for independent treatment and advice. 
Notwithstanding these comments, we did design the protocol in such a 
way so as to standardize for a few of the extrinsic sensitising 
factors impacting on the infants. 
In particular, this was of relevance in two areas. 
(i) The standardisation of the season of birth. 
The study was designed so that the newborns on the study were 
all delivered in the South African autumn months of March, April 
and May. This precluded any possible influence which the high 
pollen counts prevalent in the spring months could have exerted 
in selectively influencing the development of atopic 
sensitisation in newborns if some were to have been born in the 
autumn and some in the spring months (Section II. Ch. 2.7). 
(ii) The standardisation of the three-in-one DPT inoculations. 
Good evidence exists that the administration of the DPT 
illlTiunisation in infancy could enhance the development of atopic 
sensitisation by acting as an adjuvant for the production of IgE 
and by stimulating the development of specific IgE antibodies to 
the Bordetella pertussis antigen (Haus et al, 1988a). For this 
reason, it was considered essential that all of the infants 
uniformly received all of the three immunisations, at more or 
less the same time. The mothers were therefore instructed to 
ensure that their infants have the first DPT illlTiunisation after 
the 3 month follow-up visit, and that all three i111Tiunisations 
were to be completed before the 7 month follow-up visit (Section 
IV. Ch. 2.3.4). In this way, the potential of the Pertussis 
vaccine to enhance atopic sensitisation impacted equally on all 
of the infants in this study. 
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1.6 ETHNIC VARIATIONS IN THE DEVELOPMENT OF ATOPY DURING INFANCY 
Ethnic variations in the prevalence of atopic disease have been well 
described in the literature. This concept has been reviewed in 
Section I. Ch. 2.2. Whether these variations are a result of 
socio-cultural and environmental factors (Section I. Ch. 2.1) or 
i ntri ns i c ethno-geneti c and immuno-geneti c factors ( Section I I. Ch. 
2) has not yet been resolved. In all probability, the conclusions of 
Soothill (1976), Marsh et al (1981) and Zeiger et al (1986), who 
suggest that the expression of atopic 
interaction between multigenic, intrinsic 
extrinsic non-genetic factors, is correct. 
disease is a complex 
hereditary factors and 
The conclusion of most of the literature reviewed (Section I. Ch. 
2.2) is that the prevalence of atopic disease in Black populations is 
far less than in other ethnic groups. The results of Phase I of this 
study, which demonstrated a far lower incidence of an aFH in the 
first degree relatives of the Black newborns (9.4%) on this study 
relative to the incidence of an aFH in the White newborns (75%) 
seemed to endorse this perception. 
The results of Phase II of this study cha 11 enge the contention that 
atopic sensitisation is rare in the Black ethnic groups. Table 
VI I I. 2 shows that the percentage of Black infants with a CAS of 
11 atopi c 11 was greater than that of tne White or the Mixed infants 
(64.0%, 47.4'.t and 58.7'.t respectively). Furthermore, 52.0% of the 
Black infants who were assessed at the end of the study peri ad had 
developed specific IgE antibodies to at least one of tne allergens 
tested for (cow's milk, egg white or Dermatophygoides pteronyssinus) 
at some stage during the first 12 months of their lives, in contrast 
to only 18.4'.t of the White and 37.0'.t of the Mixed infants. 
The incidence of the development of atopy in the White and Mixed 
infants, whi 1 e 1 ower than that found in the Black infants, is sti 11 
high. This is not unexpected, however, when seen in the light of the 
relatively high incidence of a positive aFH in these White and Mixed 
infants ( Section V. Ch. 4. 1 ) , i ndi cati ng a high genetic 1 oad for 










































































What is unexpected, is the finding that the extremely high percentage 
of Black infants who developed atopy is, paradoxically, at variance 
with their very 1 ow incidence of a pas i ti ve aFH. The genetic load 
for the development of atopy in this ethnic group should have been 
low, and contradicts the predictive nature of an aFH on the 
development of atopic sensitisation as reviewed in Section II. Ch. 
1.1. In the White infants, all who developed atopy also had an aFH 
(Fig VI. 2) whereas a 1 arge number of the Black inf ants without an 
aFH developed atopy (Fig VI.1). 
Of interest also was the finding that the Black infants with a CAS of 
11 atopic 11 had a lower median CBsigE concentration than their healthy 
counterparts with a CAS of 11 not-atopic 11 (Table VI. 13). This 
contrasts with the data for the White and the Mixed infants, where 
the median CBsigE concentrations in the groups with a CAS of "atopic" 
were significantly higher than in the groups with a CAS of 11 not 
atopic". 
The factors at play in the development of atopy in the Black South 
African infants seem, therefore, to be complex, and do not follow the 
generally accepted patterns relating to the rel ati onshi p between an 
aFH, raised CBsigE concentrations and subsequent atopic disease 
(Section II. Ch. 2.1). 
1. 7 THE RATIONALE FOR THE HIGH INCIDENCE OF ATOP IC SENSITISATION IN THE 
BLACK INFANTS 
Van Niekerk (1979) has shown that rural Black South African children 
have a far lesser incidence of asthma than their urban counterparts. 
It was pointed out in Section VII Ch. 1.4 that the Black newborns on 
our study had a rural heritage, even though the study was executed in 
an urban environment. 
The fact that such a 1 arge number of the Black infants on our study 
developed atopy during infancy, often with objective immunological 
evidence of atopic sensitisation, (Table VIII. 2), indicates that 
environmental, extrinsic factors which are prevalent in the urban 
milieu are potent catalysts for atopic sensitisation in this ethnic 
group. The Slack newborns on this study, almost invariably, were the 
first generation to be born in an urban environment. 
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Their parents had spent most of their lives in the rural environment 
of the Eastern Cape (Section IV. Ch. 1.2.1). This fact was mirrored 
by the extremely low incidence of an aFH in the first degree 
relatives of the newborns (9%), concording with Van Niekerk 1 s 
conclusions regarding tne relatively low incidence of atopic disease 
in rural conmunities. 
It seems, from this epidemiologic evidence, that modulating factors 
associated witn urbanisation may constitute potent stimuli for atopic 
sensitisation in Black infants, and that these stimuli often result 
in objective evidence of sensitisation almost inmediately after 
exposure to urban environments. The reasons for this pnenomenon is 
still, at present, speculative. Animal studies done by 
Rousseaux-Prevost et al (1977) and Pauwels et al (1979) have, 
nowever, provided a model which could be paralleled in man. Inbred 
strains of rats with high basal IgE concentrations ( the high IgE 
responder phenotypes) developed powerful serum IgE responses 
subsequent to antigen exposure, in contrast to inbred strains of rats 
with low basal IgE concentrations (low IgE responder phenotypes) who 
subsequently developed very weak reaginic responses after antigen 
exposure. 
Phase I of this study showed tnat some of tne Black newborn cohort 
had extremely. high CBsigE values at birth ( greater than 6.00 kU/1). 
Furthermore, the median CBsigE values in the Black cohort were 
significantly higher than that found in the White and Mixed cohorts, 
in the sup-groups without an aFH. This IgE was non-specific and 
polyclonal to the best of our knowledge (the specific IgE antibodies 
tested for on the cord blood were all negative on the supersensitive 
RAST), and confirmed the impression held by Croner et al (1982) on 
the non-specific nature of CBsigE. It is reasonable to assume that 
our Black newborn cohort could therefore represent the human 
counterpart of the inbred rat high IgE responder phenotypes (Haus et 
a 1, 1988). If this as sump ti on is correct, the subsequent apparent 
clinical hyper-responsiveness of our Black infants to the urban 
environment, where both the allergen profile as well as the cultural 
feeding habits and practices are so fundamentally different to that 
found in the rural areas, is not difficult to appreciate. 
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One confounding aspect of this situation remains. The Black infants 
who developed atopy were, statistically, not necessarily those with 
the highest CBslgE values at birth. This observation was discussed 
above, in Ch. 1 • 6, and wi 11 be addressed again in the fo 11 owing 
Chapter (Ch. 2.1). 
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CHAPTER 2 THE PREDICTIVE RELEVANCE OF THE CORD BLOOD ATOPIC MARKERS 
IN EACH ETHNIC GROUP 
Table VI. 13 sunvnarises the statistical comparative analysis of the 
four cord blood atopic markers in relation to the infants who became 
11 atopi c11 during infancy and those who remained 11 not atopic 11 in each 
ethnic group. 
2.1 CORD BLOOD SERUM IgE CONCENTRATIONS 
This marker discriminated significantly at birth for the White and 
the Mixed newborns between tne II a topi c11 and the 11 not atopi c11 infants 
(p less than 0.05 in both ethnic groups). The median CBsigE values 
of tne infants who developed atopy were moreover significantly nigher 
than the CBsigE values of those who remained healthy. This finding 
is in line with the previously published data in this field as 
regards the predictive value of CBsigE concentrations in 
predominantly First World, Western populations (Section III. Ch. 
1.7). Figure VI. 2 shows that, of the White infants who completed 
the study, all but one with CBslgE values greater than 0.50 kU/1 
developed atopic disease (87.5'.t). Figure VI. 3 shows that, of the 
Mixed infants who completed the study, seven of eleven with CBslgE 
values greater than 0.50 kU/1 developed atopic disease (63.6'.t). 
In tne Black newoorns, this situation was reversed. The median 
CBslgE values of the 11 atopic 11 infants were not statistically 
significantly different from the median CBslgE values of those who 
remained 11 not atopic 11 (p = 0.57). Furtnermore, the median CBslgE 
values of the 11 atopic 11 infants were lower than the CBslgE values of 
those who remained 11 not atopi c11 • Figure VI. l shows tnat, of tne 
Black infants wno completed tne study, only 50'.t with CBslgE values 
greater than u.50 l<U/1 developed atopy. Most of the infants who 
developed atopy had CBslgE values below 0.2 l<U/1. 
The results for our Black infants did not snow statistically 
significant associations between CBslgE and the subsequent 
development of atopy. This part of the analysis was, however, based 
on only 16 Black infants who developed atopy during the foll ow-up 
period. We were therefore unable to conment as to tne true 
predictive relevance of CBsIGE. Noenetheless, it appears unlikely 
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that CBsigE as a predictor of atopy would be clinically useful among 
South African urban Blacks. These findings confirm the second part 
of the hypothesis on which this thesis is based. 
2.2 CORD BLOOD TOTAL EOSINOPHIL COUNT~ 
The values of this marker did not clearly differ between those 
inf ants who became II a topi c11 and those who remained II not atopi c11 in 
any of the ethnic groups. 
In tne Black infants, the statistical test of comparison was, 
however, equivocal (p = U.05) with the infants who became 11 atopic 11 
having a median CBTEC of 291 cell s/mm3 and the infants who remained 
11 not atopi c11 having a median CBTEC of 196 cell s/mm
3• 
Even tnough Phase I of tnis study did not confirm the work of Dry et 
al (19d0) who showed that CBTEC's were significantly higher in 
newborns with an aFH than in newborns with no such history, it is 
possible that a larger study could indicate that, of the four markers 
studied, the CBTEC's in Black, South African newborns is the most 
useful atopic marker in terms of its predictive capacity for the 
development of future atopic sensitisation. 
2.3 CORD BLOOD PLATELET COUNTS 
Since the values of this marker did not differ at birth between those 
infants who became 11atopic 11 and those who remained "not atopic 11 in 
any of the ethnic groups, its relevance as a predictive cord blood 
atopic marker seems to be limited. The results of this study did not 
support the rnetoric of Magnusson and de week (1985) on the possible 
predictive function of cord blood thrombocytopaenia. 
2.4 CORD BLOOD ANTI-COW'S 1't1ILK SERUM IgG CONCENTRATIONS 
This marker similarly did not differ at birth between those infants 
who became 11 atopic 11 and those who remained "not atopic 11 any of the 
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ethnic groups. In spite of the outcome of Pnase I of tni s study, 
wnere it was snown that an aFH influenced the CBacmigG values in tne 
White newborns, a possible predictive relevance for tnis marker 
regarding the development of atopic disease in infancy was not 
demonstrated for any ethnic group in Phase II. Of interest, however, 
is the proposal by Dannaeus et al (1978) Bousquet and Michel (1984), 
and Kjellman (1985), that relatively high titres of CBacmigG may 
afford the newborns a measure of protection insofar as the 
development of atopic symptomatology is concerned (Section III. Ch. 
4.2 and Ch. 4.3). In all of the infants who completed Phase II of 
this study, irrespective of the ethnic groups to wnich they Delonged, 
those that became 11 atopic 11 had lower values of CBacmigG at birth than 
those who remained "not atopic" (Table VI. 13). This difference was 




CONCLUSION AND SUGGESTIONS FOR FUTURE STUDY 
CHAPTER I CONCLUSION 
This study has tested and confirmed certain aspects of the hypothesis, 
shed light on the remainder, and has satisfied the aims as detailed 
in Section I. Ch. 3. It has provided an insight into possible 
genetic and environmental mechanisms operative in Black, Third World 
popul ati ans, and has shown tnat tnese are profoundly different to 
those mechanisms operative in White, First World populations. 
More specifically, this study has provided new information in the 
following areas: 
1 .1 THE RELEVANCE OF GENETIC AND ENVIRONMENTAL INFLUENCES ON CORD BLOOD 
SERUM IgE CONCENTRATIONS IN SOUTH AFRICAN NEWBORNS AND INFANTS 
(i) This study has shown that, in a randomly selected sampling of 
full-term Soutn African Black, White and Mixed newborns, the 
Black group had the highest CBsigE values. This ethnic 
difference was statistically significant if the newoorns with 
an aFH were excluded from the analysis, indicating an 
ethno-genetic influence on this atopic marker, independent of 
the influence of a high genetic load for atopy. 
(ii) This study set out to challenge previously published 
literature which suggests that an aFH is reflected in newborns 
by raised levels of CBsigE. Because of the small number of 
newborns wi tn an aFH in our Black cohort ( 5 cases) we were 
unable to provide definitive evidence to this effect in the 
Black ethnic group. As expected, however, the aFH did 
influence the CBsigE in our White and Mixed newborns. 
(iii) This study has shown that CBsigE values in the Black newborns 
did not differ at birth between those who became 11 atopic 11 and 
those who remained "not atopic 11 during infancy. 
Paradoxically, those Black inf ants who deve 1 oped a topy during 
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infancy had lower median CBsigE values at birth than tnose who 
remained "not atopic", although this difference was not 
statistically significant. The conclusion to be drawn from 
this is that raised CBslgE values at birth are probably 
clinically not relevant as predictive markers for the 
development of atopic disease in infancy for the Black South 
African population. This contradicts the previously published 
literature which suggests that a raised 
almost invariably associated with 
subsequent atopy in that newborn. 
CBsigE in a newborn is 
the development of 
The White and Mixed 
newborns on our study did, however, reflect the previously 
published literature on this subject, by showing clear 
statistical differentiation in their CBsigE values between 
tnose who became "atopic" in infancy and those who remained 
"not atopic". This indicates tnat CBsigE has been confirmed 
as being of probable value as a predictive atopic marker for 
our Wnite and Mixed South African newborns. 
(iv) This study has refuted the suggestions made in the literature 
tnat Black, underdeveloped populations do not readily develop 
atopy. We nave clearly shown that Black infants precipitously 
and vigorously develop a topic sensitisation if Dorn into an 
urban environment, to a greater degree than White and Mixed 
newborns in the same environment. The high percentage of 
Black infants who developed atopy occured in spite of their 
very low incidence of a positive aFH, indicating that the 
dynamics operative in the transition from a rural to an urban 
environment for our Black populations have profound effects on 
the epidemiology of atopic sensitisation. The implications of 
this situation are not yet clear, particularly since the 
levels of CBslgE in the Black newborns did not seem to be 
related in any way to tne suosequent development of atopi c 
disease in these infants. 
(v) This study contributed to the current knowledge on tne 
epidemiology of CBsigE. More specifically, the effects of 
ethnicity, an aFH, maternal Ascariasis, the newborn's sex and 
maternal cigarette smoking on the CBslgE values in the three 
ethnic groups under consideration, were assessed. Even though 
the size of some of the sub-groups assessed were small, our 
statistical methods of analysis were, in our opinion, reliable 
enough to draw our conclusions. 
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1 .2 THE RELEVANCE OF GENETIC AND ENVIRONMENTAL INFLUENCES ON ALTERNATIVE 
CORD BLOOD MARKERS IN SOUTH AFRICAN NEWBORNS AND INFANTS 
(i) This study has assessed cord blood eosinophils, cord blood 
platelets and cord blood anti-cow's milk IgG for their 
possible relevance as predictive atopic markers for the 
development of atopy in infancy in three South African ethnic 
groups. 
The cord blood total eosinophil count was not influenced oy an 
aFH in any of the ethnic groups, but was possibly of value in 
predicting the "high-allergic-risk" Black newborn who goes on 
to develop atopic disease in infancy. This cord blood marker 
was tne only one to suggest that the "high-allergic-risk" 
Black newborn can possibly be identified at birth. 
The cord blood platelet count was not influenced by an aFH in 
any ethnic group nor did it differ between those infants who 
became 11 atopic 11 and those who remained "not atopic 11 in any 
ethnic group. Its possible relevance as a cord blood 
predictive atopic marker in South African populations was, 
therefore, not supported by this study. 
The cord blood anti-cow's milk IgG concentration was 
influenced by an aFH in White newborns only. It did, however, 
not differ between the infants who became II atopi c11 and those 
who remained "not atopic" in any ethnic group. Its possible 
relevance as a predictive atopic marker in South African 
populations was, therefore, similarly not supported by this 
study. 
(ii) This study has contributed to the current knowledge on the 
epidemiology of cord blood total eosinophil counts, cord blood 
platelet counts and cord blood anti-cow's milk IgG 
concentrations by considering the effects of ethnicity, an 
aFH, maternal Ascariasis, the newborn's sex and maternal 
cigarette smoking on their values. 
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CHAPTER 2 SUGGESTIONS FOR FUTURE STUDY 
As is the case with most studies of this nature, the new questions 
posed by the data presented in the study i nvari ably outnumber the 
questions answered. 
Tnis study was no exception to the rule. Quite clearly, the future 
challenge in this field lies in attempting to understand more fully 
the immunogenetic and environmental mechanisms responsible for the 
rapid development of atopic sensitisation in the urDanised Black 
infants in the Soutn African environment. Only when these are 
understood, will we be able to devise methods whereby the 
11 nigh-a 11 ergi c-ri sk 11 Black newborn can be i den ti fi ed and manipulated 
in terms of the prevention of future atopic disease. 
More specifically, future studies could include investigation into 
the following areas: 
(i) The establishment of normal reference values for CBsigE in all 
of the ethnic groups in this country. This is imperative 
Defore clear guidelines can De given as to any deviations from 
normality. This study has shown tnat international data and 
values are not always applicable to local populations. 
11 Normal value 11 studies in this context imply that large 
numbers of normal, non-atopic newborns need to be assessed. 
(ii) The identification of alternative predictive atopic markers 
for the identification of the 11 high-allergic-risk
11 South 
African Black newborns should be a priority now that the 
predictive relevance of CBsigE values in this ethnic group has 
been disputed. In this regard, the further assessment of the 
cord blood total eosinophil count in this ethnic group seems 
to hold the most promise. 
(iii) The extremely high basal values of CBsigE in some of the Black 
newborns merit further study. The influence of the mother I s 
diet and environment during her pregnancy on the CBslgE values 
could be assessed and compared to that operative in White 
mothers. The question also arises whether the high CBsigE 
values in the Black newborns are truly polyclonal, or whether 
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a significant degree of intrauterine sensitisation has not 
already occured by birth. The opportunity exists for the 
intensive screening of cord blood with a far larger panel of 
RAST antigens, using very sensitive techniques to detect the 
development of any possible specific IgE antibodies. 
Intra-amniotic fluid, obtained by amniocentesis, could also be 
studied to clarify the ontogeny and development of the 
intrauterine IgE response in these Black, high IgE-responder 
phenotypes. 
(iv) The effect of urbanisation in enhancing the development of 
atopic disease in Black infants needs to be clarified. 
Specific environmental, socio-cultural and epidemiological 
influences acting differentially on rural and urban Black 
infants need to be identified and compared. 
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APPENDIX I 
CONSENT FORM 
PATIENT STUDY CODE NO.~~~~ 
MATERNAL CONSENT FORM FOR CHILD AND SELF TO PARTICIPATE IN 
CORD BLOOD AND 1 YEAR FOLLOW-UP IgE STUDY 
1 ' 
of ( address) 
confirm that the details of the study have been explained to me 
satisfactorily and I am willing to give my consent for myself and my 
son/daughter to participate in the above study. 
NAME OF SON/DAUGHTER: 
I also understand that my child and myself inay withdraw from this 
clinical trial at any time if I should wish to do so. 
Signature of Parent 
I confirm that I have explained to the mother the full extent and 
nature of this clinical study. 
Signature of Investigator 
Date 
GENERAL DETAILS 
Patient code number 
Ethnic group 
APPENDIX II 
PHASE 1 QUESTIONNAIRE 
Black = 1 
White = 2 
Mixed = 3 
Surname (Mother) ------------------------------
Christi an name ( 1~other) ------------------- -----------
Christian name (Baby) ------------------------------
Address 
Postal code ------------------------------------------
Telephone number Home ------------------------------
Work ------------------------------
Other------------------------------
Hospital of Delivery 
Peninsula Maternity Home = 1 
Mowbray Maternity Home = 2 
Midwife Obstetric Unit = 3 
(Hanover Park) 
INFORl~A TI ON FROM MOTHER 




Age of mother in years 
Number of years domiciled in Cape Town 
Family status 
Married = 1 
Stable relationship but unmarried = 2 




Smoking habits of mother 
does smoke 
does not smoke 
other members of family smoke 




smoking & frequency: ----------------------------
Drugs taken during pregnancy and labour 
Insulin I. V. Yes = 1 No = 2 Unknown or Unsure 
Progesterone Yes = 1 No = 2 Unknown or Unsure 
Propranolol Yes = 1 No = 2 Unknown or Unsure 
H.C.G. (Pregnyl) Yes = 1 No = 2 Unknown or Unsure 






Medical problems during pregnancy 
Yes = 1 No = 2 Unknown or Unsure = 9 
Specify: -----------------------------------------·-----------
FAMILY HISTORY OF ATOPIC DISEASE 
Relationships 
Mother Yes = 1 No 
Father Yes = 1 No 
Siblings of Infants 
(Brothers & Sisters) 
PHYS I CAL EXAMINATION OF THE INFANT 




Sex of infant 
Male = 
Female = 2 
Birthweight (grams) 




Estimated gestational age of infant (weeks) 
From date of last menstrual period 
From bimanual abdominal palpation 










Selection criteria satisfied (Yes = 1 No = 2) 
unsure) = 9 
unsure) = 9 
No = 2 
unsure = 9 
Newborn 1. Full-term (38 weeks or more by above criteria) 
2. Birthweight (2,500 grams or more) 
Maternal 1. No specified medication in pregnancy 
2. Resident for 1 year or more in Cape Town 
LABORATORY INVESTIGATION OF CORD BLOOD 
Total eosinophil count (cells/m3) 
Platelet count (x 109 L) 
~ (kU/1) 
~ (mg/dl) 
.!..9.§. (anti-bovine milk-specific)t::..O.D. 
( 414rrm) 
RAST (specific IgE antibodies) 
Phadebas RAST Class 
cows milk Neg = 0, = 1 ' 
egg white Neg = 0, 1 = 1 ' 
Ascaris lumbricoides Neg = 0, = 1 ' 
LABORATORY INVESTIGATION OF MATERNAL BLOOD 
Total eosinophil count (cells/m3) 
Platelet count (x 109 L) 
~ (kU/1) 
~ (mg/dl) 
.!..9.§. (anti-bovine milk-specific) L\ .o.o. 
(414mm) 
RAST (specific IgE antibodies) 
Score Code 
2 = 2, 
2 = 2, 
2 = 2, 
Phadebas RAST Class Score Code 
cows milk Neg = 0, 1 = 1 ' 2 = 2, 
egg white Neg = 0, 1 = 1 ' 2 = 2, 



















AP PENO IX II I 
1~0Th'AlIOr.JAL LETTER FR01~ ALITHO~ (M.H.) TO PARENTS FOR 7 ,~ONTH FOLLOW-UP VISIT 
UNIVERSITY OF CAPE TOWN 
' Department of Paediatrics 8c Child Health 
21st October 1985 
Dea.r 
lnstlMe of Child Health 
Red Cross War Memorial Children's Hospital 
Rondebosch. Cope 7700 
Telephone 65-6529 
Telegraphic Address: Hosfll 
Head: Prof. H. de V. Heese, M.D., I.Sc., F.R.C.P., D.C.H. 
We would lii<e to thank you rnost sincerely for being so co-operative 
and enthusiastic regarding compliance with our cord blood lgE - Allergy 
St•.1dy. 
We knm,, it is not pleasant to hear the little infants cry while blood 
is beir.g taken b~t somehow, they soon forget, and the information 
obtained from the results will ensure that any abnormality is picked up 
at the earliest possible stage. 
Since the stu~y is not yet finished, the conclusions drawn from 
the results wi"li cbviously not be to the immediate benefit of this 
i r,f dnt. 
H0wever, we r,.:1ve some i~x.citing preliminary results, but \'iithout your 
continued suppoi·t, our study will not realise its full potential, and 
a golden opportunity will be lost to successfully predict and prevent 
dllergic disease. 
May we therefore ask you, if at all possible, to keep your 7 month 
follow-up appoint~enl - be assured it is much appreciated, and you will 
be contributing i~ a very positive way to ongoing medical research. 
Yours si;1cerely 
DR MATT HAUS 
PROFESSOR H. DE. V. HEESE 
APPENDIX IV 
LETTER OF THANKS FROM AUTHOR (M.H.) TO PARENTS ON COMPLETION OF THE STUDY 
UNIVERSITY OF CAPE TOWN 
' Department of Paediatrics & Child Health 
16 JUNE 1986 
Dear 
Institute of Child Health 
Red Cross War Memorial Children's Hospital 
Rondebosch. Cape 7700 
Telephone 65-6529 
Telegraphic Address: Hosfil 
Head: Prof. H. de V. Heese, M.D., B.Sc., f.R.C.P., D.C.H. 
Once again, I would like to thank you most sincerely for the continued 
support and interest you showed during the year in which I followed up your 
babies on the Allergy Study. 
I want you all to know that the study is a great success, and I trust that 
it will go a long way towards helping the successful prevention of allergic 
disease in the country. 
As promised, here are the final 1 year results for your baby: 
Total IgE 







iu (Normal - up to about 10) 
Thank you once more for all your co-operation. I hope that we will not 
lose contact altogether. If you have any queries, you may phone me at Cape 
Town 65-5011 ext 519. I will still be here for a few months, after which 
Mrs Heuer will give you my forwarding address. 
Keep wel 1 
/c(r, <( 1l<v. s . 
MATT HAUS 
APPENDIX V 
PHASE II QUESTIONNAIRE 
GENERAL DETAILS 
Follow-ue study . 
3 /12 = 3 
7 /12 = 7 
12/12 = 12 
Patient code number 
Ethnic groue Black = l 
White = 2 
Mixed = 3 
Surname (Mother) ------------------------------
Christian name (Mother) ------------------------------
Christian name (Baby) ------------------------------
Address 
Postal code ------------------------------------------




INFORMATION FROM MOTHER 
Medical history of infant 
l. Feeding 
Breast only = l 
~reast and artificial = 2 
Artificial only = 3 
2. Illnesses 
Has child been ill? Yes = No = 2 
If YES, 
Unwell, but no 
health care Yes = l No = 2 
Visit to clinic Yes = l No = 2 
Vis it to doctor Yes = l No = 2 
Admission to hosp ita 1 Yes = No = 2 
Specify 
3. Allergic history 
General 
- Irritable, miserable, wakeful child yes = 
- Failure to thrive 
Dermatological 
- Facial eczema 
no = 2 
unsure= 3 
yes = l 
no = 2 
unsure = 3 
yes = 
no = 2 
unsure= 3 
- Flexural eczema yes = 1 
no = 2 
unsure= 3 
- Seborrhoea/cradle cap yes = 1 
no = 2 
unsure = 3 
- Itchy rash yes = 1 
no = 2 
unsure= 3 
- Dry skin yes = 1 
no = 2 
unsure= 3 
- Napkin dermatitis yes = 1 
no = 2 
unsure = 3 
- Other e.g. 11 suur11 , heat rash 
Specify 
yes = 1 
no = 2 
unsure = 3 
Occular 
- Recurrent, itchy, discharging eyes: 
Ongoing, possibly allergic Yes = 1 No = 2 
Treatable bacterial/viral Yes = 1 No = 2 
Blocked tear duct Yes = 1 No = 2 
ENT 
- stuffy nose, constant cold/watery yes = 1 
nasal discharge no = 2 
unsure = 3 
Otitis media/ear infect ion/ yes = 
discharging ear no = 2 
unsure = 3 
- Tonsillitis yes = 1 
no = 2 
unsure = 3 
Respiratory 
- wheezing/LAO (lower airways yes = 
obstruction) no = 2 
unsure = 3 
- if YES - how many "attacks" one = 1 
two = 2 
three = 3 
more than 3 = 4 
were these "attacks" yes = 1 
associated with an i 11 ness no = 2 
and a temperature. 
were these "attacks" yes = 1 
with hyperventilation/ no = 2 
tachypnoeic or shortness 
of breath 
Gastrointestinal 
- vomiting soon after ingestion of yes = 1 
certain foods no = 2 
unsure = 3 
- if YES how many times has once = 
this occurred? twice = 2 
thrice = 3 
more than thrice = 4 
is it always the same yes = 1 
food? no = 2 
unsure = 3 
Colic and abdominal cramps yes = 
no = 2 
unsure = 3 
PHYSICAL EXA~INATION OF THE INFANT 
Weight of infant (grams) 
Head circumference (cm) 
Length (cm) 
General examination 
Clinically anaemic Yes = 1 No = 2 Unsure = 3 
Clubbing Yes = 1 No = 2 Unsure = 3 
Lymphadenopathy 
Generalized Yes = 1 No = 2 
Local - Cervical Yes = 1 No = 2 
- Axi 11 ary Yes = 1 No = 2 
- Inguinal Yes = 1 No = 2 
General Condition/Nutritional Good = 1 
Status Bad = 2 
Intermediate = 3 
Irritable, miserable child Yes = 1 No = 2 
Skin 
Facial eczema Yes = 1 No = 2 
Flexural eczema Yes = 1 No = 2 
Cradle cap/seborrhoea Yes = 1 No = 2 
Dry skin Yes = 1 No = 2 
Papular urticaria Yes = 1 No = 2 
Nutritional lesions Yes = 1 No = 2 
Occul ar 
Recurrent, Itchy, discharging eyes: 
- Ongoing allergic Yes = 1 No = 2 
- Treatable bacterial/viral Yes = 1 No = 2 
- Blocked tear duct Yes = 1 No = 2 
ENT 
Stuffy nose, watery nasal Yes = 1 No = 2 
discharge 
Swollen nasal mucous memorane Yes = 1 No = 2 
{Turbinates) 
- Ear Drums normal = 1 
dullness/red injected = 2 
discharging = 3 
perforated = 4 
perforated & discharging = 5 
High arched palate Yes = 1 No = 2 
- Posterior pharangeal Yes = 1 No = 2 
lymphoid hyperplasia 




Hepatomegaly Yes = 1 No = 2 
If YES, size in ems 
Splenomegaly Yes = 1 No = 2 
If YES, size in ems 




Chest movements Normal = 1 Abnormal = 2 
Anatomical defects Yes = 1 No = 2 
- Respiratory rate/min 
Use of accessary Yes = 1 No = 2 
respiratory muscles 
Palpation 
Trachea central Yes = 1 No = 2 
Cardiac apex Normal position = 1 Abnormal = 2 
Specify 
Percussion 
Hyperresonant Yes = No = 2 
Liver pushed down Yes = No = 2 
Abnormal dullness Yes = 1 No = 2 
Auscultation 
- Rhonchi Yes = 1 No = 2 
- Crep itat ions Yes = 1 No = 2 
- Transmitted sounds Yes = 1 No = 2 
Wheeze/lower airways Yes = No = 2 
obstruction 
If YES •••• Unilateral = 1 B i1 atera 1 = 2 
Expiratory = 1 Inspiratory= 2 
Cardiovascular System 
Pulse Rate (per minute) 
- Regular Yes = 1 No = 2 
Heart 
Cardiomegaly Yes = 1 No = 2 
Heart sounds Abnormal = 1 Norma 1 = 2 
lvturmurs Yes = 1 No = 2 
Specify 
Clinical atopic classification of infant 
No atopic signs or symptoms = 1 
Possible atopic signs or symptoms = 2 
Definite atopic signs or symptoms = 3 
Immunization progra11111e 
B.C.G. (Bacillus Calmette Guerien Vaccine) 
Yes = 1 No = 2 
Unknown= 9 
If yes, give date: Year 19 
Month 
Day 
D.P.T. (Diptheria, Pertussis and Tetanus) 
no 1. + Polio Yes = 1 No = 2 
Unknwon = 9 
If yes, give date: Year 19 
Month 
Day 
no 2. + Polio Yes = 1 No = 2 
Unknown= 9 
If yes, give date: Year 19 
Month 
Day 
no 3. + Polio Yes = No = 2 
Unknown= 9 
If yes, give date: Year 19 
Month 
Day 
- r~easles Yes = 1 No = 2 
Unknown= 9 
If yes, give date: Year 19 
Month 
Day 
LABORATORY INVESTIGATION OF THE INFANT 
Total eosinophil count (cells/m3 ) 
Platelet count (x 109/L) 
~ (kU/1) 
_!s1§. (anti-bovine milk-specific) .O.D. (414mm) 
RAST (specific IgE antibodies) 
Phadebas RAST Class Score Code 
cows milk 0 = 0 1 = 1 2 = 2 3 = 3 4 = 4 
egg white 0 = 0 1 = 1 2 = 2 3 = 3 4 = 4 
Ascaris lumbricoides 0 = 0 1 = 1 2 = 2 3 = 3 4 = 4 
Dermatophygoides 0 = 0 1 = 2 = 2 .3 = 3 4 = 4 
Pteronyssinus 
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